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Abstract 
Name: Jodielin Antoinette Ofori 
Title: Effect of Short Term Stretching on Ankle Stiffness and Range of Motion in 
People with Multiple Sclerosis  
 
Hypertonia is seen in 85% of people with Multiple Sclerosis (pwMS) resulting in disability 
and functional restrictions.  Hypertonia can be caused by increases in passive stiffness and 
enhanced stretch reflexes (spasticity) and is frequently managed clinically using passive 
stretches. However, the optimal parameters of stretching such as the applied torque and 
stretch duration remain unclear. During commonly prescribed ankle plantarflexor stretches 
pwMS produced higher torques when standing in a weight bearing position compared to 
stretches applied using the upper limbs.  Stretches could be held for 120 seconds on 
average and stretch duration was mainly limited by fatigue. People with higher disability 
tended to favour more supported stretching positions. The effects of stretching for either 30 
or 10 minutes using a customised motor at three torque levels covering the range that MS 
participants could produce was investigated. Compared to the 10 minute stretch, greater 
reductions in passive stiffness and greater increases in range of movement (ROM) were 
seen immediately following the 30 minute stretch with the effects being sustained for the 30 
minute post stretch period. Higher levels of applied torque resulted in a greater change in 
ROM however; there was no effect of applied torque on passive stiffness. Stretch reflex 
mediated stiffness was unaffected by the stretching intervention and showed transient post 
stretch increases. Ultrasonography was used to investigate changes in muscle–tendon 
length and strain in pwMS and controls and following stretching.  PwMS showed evidence 
of stiffer muscles and increased tendon length at baseline compared to controls. Following 
a 10 minute stretch overall muscle length did not increase in pwMS, although increases in 
strain in the musculotendinous junction region were observed suggesting that more 
proximal regions of the muscle was likely to have contributed significantly to overall 
stiffness. This work highlights that stretch duration and levels of applied torque are critical 
factors in determining the effectiveness of stretches. The pathological mechanisms 
underlying hypertonia at a molecular and structural level and the effects of stretching on 
components of the musculo-tendinous structure and on functional ability should be 
ascertained.  
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1. Chapter One: Thesis Introduction and Overview 
This section of the thesis is intended to provide the reader with a brief outline of the 
thesis justification, aims and structure; followed by an overview of the interrelationship 
between the three experimental studies. In addition a timeline of the work presented in 
this thesis is provided see (Figure 1A) as well as a flow chart indicating the overlap of 
subjects across the three experimental studies see (Figure 1B). 
1.1 Thesis Justification, Aims and Structure 
To date there is evidence that a constant torque stretch produces greater 
improvements in passive stiffness, spasticity and ROM compared to constant angle 
and cyclic stretches.  However, it is unclear, during a constant torque stretch, what the 
optimal applied torque or duration of stretch actually is. This thesis therefore aims to 
assess the effects of different torques applied over different durations on passive 
stiffness, spasticity and ROM.  In keeping with past study designs that have compared 
different types of stretches, a repeated measures design will be used where the same 
participants are seen over three different sessions and where in each session a 
different torque is applied for a set duration.   
When applying stretches using a motor no justification has been given in previous work 
as to why a particular torque was chosen. The use of motors to deliver stretches have 
several advantages in that an exact specified torque can be delivered and the motor 
can be used to assess ROM and stiffness pre and post intervention. However, the use 
of motors are expensive and impractical for the majority of clinical stretching regimes 
(e.g. in the home environment). Therefore, it is important that the torques assessed, in 
this and future studies, include the range of torques that can be applied by patients for 
the purpose of self-management programmes.  This will allow an assessment of 
applied torque delivered using motors to be ecologically valid and relevant to clinical 
practice. 
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Finally, it is important to ascertain the exact site of passive stiffness changes following 
a neurological insult and whether stretching specifically targets the sites (e.g. tendon 
vs. muscle) of increased stiffness. This can be done by imaging muscle motion using 
ultrasound during standard ankle perturbations. 
This thesis therefore aims to: 
a) Define the torques that can be applied by pwMS during commonly prescribed 
manual stretches (Chapter 5) 
b) Investigate the effects of different levels of applied torque and durations of 
stretch using a motor on passive stiffness, spasticity and ROM in pwMS 
(Chapter 6 and 7) 
c) Investigate the effects of constant torque stretching on direct measures of 
muscle  strain using ultrasonography (Chapter 8) 
 
Chapter 2 discusses the pathology and pathophysiology of Multiple Sclerosis, followed 
by an in-depth review of the causes of limb stiffness, the clinical and scientific 
measurements tools used to measure stiffness and current management techniques. 
Chapter 3 presents a review of the literature on the effects of stretching for the 
treatment of hypertonia in the plantarflexors of people with acute and chronic CNS 
lesions. Chapter 4 will describe common methods that are used throughout the thesis 
and chapter 9 will provide an overview of the thesis findings an appraisal of the 
underlying study assumptions and their limitations, and directions for future work. 
1.2 Inter-relationship between studies 
It has been reported that as much as 80% of people with MS present with an increase 
in muscle stiffness, leading to difficulties with functional tasks by making movements 
slower and more effortful.  Clinically, stretching is commonly used to treat muscle 
stiffness; however, there is little evidence to guide the implementation of stretching 
programmes. Therefore this project aims to provide initial guidance for stretching in 
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people with increased muscle stiffness, by undertaking three interrelated studies. As 
mentioned above study 1 (Chapter 5) determined the magnitude of plantarflexor torque 
people with MS can produce during commonly prescribed manual stretches for the 
plantarflexors and the duration of stretch that pwMS can achieve while stretching.  
The finding(s) from this study directed the subsequent studies. In study 2 (Chapter 6) 
and study 3 (Chapter 7), a purpose built servomotor delivered stereotyped stretches 
and measured the size and rate of change of muscle stiffness during and following 
stretches. Study 2 determined how stiffness varies after a 30 minute constant torque 
stretch and over a 30 minute post stretch time period when different levels of force, 
known to be achievable by people with MS were applied. Study 3 determined how 
stiffness varied following a 10 minute stretch, which is a more clinically feasible time 
frame, and what area of the muscle tendon complex is targeted with this intervention. 
The combined study sample of all three experiments consisted of 54 people clinically 
diagnosed with MS who were mild to moderately disabled. In study one, 30 participants 
with MS were recruited, 27 of which completed the study in addition to 15 healthy 
controls (Figure 1A). The recruitment of study 1 participants occurred over a two month 
period from January 2010 to February 2010. Data collection occurred between the 
months of February 2010 to March 2010. The high, medium and low torques generated 
by PwMS during study 1 was further investigated in study 2 over a 30 minute 
intervention and 30 minute follow-up period.  In study two, 17 participants with MS were 
recruited, 14 of which completed the study in addition to 13 healthy controls. The 
recruitment of study 2 participants and experimental setup occurred over a 6 month 
period, from April 2010 to September 2010. Data collection and analyses occurred 
between September 2010 and March 2011; it was established that increases in ROM 
and reductions in stiffness plateau at around 10 minutes. These findings therefore 
informed study 3 which primarily investigated the effects of a 10 minute constant torque 
stretch on ROM and stiffness, in addition to investigating the changes that occur in the 
muscle and tendon with stretch using ultrasound.  In study three, 17 participants with 
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MS were recruited, 13 of which completed the study, the control sample used in study 
2 was also used to compare study 3 MS participant data. The recruitment of study 3 
participants occurred over a 4 month period from March 2011 to July 2011, followed by 
the data collection and analysis from July 2011 to October 2011.  
 
    
Figure 1A: Flow chart showing overlap of MS subjects across studies 
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2 Chapter Two: Background 
2.1 Introduction 
This thesis investigates how lower limb passive stiffness and spasticity are affected by 
stretching in people with Multiple Sclerosis (MS).  This chapter will briefly look at the 
pathology and pathophysiology of MS (Section 2.2) before discussing the causes of 
limb stiffness (Sections 2.2-2.3) and providing an overview of current measurement 
(Section 2.4) and management techniques (Section 2.5).  
2.2 Multiple Sclerosis 
MS is a chronic demyelinating disorder of the central nervous system (CNS). It is one 
of the leading causes of neurological disability in young adults and is estimated to 
affect 2.5 million individuals worldwide (Roncaroli, 2005). Onset typically occurs 
between the age of 20 and 40 and affects females at a ratio of 2:1 compared to males. 
In the United Kingdom (UK) MS is thought to affect around 85,000 individuals with a 
variable prevalence of 115/100,000 increasing to 224/100,000 in the Orkneys region 
(Burgess, 2003). The variable incidence of MS indicates a potential geographical 
gradient effect leading to suggestions of an environmental link to causation.        
2.2.1 Pathology 
The aetiology of MS remains unclear, although the autoimmune hypothesis is 
reasonably well established. It is thought that precursor T cells (partially differentiated), 
located in the peripheral lymphoid tissue, become myelin-reactive secondary to 
interactions with antigen presenting cells exposing myelin-cross-reactive antigens. The 
newly formed myelin-reactive T cells have the potential to express several chemokine 
receptors and along with the help of unregulated cell adhesion molecules and matrix 
metalloproteinase (MMPs), aid in the breach of the blood brain barrier and entry into 
the CNS (Weiner & Seikoe, 2002).  
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Once in the CNS, T-cells bind with specific antigens on macrophages and microglia, 
resulting in the secretion of cytokines, leading to an inflammatory response. Cytokines 
and gamma interferons then begin to break down the blood brain barrier resulting in 
further escalation of the inflammatory response. Excessive inflammation alongside a 
severely compromised blood brain barrier leads to the proliferation of B- lymphocytes 
with antibodies specific to myelin; these enter the CNS and attach themselves to the 
myelin surface whilst attracting macrophages and killer T-cells which then begin to 
phagocytise the myelin and damage oligodendrocytes (Matthews et al, 1991; Burgess, 
2003).  
There are two distinct pathological processes occurring in MS: early inflammation with 
associated demyelination and progressive axonal damage with irreversible deficits 
(Brinar, 2003).  Both processes are thought to start at disease onset. However, early 
axonal damage may not produce observable neurological signs, primarily due to: the 
CNS’s ability to compensate; spontaneous remyelination in specific sites; and the level 
of axonal damage  not exceeding a predefined threshold (Burgess, 2003).  
Demyelination, in association with axonal damage, results in disordered conduction 
and propagation of action potentials, leading to a wide range of signs and symptoms. 
Although the inflammatory process often resolves spontaneously and areas of patchy 
remyelination are observed, repeated insult to the same site results in the formation of 
plaques and potentially irreversible axonal damage.  
2.2.2 Types of MS 
MS can be extremely variable and multiple variants have been identified; this is 
primarily due to differences in the location and severity of damage in the CNS.  Current 
definitions of the variations of MS are based on the prospective pattern of disease 
development individuals are likely to follow (Burgess, 2003).  Relapsing remitting MS is 
the most commonly diagnosed variant and is characterised by multiple periods of 
exacerbation and remission. It is documented that approximately 80% of relapsing 
remitting cases go on to develop a secondary progressive disease pattern. The primary 
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progressive variant of the disease tends to occur in around 10% of cases and often 
develops after age 40; it is characterised by a continually degenerative pattern from 
onset, affecting primarily the spinal cord, and has no observable periods of 
exacerbation or remission (Herndon, 2003).      
2.2.3 Signs and Symptoms  
Presenting signs and symptoms can be very unpredictable at disease onset and vary 
depending on the site and degree of neural compromise. MS can be associated with 
altered balance and co-ordination, visual disturbances, bladder and bowel dysfunction, 
pain, fatigue, cognitive dysfunction, weakness, stiffness and spasms (Boyce, 1998). 
Increased limb stiffness, or hypertonia, is one of the leading causes of disability in MS 
and is present in up to 85% of cases  (Nielsen et al. 2007). Hypertonia is clinically 
observed as an increased resistance to passive movements of a limb. It is associated 
with considerable functional limitations, pain, increased energy expenditure to perform 
activities of daily living which can in tern reduce quality of life (Barber et al. 2011;  Gao 
et al. 2011). Hypertonia can be caused by two main factors: an increase in passive 
stiffness and spasticity (Dietz & Sinkjaer, 2007). The causes underlying these two 
factors will be discussed in the next two sections.  
2.2.4 Passive Stiffness 
It is apparent in the literature that the nature of hypertonia unrelated to stretch reflex 
activation is not clearly understood. There are varying schools of thought regarding the 
contributing mechanisms including changes in:  the extracellular matrix (ECM) of 
muscle and tendon, intramuscular proteins, cross bridge attachment and fascicle length 
and sarcomere length/number. The contributions of these components to passive 
stiffness in healthy muscle will firstly be described (Section 2.2.5) before describing 
changes that occur with pathology (Section 2.2.6). 
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2.2.5 Extracellular Matrix of Muscle and Tendon 
The ECM has a variety of functions and plays an important role in force transmission 
and tissue structure maintenance in tendons, ligaments, bone and muscle. It is 
composed of a mesh of fibrous proteins and glycosaminoglycans; collagen and elastin 
are common fibrous proteins and contribute to the structural integrity of cells 
throughout the body (Harvey & Ferrier, 2011). 
2.2.5.1 Collagen  
Collagen is synthesised by fibroblasts and the preprocollagen gene is transcribed into 
mRNA; intracellularly, the translation of preprocollagen mRNA occurs in the ribosomes 
and the assembly of procollagen in the lumen of the rough endoplasmic reticulum 
(Harvey & Ferrier, 2011). This process involves the hydroxylation of proline and lysine 
to form hydroxyproline and hydroxylysine; in some instances hydroxylysine residues 
are adapted through the process of glycosylation with glucose (Kjaer 2004). After 
hydroxylation and glycosylation, three polypeptide chains assemble with the formation 
of intrachain and interchain disulphide bonds, bringing chains into an alignment 
appropriate for the helix formation seen in fibrillar collagen types. Levels of 
hydroxyproline are often used as a marker for collagen synthesis in animal studies 
looking at passive stiffness.  
The procollagen molecules progress through the golgi apparatus where they are 
secreted from golgi vesicles into the ECM. Within the ECM, procollagen is converted 
into collagen and incorporated into  stable cross-linked collagen fibrils; these cross 
links can change with pathology and ageing as discussed later (Harvey & Ferrier, 
2011). The triple helical formation of collagen fibrils allows it to demonstrate great 
tensile strength.    
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2.2.5.2 Proteoglycans  
Proteoglycans are an essential component of connective tissue and muscle ECM; the 
basic proteoglycan unit comprises a core protein and one or more glycosaminoglycan 
side chains (Harvey & Ferrier, 2011). Proteoglycans can be categorised by the nature 
of the attached glycosaminoglycan chain or their size: decorin, biglycan, fibromodulin 
and lumican all belong to the family of small leucine-rich proteoglycans and versican, 
perlecan, neurocan and aggrecan are large proteoglycans (Gillies & Lieber, 2011). 
Chondroitin and dermatan sulphate are common proteoglycans found in skeletal 
muscle ECM.  
Both collagen and proteoglycans have unique interactions that maintain the structure 
and composition of the ECM. Proteoglycans bind with collagen in specific locations and 
decorin is thought to regulate type one collagen, the type found in tendons and muscle. 
Decorin in combination with biglycan, for example, has been associated with altered 
transforming growth factor signaling and fibrillogenesis (formation of new fibres) in 
skeletal muscle (Gillies & Lieber, 2011; Blalock et al. 2003). Transforming growth factor 
is used to describe two classes of polypeptide growth factors, transforming growth 
factor alpha and beta, the latter of which has many functions in skeletal muscle and is 
thought to induce fibroblasts to produce collagen and fibronectin (Blalock et al. 2003). 
2.2.5.3 Role of Muscle and Tendon ECM in Contributing to Passive Stiffness 
The study of muscle ECM is considerably complex and often what is known is based 
on studies of bovine and feline tissues. The ECM of muscle is considered to be 
subdivided into three areas: the endomysial (around the muscle cell), perimysial 
(around muscle fascicle) and epimysial (around the whole muscle).  It is thought that, 
the endomysial and perimysial ECM are, in some instances, intimately related. 
However, due to difficulties in isolating regions of ECM, it is not clear whether the 
structural properties of perimysium and endomysium are distinctly dissimilar. 
Furthermore, work conducted by Passerieux and his team (2006) looking at digested 
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bovine muscle fibres, suggests that sheets of perimysial collagen are in fact continuous 
with tendon. This suggestion is further strengthened as both tendon and perimysium 
are composed of type one collagen and the primary proteoglycan decorin (Passerieux 
et al. 2006).   Recent experimental work  has stipulated that the ECM  bears the 
majority of passive load, leading  to  implications that clinical examinations of ROM and 
stiffness are potentially a good  indication of ECM properties (Gillies &  Lieber, 2011).    
2.2.5.4 Fibres Vs Whole Muscle  
 Work conducted in decellularizing skeletal muscle has shown that the modulus1 for 
single fibres is almost identical to grouped fibres that have had the ECM biochemically 
removed. In contrast, the modulus of fibre bundles with intact ECM was approximately 
five fold higher than that of single fibres, leading to speculation that the ECM is an 
extremely stiff structure encompassing relatively compliant muscle fibres (Winters et al. 
2009). 
2.2.6 Intramuscular Proteins 
2.2.6.1 Titin 
Passive stiffness is often described as a mechanical response secondary to tensile 
loading of non-contracting muscle (Harlaar et al. 2000). As muscle is stretched beyond 
its slack length the subsequent passive tension developed within fibres has been 
attributed in part to titin, a giant protein that extends from the z-line to the a-band in 
sarcomeres (Granzier 2007). Titin is thought to play a central role as a molecular 
scaffold within sarcomeres and is reported to contribute an estimated 90% towards 
passive force in skeletal muscle within the physiological sarcomere length. Beyond this 
length, work looking at cardiac muscle and animal literature has shown that collagen 
has a greater contribution to passive force (Wu et al. 2000). Titin can be subdivided 
into two sections namely IG (immunoglobulin) and PEVK. These constituents vary in 
composition between muscle groups and both sections have been found to be longer in 
                                                          
1
 Modulus is the ratio between stress and strain and gives an indication of the elasticity of a material 
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slow twitch muscle, thus leading to less resistance to a given stretch compared to fast 
twitch muscles (Fukuda et al. 2008).  
2.2.6.2 Cross Bridge Attachments 
The support for the role of cross bridge formation to tension development relies mainly 
on work conducted in animals.  It is thought that when a muscle fibre is stretched there 
is an initial marked increase in stiffness, termed short range stiffness, which then 
decreases (Proske & Morgan, 1999). This initial increase in stiffness is felt to be due to 
the resistance applied by attached cross bridges that then break, leading to the 
reduction in stiffness. Huxley, (1957) provided evidence that during an active muscle 
contraction, active cross bridges form between actin and myosin; this process, which is 
Ca2+ dependent, requires the action of ATPase and is therefore energy dependent. In 
contrast low rates of cross bridge formation and detachment (termed low cycling) are 
felt to be present in resting muscle; their turnover is not dependent on ATPase. Low 
cycling cross bridges are felt to contribute to short range passive stiffness and to 
underlie the phenomenon of thixotropy, where the stiffness of a muscle is dependent 
on its history (Brenner et al. 1982). Muscle stiffness at a set length, for example, will be 
higher after the muscle has contracted in a shortened position (Williams 1990), which is 
felt to increase the number of stable attached cross bridges in the passive state. 
Stretching and perturbations can further decrease stiffness on a trial by trial basis by 
breaking cross bridge attachments and the number attached at any one time.  
2.2.6.3 Changes in Stiffness with Neurological Pathology  
Having an understanding of the structural and biomechanical changes that occur in 
muscle and tendons secondary to age, pathology and training has important treatment 
implications. However, the literature in this area is limited and the take home message 
often inconsistent. 
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2.2.6.4 Changes in ECM  
Musculo-tendinous changes secondary to CNS pathology are variable (Shortland et al. 
2002; Lieber et al. 1996).  Nevertheless the general consensus indicates that, following 
CNS pathology, there may be observable changes. These can include an increase in 
tendon length and lower tendon stiffness associated with shorter and stiffer muscle 
fibre length, and variable fibre size and type. Further, increased endomysium and 
perimysium volume and changes in the quality of the ECM is associated with  
increased stiffness (Alexakis et al. 2007; Lieber et al. 2004; Zhao et al. 2009; Foran et 
al. 2005).  
2.2.6.5 Titin 
Work by Udaka and colleagues demonstrated a 45% decrease in titin following 
immobilization of the hind limbs of rats (Udaka et al. 2008). In addition, a 20% loss in 
actin and myosin was observed resulting in a shortening of the thick and thin filaments; 
this in association with the reduction in titin is believed to result in a disorganisation of 
sarcomere structure, thus affecting passive force output (Udaka et al. 2008). Titin can 
exist in multiple isoforms in both skeletal and cardiac muscle. It has  been established 
in work by Wu and colleagues that titin isoform switching occurs secondary to disuse, 
leading to an increase in myocardial stiffness as a result of increase up-regulation of 
collagen (Wu et al. 2002). It has therefore been postulated that titin isoforms may be 
altered in spastic skeletal muscle (Foran et al. 2005). However, Olsson et al. (2006) 
and others investigating increases in passive muscle tension in spinal-cord injured 
subjects with spasticity concluded that the difference found in passive tension between 
spastic and control subjects was unrelated to changes in titin content but were likely to 
be due to remodelling within the ECM and the muscle cell. Similarly, direct 
measurements of fibre length in children with cerebral palsy indicated that there was no 
evidence of fibre length change secondary to spasticity, suggesting that there was no 
change in the length of intramuscular proteins like titin (Lieber et al., 2004).  
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2.2.6.6 Cross Bridges 
Carey, (1990) evaluated the control of active movement of the index finger in subjects 
with hemiparesis. He reported an observable impairment in extension following an 
initial flexion movement. This history dependence of movement was thought to be due 
to an increase in cross bridge related stiffness. Furthermore, these findings are 
reported to be consistent with the cross bridge stiffness theory described by Hagbarth 
and colleagues, where large amplitude flexion contraction of the muscle is thought to 
promote the formation of new bonds in a shortened position, resulting in increased 
flexor stiffness (Hagbarth et al. 1985). It is thought that once myosin engages with actin 
during an active contraction, it may fail to disengage readily or re-engage 
spontaneously with a lower detachment rate therefore adding  frictional resistance, 
which weaker extensor muscles may not be able to overcome (Carey & Burghardt, 
1993). However, other factors such as abnormal motor programming or perceptual 
limitations may account for some of the findings observed; further exploration of these 
findings is warranted.     
As demonstrated thus far, there are varying theories regarding the mechanism 
responsible for the development of passive tension in the musculotendinous complex 
and it is clear that no single structure is responsible. A combination of structures in both 
healthy and pathological conditions is thought to contribute to passive stiffness. The 
current evidence suggests that the main contributing factors to increases in passive 
stiffness following a neurological insult are changes in the quality and quantity of the 
ECM. 
2.2.6.7 Muscle Fascicle Length and Sarcomere Number 
Animal studies highlight that immobilisation of a muscle in a shortened position results 
in a reduction in sarcomere number (Williams 1990;  Williams & Goldspink 1984). More 
recently human studies have directly measured muscle fascicle length using 
ultrasound. They have shown that fascicle length post stroke (Gao et al. 2011; Kwah et 
al. 2012) and in cerebral palsy can be reduced (Barber et al. 2011). This can often be 
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associated with a longer tendon (Barber et al. 2012). Shorter muscle fascicles will 
result in a decrease in “slack length”; the length at which the muscle begins to generate 
tension (Herbert & Balnave 1993). This in turn results in an increase in resistive tension 
at a specific length thus increasing stiffness. 
2.3 Spasticity 
The most frequently cited definition of spasticity is that reported by Lance (1980) which 
states: “Spasticity is a motor disorder characterized by a velocity-dependent increase in 
tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from 
hyperexcitability of the stretch reflex, as one component of the upper motor neurone 
syndrome”. Throughout this thesis, the term spasticity will be used to describe 
increases in muscle tone secondary to enhanced stretch reflex size. It is speculated 
that a number of central and peripheral mechanisms may be involved in the genesis of 
spasticity. These mechanisms and their potential contribution to the development of 
spasticity will be discussed below (Sections 2.3.1-2.3.2).         
2.3.1 Role of Descending Pathways 
Descending pyramidal and parapyramidal tracts originating from the motor areas of the 
cerebral cortex and brainstem play a central role both in the activation of inhibitory 
spinal circuits and the modulation of alpha motor neurone activation (Stevenson & 
Marsden, 2006). Animal studies suggest that two descending systems exist, primarily 
controlling tone. These are the inhibitory dorsal reticulospinal tract and the facilitatory 
medial reticulospinal and vestibulospinal tracts. Extensive lesions of the lateral 
funiculus that include the inhibitory dorsal reticulospinal tract are associated with the 
development of spasticity and hyperreflexia (Brown 1994).  The inhibitory centres in the 
brainstem are in turn excited by descending inputs from the motor cortex. Therefore, a 
cortical and capsular lesion results in a loss of excitatory drive to the inhibitory centres 
in the brainstem and thus a loss of inhibitory input to the spinal cord (Brown, 1994).  
Additionally, lesions to serotonergic pathways from the raphe nucleus in the brainstem 
may contribute to the alterations in motor neurone properties of patients with spasticity 
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(see plateau potentials section 2.3.2.5) (Bennett et al. 2001). The role of specific 
descending tracts in the development of spasticity remains unclear in humans, in part 
due to difficulties in stimulating tracts in the brainstem electrically or pharmacologically. 
2.3.2 Role of Spinal Cord Inhibition 
Numerous inhibitory pathways contribute to the control of spinal motor neurone activity 
in relation to movement. This is achieved either by affecting the transmission of muscle 
spindle sensory information through presynaptic inhibition or via direct or indirect 
reductions in the excitability of the alpha motor neurons (Stevenson & Marsden, 2006). 
It is thought that some of these pathways may be involved in the subsequent 
development of spasticity following pathology of the CNS (Nielsen et al. 2007). 
2.3.2.1 Disynaptic Reciprocal Ia Inhibition 
Due to disynaptic inhibitory pathways within the spinal cord, contraction of the agonist 
leads to relaxation of the antagonist muscle. Reduced reciprocal inhibition is thought to 
contribute to the clinical manifestation of hyperreflexia and spasticity and has been 
observed in patients with MS, spinal cord injury and hereditary spastic paraparesis 
(Crone et al. 2006). It is important to note that this form of inhibition is absent in many 
healthy subjects (Crone et al. 1994), therefore demonstrating variability within this 
measure and potential misinterpretation of findings in studies that are not sufficiently 
controlled.   
2.3.2.2 Presynaptic Inhibition 
Work by Nielsen et al. (2007) looked at the size of monosynaptic facilitation of the 
soleus H-reflex evoked by stimulation of the femoral nerve. They demonstrated that 
presynaptic inhibition of Ia afferent terminals decreased in MS and spinal cord injured 
patients with spasticity. This is in line with the use of diazepam to manage spasticity 
which  is reported to reduce spasticity by increasing presynaptic inhibition (Nielsen et 
al. 2007). Similarly, work by Lamy and colleagues investigating the efficacy of 
presynaptic mechanisms in  stroke patients with spasticity, reported that presynaptic 
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inhibition was notably depressed on the affected side of stroke patients when 
compared to healthy controls (Lamy et al. 2009). They  observed that changes in 
presynaptic inhibition were not positively correlated with the severity of spasticity and 
subsequently speculated that this form of inhibition does not play a major role in the 
development of spasticity  but is a general consequence of an upper motor neurone 
lesion (Lamy et al. 2009).  
2.3.2.3 Autogenic Ib Inhibition  
Autogenic Ib inhibition is caused by activation of Ib afferents from golgi tendon organs 
(GTO) situated in joint tendons; it is mediated by spinal inhibitory interneurones 
projecting to the motor neurones of the same muscle.  The effect of Ib stimulation on 
the parent motor neurone is not static and not always inhibitory. Ib stimulation in 
walking cats, for example, results in excitation of the parent motor neurone (Conway et 
al. 1987). This is felt to be important for stance phase activity; load is detected by the 
GTOs resulting in activation of the muscle to maintain extensor activation. There is 
evidence for these pathways in humans (Stephens & Yang, 1996). In people with 
spasticity there is less inhibition at rest following stimulation and instead excitation is 
seen (Delwaide & Olivier, 1988), suggesting that these excitatory pathways may be 
active at rest and contribute to spasticity. 
2.3.2.4 Recurrent Inhibition 
Recurrent inhibition is mediated by renshaw cells which are located in the ventral horn 
of the spinal cord. They receive excitatory stimuli from motor neurone axon collaterals 
and in turn synapse onto motor neurones and Ia inhibitory interneurones (Baldissera et 
al. 1981). Pierrot-Deseilligny & Brussel, (1975) investigated changes in recurrent 
inhibition using an H-reflex based technique. They demonstrated that recurrent 
inhibition was relatively normal in patients with spasticity, with some impaired 
modulation of the inhibition being observed during voluntary movement. It was 
therefore concluded that changes in recurrent inhibition may not play a major role in the 
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development of spasticity as assessed at rest but may contribute to the functional 
limitation observed in these patients.     
2.3.2.5 Role of Adaptive Changes 
The slow clinical development of spasticity following the onset of neurological 
pathology indicates it is not a release phenomenon where an abrupt decrease in 
inhibitory control over the spinal cord leads to the simultaneous onset of spasticity 
(Stevenson & Marsden, 2006). The literature suggests that motor neurones 
demonstrate intrinsic changes over time, along with potential morphological changes 
such as collateral sprouting of partially denervated neurones, that in turn alter how 
muscle spindle signals are processed at the spinal level (Nielsen et al. 2007).  
Hultborn and colleagues postulated that muscle spasms develop secondary to the 
activation of voltage dependent, persistent inward currents in motor neurones 
generating continual depolarisation termed plateau potentials (Hultborn et al. 2003).  
Further,  plateau potential activation was found due to calcium and sodium mediated 
persistent inward currents (Li & Bennett, 2003) in rats with a  chronic spinal cord injury 
and associated spasms and hyperreflexia. These plateau potentials could be caused 
by non-noxious stimuli and could contribute to spasticity as well as spasms.  
In healthy rats, plateau potentials are mediated by descending serotonergic inputs. 
Importantly, as plateau potentials are voltage dependent they can be turned off by the 
action of other inhibitory inputs. It seems with a CNS lesion, abnormal motor neurone 
properties may develop over time, possibly as a result of lesions to serotonergic 
pathways.  As discussed above, the lack of inhibitory activity in the spinal cord in 
spasticity compounds the development of plateau potentials by allowing them to 
continue relatively unabated. Similarly, it has been  shown that stimulation of lower limb 
muscles in humans with spinal cord lesions resulted in non-linear increases in force 
and persistent motor neurone firing after cessation of electrical stimulation (Nickolls et 
al. 2004). The authors  suggested that the potential causative mechanism was related 
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to “afferent feedback coupled with feedback circuits within the spinal cord, leading to a 
large synaptic input into neurones driving them into a plateau state that in turn gives 
rise to motor neuronal firing” (Nickolls et al. 2004 p.669). 
Changes in the properties of the Ia – motor neurone synapse may also occur as 
suggested by changes in the degree of post activation depression in people with 
spasticity.  Post activation depression is seen in healthy participants and is the 
decrease in motor neurone response size to repeated stimulation of the Ia afferent. 
This is felt to reflect changes in the Ia-motor neurone synapse. In spasticity a reduction 
in post activation depression is seen such that motor neurone excitability does not 
decrease with repetitive activation. Post activation depression is reported to be strongly 
correlated to hyperreflexia and spasticity (Aymard et al. 2000) and is a strong 
candidate for mediating spasticity. This is in line with work by Lamy who observed a 
reduction in post activation depression on the affected side of spastic stroke patients, 
which was found to be significantly correlated with the severity of spasticity (Lamy et al. 
2009).  
Summary 
In humans, the specific role of different descending tracts in mediating spasticity 
remains unclear. It is clear, however, that some changes in spinal cord inhibitory 
circuits develop; some of these may be a marker of CNS pathology and not mediate 
spasticity per se. Changes in motor neurone properties and in 1a – motor neurone 
synapses may underlie the development of plateau potentials and reduction in post 
activation depression, both of which may play an important role in mediating spasticity. 
2.4 Measurement of Hypertonia 
The term hypertonia, as previously mentioned, relates to the resistance felt when a 
joint is moved passively through its range while the participant is relaxed. The 
resistance is the product of the physical inertia of the limb, the mechanical and elastic 
components of muscle and connective tissue, and reflex muscle contraction (stretch 
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reflex) (Morris, 2002).  However, since the properties of inertia are unchanged following 
a neurological insult, changes within the segmental reflex arc and the 
musculotendinous unit are thought to be joint contributors to the added resistance felt 
during clinical examination of a person with an upper motor neurone lesion.   
Clinically the term hypertonia and spasticity are often used interchangeably and the 
lack of a precise clinically relevant definition for spasticity has  led to difficulties in the 
development of a valid measurement tool (Johnson & Pandyan, 2008). Furthermore, 
the  wide variety of measurement tools available for the assessment of spasticity and 
issues relating to the psychometric properties of some of these measures is an on-
going limiting factor (Bohannon & Smith, 1987; Pandyan et al. 2001; Bakheit et al. 
2003). The measurement tools for the assessment of hypertonia range from clinical 
ordinal scales to more complex electrical and biomechanical equipment, and will be 
discussed below.  
2.4.1 Clinical Measures 
2.4.1.1 Ashworth and Modified Ashworth 
The Ashworth and modified Ashworth scales frequent clinical practice as their 
application is inexpensive and easily implemented. The Ashworth scale is an observer 
related subjective test based on grading the perceived resistance to passive stretch on 
a scale of 0 - 4.  Its validity has been questioned since it has been argued that the   
resistance to passive movement  could be due to multiple factors including increased 
passive stiffness and contracture, dystonia, inadvertent voluntary contraction and 
spasticity and that this scale is not able to accurately differentiate between these 
constructs (Morris, 2002).  
The scale was  modified (the modified Ashworth scale) to include an additional level of 
measurement (1+) with a revised description of grades at the lower portion of the scale 
(Bohannon & Smith, 1987). It was thought that this additional level would potentially 
increase the responsiveness of the measure. However, these modifications  have 
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appeared to present an ambiguity in the scale,  increasing the potential for error and 
reducing it to a nominal level of data (Johnson & Pandyan, 2008). A number of studies 
have now shown  that the modified Ashworth scale, when compared with the original, 
has lower reliability particularly for the assessment of the lower limb (Sloan et al. 1992; 
Nuyens et al. 1994; Haas et al. 1996).   
Numerous studies have been conducted regarding the inter-rater and intra-rater 
reliability of both the Ashworth and modified Ashworth scales; it is evident that there is 
clear variability in the research findings ranging from poor to good within and among 
different muscle groups, pathological conditions and patient populations (Pandyan et 
al. 1999; Sehgal & McGuire, 1998; Brashear et al. 2002; Nuyens et al. 1994; Haas et 
al. 1996; Bohannon & Smith, 1987; Price et al. 1991). These variations in reliability are 
perhaps unsurprising given  that the application of this measurement tool is often not 
standardised and uses a variable stimulus (Engsberg et al. 1996). In addition, some of 
the inconsistencies found may also be related to flaws in the analysis of findings such 
as the use of parametric tests  and  summed scores for ordinal level data (Johnson & 
Pandyan, 2008).   In recognition of these issues the current consensus among 
researchers regarding the use of this tool indicates that application should involve: a 
single trained assessor; notation of the passive available ROM, resting limb posture 
and pain experienced throughout testing; repeated movements being kept to a 
minimum; and the following of a standardised measurement protocol (Johnson & 
Pandyan, 2008). In addition it is recommended that individual scores are taken for 
joints or muscles assessed as opposed to the use of summated scores.  
2.4.1.2 Tardieu Scale 
The Tardieu scale, is an observer rated measure which attempts to quantify muscle 
tone by subjectively measuring the perceived resistance to passive movement and, 
additionally, the intensity and timing of any stretch-evoked muscle response. It is rated 
on a 5 point scale and measured at three predefined velocities. The addition of a 
quantifiable component to the scale (the point at which there is a muscle contraction 
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leading to a catch in the movement) potentially increases its objectivity compared to the 
Ashworth scale. It’s validity is potentially further enhanced by  taking into account the 
velocity dependency of the stretch reflex (Lance, 1980).  
However, this method was reported to be quite complex and time consuming (Scholtes 
et al. 2006) and a modified version was therefore created. The modified version 
required simply defining the ROM when there is a catch during the fast passive stretch 
(Scholtes et al. 2006). It is thought that the relationship between the muscle length and 
the initial angle and the catch angle found during a fast stretch has a wide application 
and can be used to estimate the relative contribution of neural mechanisms and the 
mechanical resistance from the soft tissue (Morris, 2002).  
However, it appears that the three applied velocities  and the starting position of  
patients during testing was often variable, potentially affecting the results obtained by 
this measure (Frerebeau et al. 2003; Filipetti & Decq, 2003).  In addition to this clonus 
is included in the definition of the highest level of spasticity. Clonus, however, is a 
distinct symptom related to spasticity but not specific for the presence of spasticity. 
Whereas clonus is specific to certain muscle groups, spasticity can be observed in any 
muscle group (Scholtes et al. 2006).   
2.4.1.3 Multiple Sclerosis Spasticity Scale -88 
More recently a self-report scale has been developed to assess the subjective impact 
of spasticity and spasms in pwMS; the 88-item MS Spasticity Scale (Hobart et al, 
2006). The items of the scale were initially chosen on the basis of interviews, focus 
groups, expert opinion and literature review and were developed into questionnaires 
which were subsequently validated on people with MS and their reliability established. 
The final scale has 88 items that assess the person’s experience of (a) the impact of 
the symptoms of muscle stiffness, pain and discomfort and spasms (b) the physical 
impact on activities of daily living, walking and body movements (c) the impact on 
feelings and social functioning (Hobart et al. 2006). As such this scale is an important 
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additional outcome that addresses the subjective impact of spasticity that other 
objective scales omit. However, its relationship with more objective measures of 
stiffness have not been investigated to date. In addition it is though that further 
research is required to understand the meaning of the score achieved and any change 
in score with treatment (Hoang 2009). 
2.4.2 Mechanical  
2.4.2.1 Wartenberg Test 
The pendulum test described by Wartenberg  involves the knee being released from 
full extension,  the leg is allowed to swing until motion ceases and the number of 
swings recorded (Wartenberg, 1951).   Bajd and Vodovnik examined this measurement 
tool by attaching a goniometer to the knee and noted the movement at the knee joint 
following release (Bajd & Vodovnik, 1982).  They proposed a relax index based on the 
rate of decay of oscillations as a measure of spasticity; however this was never 
clinically validated. Others have used mathematical analyses of changes in gain and 
threshold of the reflex arc to demonstrate the potentially complex nature of this form of 
examination (He & Norling, 1997). An investigation of the validity of this measure was 
undertaken wherein  the Ashworth scale and the Wartenberg tests were compared 
(Leslie et al. 1992); this  demonstrated  that the two methods appear to measure 
similar constructs; it was suggested  that  the Wartenberg appeared to be  a more 
responsive  measure  (Leslie et al. 1992). Furthermore, Katz and Rymer suggested 
that it has more face validity and is a more acceptable measure than the Ashworth 
scale, since it corresponds better to the clinical perception of spasticity (Katz & Rymer, 
1989). It is important to note that, while this method is applicable for use in participants 
with mild spasticity, those with more severe stiffness from a practical point of view 
could not be accurately assessed with this measure due to lack of oscillatory 
movement available ( Johnson & Pandyan, 2008).   
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2.4.2.2 Myometer and Motorised Devices 
Various studies have demonstrated the usefulness of motorised devices in the 
accurate differentiation and objective measurement of spasticity within a laboratory 
setting  (Lorentzen et al. 2010; Katz & Rymer, 1989). Boiteau and colleagues found 
that a manual dynamometer used to measure spastic hypertonia showed high 
reproducibility and high intra-rater reliability (Boiteau et al. 1995). Furthermore the 
validity and responsiveness of dynamometers have been evaluated and is reported to 
produce highly accurate resistive force values in healthy and neurological person’s at 
both high and low angle velocities (Farrell & Richards 1986). Additionally, the 
application of powered computerised systems allows the detailed recording of the 
kinematics and resistance to motion (Johnson & Pandyan, 2008). However, 
measurement tools which offer a quantifiable method of evaluating spasticity such as 
motorised myometers and dynamometers are often considered too complex and 
expensive for use in the clinical setting (Haas et al. 1996) and are thought to be 
associated with compliance issues in children (Katz & Rymer, 1989). 
2.4.3 Physiological  
2.4.3.1 Tendon Jerks 
The tendon jerk is commonly used to elicit a spinal reflex by the delivery of a rapid 
stretch to a muscle. The response is thought to predominantly involve the 
monosynaptic pathway although it has been suggested by Rothwell (1994) and Pierrot-
Deseillingny and Burke (2005) that the oligosynaptic pathways may be involved. The 
tendon jerk may be a quantifiable measure of spasticity as it is easily elicited in people 
with spasticity, with a small stimuli resulting in a higher diffused amplitude response 
(Rothwell, 1994; Pierrot-Deseilligny & Burke, 2005). However it has been highlighted 
that increases in the size of the tendon jerk are not exclusive to spasticity and further 
investigation is required into the relationship between an increase in tendon jerk and its 
relation to increased gain and decreased threshold of the stretch reflex (Johnson & 
Pandyan, 2008).    
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2.4.3.2 H Reflexes 
The H reflex is a reflex obtained by electrically stimulating a nerve sub-maximally. This 
stimulates large Ia afferents that arise from the muscle spindle. Unlike the tendon 
reflex, the H-reflex response does not require stretch of the muscle spindle. It has been 
used to study excitability in the Ia afferent pathways and abnormalities in spinal 
inhibitory pathways (see section 1.7.2)  (Katz et al. 1992; Rothwell, 1994; Pierrot-
Deseilligny & Burke, 2005). The test can be conducted fairly easily but variable results 
potentially affecting the reliability of the measure have been reported due to variations 
in stimulus intensity, resting posture of the limb and body and an inability of the 
participant to completely relax (Katz, 1994). Additionally responsiveness is thought to 
vary depending on the age and activity level of the individual (Biering-Sørensen et al. 
2006). Therefore, as with other measures, a standardised protocol is required if 
comparisons are to be made across time and between different groups.  
This chapter has critically reviewed a range of measures for the assessment of 
hypertonia; the use of a motorised dynamometer as previously mentioned is both 
objective and reliable. Therefore in the studies undertaken for this thesis I will measure 
spasticity by imposing stereotyped stretches using a motor and measuring the 
mechanical response and EMG response.  This method has the advantage that it can 
measure stretch-evoked stiffness in the same units (Nm/kg.rad) as passive stiffness 
and gives a direct indication of the opposing torque that can limit functional movements 
(Wood et al. 2005). I will also use clinical measures of spasticity to define the 
participant’s baseline level of stiffness from the perspective of both the clinician 
(Ashworth scale) and the participant (MSSS-88).   
2.5 Overview of Treatment Regimes for Hypertonia  
2.5.1 Pharmacological 
The pharmacological management of hypertonia is primarily focused on the treatment 
of positive upper motor neurone signs such as spasticity and spasms. It is often 
implemented when spasticity begins to directly impact on the function of the individual, 
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such as occurs with abnormal limb posturing, motor impairment and difficulties with 
nursing or hygiene routines (Ward, 2002). As discussed in section 2.3, an 
understanding of the pathophysiology of spasticity is not definitive and several 
mechanisms have been alluded to in relation to its origin. Current pharmacological 
treatment options are thought to work by either directly or indirectly altering these 
mechanisms by stimulating inhibitory inputs at the spinal cord level or acting directly on 
the neuromuscular junction / muscle. These actions result in a reduction of spinal reflex 
excitability (Abbruzzese, 2002) . Common pharmacological agents include diazepam, 
baclofen, tizanidine, dantrolene and gabapentin (Stevenson, 2006).  
2.5.1.1 Diazepam 
Diazepam is most commonly used for the treatment of spasticity secondary to lesions 
of the spinal cord; its mechanism of action is thought to involve the stimulation of 
gamma-aminobutyric acid a (GABAa) receptors within the brain stem and spinal cord, 
resulting in an increase in presynaptic inhibition. Clinically this is manifested in a 
reduction in the resistance felt too passive movement and a decrease in tendon stretch 
reflexes and spasms (Verrier et al. 1977). The effectiveness of diazepam for the 
treatment of spasticity has been demonstrated in cerebral palsy and MS patients 
(Engle, 1966; Beard et al. 2003). However, this treatment is associated with a variety of 
side effects including drowsiness or sedation and memory impairment (Abbruzzese, 
2002).   
2.5.1.2 Baclofen 
Baclofen is used for the treatment of cerebral and spinal spasticity and works by 
stimulating gamma-aminobutyric acid b (GABAb) receptors with the resultant effect of a 
reduction in calcium influx and excitatory neurotransmitter release, thus facilitating 
presynaptic inhibition (Stevenson, 2006). It is thought that clinical benefits related to 
this treatment include reduced flexor-extensor spasms and a reduction in 
monosynaptic and polysynaptic reflexes (Abbruzzese, 2002). However, clinical trials of 
this agent have tended to focus on the immediate effects on spasticity; thus very little is 
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known of its effects on function (Stevenson, 2006). The side effects of this drug are 
primarily dose related and are consistent with those described in diazepam.    
2.5.1.3 Tizanidine 
Tizanidine has been described as an alpha2 agonist and is thought to bind at 
supraspinal and spinal levels leading to a decrease in presynaptic activity of excitatory 
interneurones (Bes et al. 1988). Additionally, work by Coward (1994) found that 
tizanidine’s inhibitory action may be mediated via coeruleo-spinal pathways (Coward 
1994). Tizanidine leads to a reduction in stretch reflex size and co-contraction of 
agonist and antagonistic muscle groups. Side effects with tizanidine have been 
reported as minimal and are broadly similar to that of baclofen. However, patients on 
this therapy should undergo liver function tests due to the possibility of hepatitis 
(Stevenson, 2006).     
2.5.1.4 Dantrolene 
Dantrolene, unlike the other treatments previously described, works outside the CNS 
and is thought to inhibit the release of calcium peripherally, thus affecting excitation-
contraction coupling within muscles (Thompson et al. 2005).  It leads to a reduction in 
both muscle tone and  spasms (Abbruzzese, 2002). It is also thought to play a role in 
the modulation of spindle activity via stimulation of intra- and extra-fusal fibres (Gracies 
et al. 1997). The use of dantrolene is often restricted due to the serious nature of its 
side effects, which include hepatotoxicity, gastrointestinal abnormalities, nausea, 
drowsiness and fatigue (Pinder et al. 1977).   
2.5.1.5 Cannabinoids 
Cannabis sativa contains multiple compounds known as cannabinoids; it is thought that 
these compounds may have beneficial effects on commonly occurring symptoms 
related to MS such as spasticity, tremor and bladder dysfunction (Killestein & 
Hoogervorst, 2002). In addition, it has been estimated that as many  as 4% of MS 
patients in the UK use cannabis illegally for the purpose of symptomatic relief (Zajicek 
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et al. 2003). It is postulated that cannabinoid receptors, when in the CNS, may 
potentially play a role in the inhibition of neurotransmitter release, and have a 
neuroprotective action; they are also found on cells in the immune system (Thompson 
& Baker 2002; Hinson & Boone 1996).   
However, four small studies (Petro & Ellenberger, 1981; Ungerleider et al. 1987; 
Greenberg et al. 1994; Killestein & Hoogervorst, 2002) and one large randomised 
control trial (Zajicek et al. 2003) looking at the effects of cannabinoids on spasticity in 
MS showed no significant treatment effect and reported only subjective improvements 
in symptoms relating to spasticity and pain. The authors of the RCT noted, however, 
that improvements in walking speed ranging from 4%-12% were observed with the use 
of oral cannabis extract and tetrahydrocannabinol (Zajicek et al. 2003).  
To summarise, there is some evidence that cannabis may have some functional 
benefits in the MS population. However, the side effects can be profound at high 
dosages and it is clear that more work is needed in this area in order to make more 
definitive claims regarding its effectiveness.     
2.5.1.6 Miscellaneous Treatments 
The use of gabapentin (Cutter et al. 2000) and a variety of other oral agents has been 
documented as having anti-spasticity effects in people with MS. Most of these agents 
appear to have similar mechanisms of action, clinical indication and side effects as 
those mentioned earlier. However, their use is not widely researched and most of what 
is known is based on participant subjective feedback. More research is warranted into 
potential benefits for the treatment of spasticity.   
2.5.1.7 Botulinum Toxin 
Botulinum toxin is a very strong neurotoxin that is commonly prescribed for the focal 
treatment of severe spasticity which is causing  serious functional limitations (Ward, 
2002). The mechanism by which botulinum toxin works is through inhibiting the release 
of acetylcholine at the neuromuscular junction (Stevenson, 2006). Intramuscular 
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administration of botulinum toxin can be painful and although side effects have been 
reported as transient they may also involve extensive and functionally limiting 
weakness (Bakheit et al. 1996). The clinical effects of botulinum toxin are reversible 
and currently only botulinum toxin A and B are used therapeutically. Their effects  have 
been investigated in a variety of neurological conditions including MS, cerebral palsy, 
and head injury, with significant reductions in muscle tone being reported (Stevenson, 
2006). However, there is still a paucity of evidence on the impact on functional 
improvements with this form of treatment (Bjornson et al. 2007; Corry et al. 1998).         
2.5.1.8 Chemical Neurolysis 
Chemical Neurolysis is a well-developed but less common form of focal spasticity 
management, associated with the injection of phenol or alcohol into problematic areas. 
This form of therapy predominantly affects alpha motor neurons and induces focal 
chemodenervation via protein coagulation, muscle death and the non-selective 
destruction of neural tissue; wallerian degeneration is often precipitated  (Stevenson, 
2006).  Peripheral phenol nerve block is commonly applied to the lower limb 
musculature of patients with brain or spinal cord injury or cerebral palsy and leads to a 
complete decrease in tone; clinically this is often used to assist with gait re-education 
and positioning (Barnes, 1993). However, the benefits  of such therapy are  thought to 
be short lived if not combined with a form of stretching regime and its effects on 
function are yet to be established (Abbruzzese, 2002). The side effects of phenol 
injections are varied and thought to include sensory damage, neuralgic pain, tissue 
damage and thrombosis.  
2.5.2 Physical  
The therapeutic management of non-neural passive stiffness is predominantly through 
the use of physical adjuncts with the fundamental focus being to: maintain or improve 
function; prevent the development of secondary complications; alter patterns of 
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spasticity and spasm development; minimise pain; and improve comfort (Lockley & 
Buchanan, 2006).  
It is evident within the clinical literature that two distinctly different forms of physical 
management strategies exist, namely prolonged low load stretching and brief high load 
stretching (Partridge, 2002). The former includes the use of positioning, 
splinting/orthotics, serial casting and standing. The latter includes passive physiological 
movements, and passive manual stretching (with or without the use of an aid) and 
motor driven continuous passive movement techniques.  An overview of these 
concepts will be discussed below. 
2.5.2.1 Standing and Positioning 
Prolonged passive stretching methods, such as standing and positioning, are an 
integral part of both acute rehabilitation and the long term management of 
neurologically impaired patients (Hass & Crow, 1995; Bovend’ Eerdt et al. 2008). It is 
thought that prolonged passive stretching techniques increase joint ROM, decrease 
spasticity and spasms, prevent the development of contractures, facilitate optimal 
positioning and comfort, and reduce pain (Odeen & Knutsson, 1981; Bohannon & 
Larkin 1985; Edwards & Charlton, 2002). Furthermore, prolonged positioning of 
muscles in a lengthened position is thought to modulate stretch reflex activity and 
promote antigravity activity in trunk and lower limb muscles (Odeen & Knutsson, 1981; 
Edwards & Charlton, 2002).  
However, as highlighted by recent systematic reviews (Bovend’ Eerdt et al. 2008); 
(Katalinic et al 2011), studies in this area consist of very small sample sizes, and are  
often carried out in conjunction with anti-spasticity medication (Bovend’ Eerdt et al. 
2008). Standing and positioning are often used as adjuncts to treatment and it is 
apparent  from the literature that a lack of standardisation of treatment exists due to a 
lack of knowledge in the timing and length of application of interventions (Lockley & 
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Buchanan, 2006). Therefore it is difficult to accurately establish the true effect of these 
prolonged passive techniques on passive stiffness and spasticity.   
2.5.2.2 Passive Movements 
Passive movement techniques are typically used in situations where patients 
experience significant difficulty in moving their limbs due to paralysis or severe 
spasticity or spasms. Although the evidence base to support the use of this intervention  
is very limited, clinically this form of treatment is administered on the premise that 
movement is beneficial for the prevention of secondary complications, preservation of 
skin integrity and reduction in spasticity (Thornton & Kilbride, 2004).  
 It is also thought that the implementation of a passive movement programme, before 
activities of daily living tasks are carried out, helps to facilitate care and increase 
comfort (Lockley & Buchanan, 2006). Work by Schmit et al.( 2000) reported reductions 
in elbow flexor stretch reflexes following repeated passive movements of the elbow, 
indicating a potential reduction in spastic hypertonia.  
Fundamentally, stretching programmes are implemented to maintain or prevent loss of 
available ROM; reduce hypertonia and to improve ROM.  Such techniques include 
static stretching, cyclic stretching, and stretching at a constant torque or a constant 
angle, such as when splinting, casting or using orthotics (Bressel & McNair, 2002; 
Chung et al. 2005). More recently studies in patients with an upper motor neuron lesion 
(e.g. cerebral palsy) have used a combination of motorised devices and servomotors to 
implement different stretching techniques (Wu et al. 2011). This includes the use of 
intelligent control stretching (Gao, et al 2011) which  involves adjusting the applied 
stretching velocity according to the movement and resistance generated by both 
muscles and soft tissue structures. 
2.5.2.3 Splinting/Casting/Orthotics  
It is not uncommon within the literature for the terms splinting, casting and orthotics to 
be used interchangeably. These devices are designed to offer a form of non-invasive 
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therapy. Their mechanism of action relates to the continuous application of a low load 
stretch and an alteration in the distribution of forces to or from the body (Lockley & 
Buchanan, 2006). This form of therapy is normally used as an adjunct to 
pharmacological treatment and provide a sustained stretch, thus potentially 
minimising/preventing the development of contractures and spasticity, compensating 
for deformity and increasing patient comfort (Mortenson & Eng, 2003; Lockley & 
Buchanan, 2006). The evidence base for these treatments is limited; they are often 
used in combination with pharmacological treatments so their effect in isolation is 
unclear and parameters, such as the length of use and the applied force, vary between 
studies with no consensus/evidence as to their optimal value. 
The effects of stretching on the prevention of contracture has attracted great attention 
in the literature and a recent Cochrane review  of stretching in populations with long 
term neurological conditions has concluded that there is no evidence supporting the 
role of stretching in improving ROM, either in the immediate, short or long term  
(Katalinic et al. 2012).  In accordance with guidance for Cochrane reviews, only 
randomized controlled trials were included in the review with the aim of minimizing, as 
much as possible, potential biases such as order effects and assessor bias. However, 
this excludes many trials that have explored the effects of different stretching 
parameters on ROM and stiffness; for example (cyclic stretching vs constant torque 
stretching in the same group). This, as well as a lack of analytical clarity and disregard 
for potential muscular changes at a cellular level, suggests that the findings may be 
inconclusive and limited requiring further investigation (Weppler, 2011).   
The Cochrane review included studies on both the upper and lower limb. This may 
complicate the meaningful interpretation of the results since upper and lower limb 
muscles vary in their muscle architecture and neural control and thus may vary in their 
response to stretch. The Cochrane review further included people with both central and 
peripheral neurological disorders, including Charcot-Marie-Tooth disease and 
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Duchenne Muscular Dystrophy, who may differ in their response to stretch due to 
differences in their underlying pathology; for example, in the degree of muscle fibrosis.  
Additionally studies were included where stretching was an adjunct to additional 
treatment such as Botulinum Toxin injections, making the effects of stretching difficult 
to ascertain. Finally, the Cochrane review did not investigate the effects of stretching 
on passive stiffness. Therefore it is evident that a more detailed and in-depth analysis 
of the literature surrounding the effects of stretching on hypertonia and ROM is 
required and this will be presented in chapter 3.   
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3 Chapter Three: Stretching for the Treatment and 
Management of Lower Limb Hypertonia in Patients with 
Neurological Disorders: Review of the Literature 
 
3.1 Introduction 
Neurological disorders such as MS, spinal cord injury (SCI), stroke and cerebral palsy 
are frequently associated with the development of hypertonia. Hypertonia, as 
mentioned in the previous chapter, refers to the increased resistance apparent in a 
muscle with passive stretching. The impact of hypertonia for individual patients varies 
enormously, ranging from relatively minor effects on quality of movement, to more 
substantial difficulties with activities of daily living (Partridge 2002). This review will 
focus on the effects of stretching for the treatment of hypertonia in the plantarflexors of 
people with acute and chronic CNS lesions. 
3.1.1 Stretching as a Treatment for Hypertonia  
The implementation of stretching techniques are felt to significantly improve symptoms 
related to hypertonia and are often an integral part of both acute rehabilitation and the 
long term management of neurologically impaired patients (Hass & Crow 1995; 
Bovend’ Eerdt et al. 2008) . It is thought that stretching techniques are able to reduce 
muscle stiffness; increase joint ROM; prevent the development of secondary 
complications such as contractures; facilitate optimal positioning and comfort; and 
reduce pain (Singer et al. 2008; Odeen & Knutsson 1981; Odeen 1981; Tremblay et al. 
1990; Tsai et al. 2001) 
More recent studies in patients with stroke or spinal cord injury have used motorised 
devices and servomotors to implement different stretching techniques.  Such 
techniques include: static stretching; cyclic stretching; continuous passive motion; 
intelligent control stretching (adjusting the applied stretching velocity according to the 
movement and resistance generated by both muscles and soft tissue structures); and 
stretching at a constant torque or a constant angle (Bressel & McNair 2002; Chung et 
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al. 2005; Gao et al. 2011; Nickolls et al. 2004; Selles et al. 2005; Zhang et al. 
2002).Thus, there is a wide variety of different stretching techniques and mechanisms 
of application available.  
The parameters of stretching may also vary in both clinical and research literature. The 
main area of focus to date has been in terms of stretch duration. A stretching duration 
of 30 minutes has been most frequently tested in the  neurological literature, with 
reports of  significant increases in range of movement as well as a decrease in stiffness 
(Chung et al. 2005; Bressel & McNair 2002). Others, however, have found that a 
minimum of six hours of stretching per day is required to prevent progressive soleus 
contracture (Tardieu et al. 1988).  In contrast,  the sports-medicine literature reports  
improvements in muscle length  with repeated stretches of as little as 30-60 seconds 
per day in healthy participants ( Bandy et al. 1997; Feland et al. 2001). Other 
parameters of stretching such as the intensity of forces applied have received minimal 
attention (Gorter et al. 2007).  
It is postulated that provision of a mechanical stimulus such as stretching a muscle-
tendon complex is potentially sufficient to induce tissue remodelling and muscle growth 
and may be able to prevent or reverse the non-neural component of hypertonia 
(Herbert 1988). Early studies investigating the efficacy of stretching in mice established 
that daily stretching prevented both the loss of in-series sarcomeres, and the increase 
in collagen within the connective tissue of an immobilised muscle (Williams & 
Goldspink 1984). It has been suggested that stretching techniques such as  PNF, may 
further increase ROM by targeting the reflex contribution to stiffness through inhibition 
of the tonic stretch reflex during stretching (Yuktasir & Kaya 2009; Katalinic et al. 
2012). Therefore stretching may potentially influence both the passive and reflexive 
components of hypertonia as well as improve ROM.   
As mentioned in section 2.5.2.3 a recent Cochrane systematic review of the 
effectiveness of stretching for the treatment and prevention of contractures in people 
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with neurological conditions, concluded that stretching has no clinically important effect 
on joint mobility and little or no effect on pain, spasticity and activity limitations in 
people with neurological conditions at risk of contracture development (Katalinic et al. 
2012). This review has been criticised based on the grounds that the conclusions were 
broad and not supported by sufficient literature (Weppler 2011).  
One potential difficulty with recent reviews is the heterogeneity of studies included. 
Different muscle groups have been assessed in different patient groups using diverse 
stretching techniques. Further, the methods of evaluation have often varied from study 
to study. Some measures, such as the Ashworth scale measure both components of 
hypertonia whilst other biomechanical and electrophysiological measures have 
attempted to delineate these components.  
This review therefore has the following aims: 
1. To evaluate the effects of stretching on the ankle plantarflexors in people with 
acute and chronic CNS lesions 
2. To review both randomised controlled clinical trials and also experimental trials 
3. To separately evaluate the effects of stretching on:  
a. Biomechanical measures of passive stiffness  
b. Biomechanical and electrophysiological measures of spasticity  
c. Clinical measures of hypertonia 
d. Measures of range of motion 
e. Measures of functional mobility  
4. To compare the relative effectiveness of different types of stretches and 
different parameters of stretches. 
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3.2 Methods 
3.2.1  Search Strategy/Data Sources 
Electronic searches were conducted in the following computerised databases: 
Pubmed, Embase, Cumulative Index to Nursing and Allied Health Literature (Cinahl), 
Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled 
Trials, Database of Abstracts of Reviews of Effects (DARE), Health Technology 
Assessment Database (HTA), The Allied and Complementary Medicine Database 
(AMED) and Physiotherapy Evidence Database (Pedro) from 1940 to 2012. Reference 
lists of included articles were also assessed as well as relevant systematic reviews. 
Potentially relevant articles that were not available for online download were ordered 
from the British Library. The following search terms were used “(Stretch*) and (ankle 
OR leg OR knee OR hip OR lower limb) and (Spinal cord OR multiple sclerosis OR 
cerebral palsy OR stroke OR head injury OR brain injury)”.   
3.2.2  Study Selection (Inclusion/Exclusion Criteria) 
Studies were included if they were in English and either published randomised 
controlled trials, clinical trials or experimental or clinical cohort studies. Only studies 
involving humans were included, with participants of any age or gender, providing they 
had a confirmed neurological diagnosis and existing lower limb hypertonia. Additionally, 
studies were only included if they had applied a stretching intervention and assessed, 
at least one of the following: ROM, stiffness or spasticity. The variable had to be 
measured both pre and post intervention in the ankle plantarflexor muscle. Study 
interventions could include static stretching, positioning such as standing, cyclic 
stretching or continuous passive motion, or any other form of manual or passive 
stretching for the treatment of hypertonia. Studies had to involve patients maintaining a 
stretching position for a minimum of one minute and could compare different stretching 
interventions.  
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Studies were excluded if: they used co-interventions such as anti-spasticity medication, 
active/active assisted ROM therapy, applied electrical stimulation; applied a stretch 
using casting or splinting methods;  were case reports, conference proceedings or 
protocols with no published data. 
3.2.3 Study Evaluation: Experimental Design and Methodological Quality 
On completion of a detailed search of the named databases, and filtration of all articles 
that did not meet the inclusion criteria, key data was then extracted from all included 
articles. This information is presented in two pre-prepared forms: the experimental data 
extraction form (Table 3.1) and the methodological quality assessment form (Table 
3.2). The experimental data extraction included information on the following: first 
author; date of publication; number of participants; neurological condition; study design; 
stretching intervention; groups; outcome measures; study results and a methodological 
quality score. The methodological quality assessment rated studies on nine criteria for 
the specific assessment of internal validity bias and confounding selection bias based 
on the Downs and Black checklist for the assessment of the methodological quality of 
randomised and non-randomised studies of health care interventions (Downs & Black 
1998). The following criteria were included: randomised allocation; allocation 
concealment; subject blinding; assessor blinding; accurate outcome measures; 
appropriate statistical tests; sufficient power calculations; free of selective reporting and 
data dredging.    
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
 
STROKE 
Gao et al, 
2011 
 
 
 
Exp: 10 
Con: 10 
  Stroke Before and 
after design 
Single session: 5 
minutes cyclic 
stretching x 120 
cycles lasting 1hour 
N/A - Ankle joint stiffness 
(Dynamometer) 
-Index of hysteresis 
(Dynamometer) 
-Achilles tendon length 
(Ultrasound) 
-Force output 
(Dynamometer) 
 
Ankle stiffness 
pre:0.60(0.13)Nm/
0 
post: 0.49 
(0.14)Nm/
0 
 (p=0.0009)  
Index of hysteresis Pre: 0.37 
(0.07) post: 0.33 (0.06) 
(p=0.0002) 
Tendon length 
No significant change (p=0.39) 
Force output 
 post: 10% increase (p=0.017) 
4/9 
Yeh et al, 
2007 
 
 
Exp:47 Stroke Before and 
after design 
3 x 30 minutes 
stretching sessions; 
cyclic, constant 
angle and constant 
torque1 week 
interval between 
sessions 
N/A -Spasticity (Modified 
Ashworth Scale) 
-ROM (Goniometer) 
-Ankle joint stiffness 
(Dynamometer) 
 
MAS:-Constant angle  
Pre:- 2 post 1 
ROM:- pre:9.72 post:16:00 
MAS:- cyclic stretching 
Pre:-2 post:1 
ROM:- pre:9.56 post:14.81 
MAS:-Constant torque  
Pre:- 3post 1 
ROM:- pre:9.19 post:18.29 
Stiffness:- reduced post 
stretch all protocols (p<0.001) 
4/9 
Tseng et al, 
2006 
 
Exp:59 Stroke Randomized 
controlled trial 
Passive ROM 
exercises 2x 10-20 
minutes per day  
6 days per week for 
4 weeks 
1.Usual care (n=17)   
2.Intervention group 1 
(n=21) nursing 
supervision of activity 
only 
3.Intervention group 2 
(n=21) nursing 
assistance to complete 
activity 
 
-Function (FIM-ADL 
subscale) 
-Joint angle (Goniometer) 
-Self reported pain (VAS) 
-Geriatric depression scale 
short form (GDS-15) 
Motor Function 
(Brunnstrom stage) 
 
FIM-ADL: usual care: -1.01 
 Group1: 0.67 Group2: 0.81 
ROM : lower extremity 
 usual care: -3.88
o
 
Group1: +2.14
o
 
Group2: +7.92
o     
Pain:  usual care: +5.41 
Group1: -7.62 
Group2: -10.00
    
GDS-15:  usual care: +2.35 
Group1: -4.76 
Group2: -4.77
 
6/9 
Wu et al, 
2006 
 
 
 
Exp: 12 Stroke Before and 
after design 
15 minutes dynamic 
repeated ankle ROM  
exercises in 
standing  
N/A -Muscle tone- MAS 
-Achilles tendon reflexes 
(5 point VAS) 
-Ankle clonus (6 point 
VAS) 
- Gait (TUG) 
-10-minute walking test 
-Cadence 
-Subjective experience  
influence of ankle 
spasticity on ambulation 
(VAS 0-10) 
MAS- pre: 1.75 post: 1.08 
(p<0.01) 
Tendon reflexes (p=0.083) 
Ankle clonus (p=0.081) 
TUG-pre: 33.7 post:29.1sec 
(p<0.01) 
10-min walk test- pre: 29.83 
post: 27sec (p<0.01). 
Cadence increased (p<0.05) 
VAS-pre: 5.92 post: 4.42 
(p<0.01)  
 
4/9 
Selles et al, 
2005 
Exp:10 Stroke Non-controlled 
trial 
45 minutes 
stretching 3 x a 
N/A -Ankle ROM 
(Dynamometer) 
Ankle ROM:  increase 8.6
o
 
(p=0.001) 
4/9 
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
 
 
week for 4 weeks -MVC (Dynamometer) 
-Ankle joint stiffness 
(Dynamometer) 
-Joint viscosity 
(Dynamometer) 
-Achilles reflex (Reflex 
hammer) 
-10min  walking  test 
-Subjective experience- 
VAS (0-100) 
MVC (PF): pre: 8.2 post:9.6 
(p=0.028) 
Stiffness- pre: 0.22N/m post: 
0.15N/m (p=0.025) 
Joint viscosity: non-
significant 
Achilles reflex: non-
significant 
Walking speed- pre: 0.52m/s 
post: 0.60m/s 
VAS- pre: 35.4 post:75.1 
(p=0.021) 
Chung et 
al, 2005 
 
 
 
 
 
Exp:12 
Con:10 
Stroke Before and 
after design 
1x 30 minutes 
intelligent stretching 
N/A -Achilles tendon reflex 
(Reflex hammer) 
-Ankle ROM 
(Dynamometer) 
-MVC (Dynamometer) 
-Stiffness (Dynamometer) 
Achilles Reflex: non-
significant 
Ankle ROM- pre: 8.12
o  
post: 
10.46
o 
(p=0.002) 
MVC- pre: 9.87Nm post: 
11.58Nm (p=0.041) 
Stiffness- pre: 0.54 post: 0.43 
(Nm/deg) (p=0.007) 
 
4/9 
Yeh et al, 
2005 
 
 
 
 
 
 
  
 
Exp:30 Stroke Before and 
after design 
1x 30 minutes 
constant torque 
stretching 
1x 30 minutes 
constant angle 
stretching 
1.Constant torque 
stretching 
2.Constant angle 
stretching 
Spasticity (MAS) 
Passive ROM  
(Goniometer) 
Ankle Stiffness (motor 
driven stretches) 
Constant torque 
ROM- pre: 8.73
o 
post: 13.5
o 
 
MAS- pre:2-4 post: 0-1 
Ankle stiffness: significant 
decrease (p<0.05) 
Constant angle 
ROM- pre: 8.77
o 
post: 12.57
o 
MAS- pre2-3 post 1-3 (p<0.01) 
Ankle stiffness: significant 
decrease (p<0.05) 
 
5/9 
Bakheit et 
al, 2005 
 
Exp:66 
Cont:21 
Stroke Before and 
after design 
1 x 20 minutes of 
either Isotonic 
stretch (WB), 
Isotonic 
stretch(NWM), 
Isokinetic stretch 
1.Isotonic stretch with 
weight bearing 
2.Isotonic stretch 
without weight bearing 
3.Isokinetic stretch 
-Spasticity (Hmax:Mmax 
ratio) 
-H reflex latency 
 
Hmax:Mmax ratio: non-
significant (p=0.4) 
H reflex latency: non-
significant (p=0.9) 
 
 
5/9 
 Yeh et al, 
2004 
 
 
 
 
 
 
Exp:25 Stroke Before and 
after design 
1 x 30 minutes 
constant torque 
stretching 
N/A -Spasticity (MAS) 
-ROM (Goniometer) 
-Ankle joint stiffness 
(motor driven stretches) 
 
MAS- pre: 2-3 post:0-1 
(p<0.05) 
Rom- pre:8.6
o
 post: 12.6
o 
(p<o.o5) 
Ankle joint stiffness- 
decreased significantly 
(p<0.05) 
 
4/9 
Bressel 
and  
McNair, 
Exp:10 Stroke Within subject 
design 
-1x 30 minutes of 
static stretching 
-1x 30 minutes of 
N/A -Gait (10 minute walk test) 
-Ankle stiffness 
(Dynamometer) 
Static stretching 
10 minute walk test: non-
significant 
6/9 
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
2002 
 
 
cyclic stretching  
1 week interval 
-Torque relaxation 
(Dynamometer) 
Stiffness :decreased by 35% 
Torque relaxation: 35% post 
intervention 
Cyclic stretching 
Stiffness: decreased by 30% 
10 minute walk test: non-
significant 
Torque relaxation: 23% post 
intervention 
Zhang et 
al, 2002 
 
 
 
 
 
 
 
Exp:4 
Con:5 
 
Stroke Before and 
after design 
1x 20 minutes 
intelligent stretching  
N/A -Passive ROM 
(Dynamometer) 
-Active ROM 
(Dynamometer) 
-Joint Stiffness 
(Dynamometer) 
-Achilles tendon reflex 
gain (Reflex Hammer) 
-Viscosity (Dynamometer) 
 
Passive ROM: pre:11.9
o 
post:16.5
o 
 
Active ROM- pre: 8.8
o 
-21.7
o 
(pf) 
Post: 2
o
-26.9
o 
(pf) 
Joint stiffness: reduced post 
stretch (significance not 
reported) 
Tendon reflex- pre: 11.6 cm 
post 2.7cm 
Viscosity: reduced post 
stretch (significance not 
reported) 
3/9 
Tsai et al, 
2001 
 
 
 
 
 
 
 
 
 
Exp:17 
 
 
 
Stroke Before and 
after design 
1x 30 minutes of 
prolonged muscle 
stretching on tilt 
table 
N/A -Spasticity (MAS) 
-Passive ROM                    
-(Goniometer) 
- Spastictiry (H/M Ratio 
(TS) F/M Ratio(TA)) 
MAS: non-significant 
Passive ROM- pre: 15.1
o ; 
post:20.2
o
; post 45 mins: 16.0
o 
(p<0.05) 
H/M Ratio (TS)- pre: 42.8%; 
post: 29.2%; post 45 minutes: 
28.5%  
Significant decrease between 
pre and post and pre and post 
45 minutes (p<0.05)  
F/M Ratio(TA)-  pre: 5.4%; 
post: 11.8%; post 45 minutes: 
significant increase from pre-
treatment (p<0.05). 
Significant increase between 
pre and post and pre and post 
45 minutes (p<0.05)  
 
4/9 
Bohannon 
& Larkin , 
1985 
 
 
 
Exp:20 Transverse 
myelitis(n=1) 
Guillaine-Barre 
syndrome 
(n=1) 
Head injury(n=3) 
Before and 
after 
30 minutes of 
stretching on tilt 
table (Variable 
intervention 
sessions) 5-22 
treatments. Average 
N/A Passive ROM 
(Goniometer) 
Passive ROM: average 
change 3-17
o 
statistical 
significance not reported  
3/9 
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
 
 
 
 
 
 
 
 
Brain hypoxia(n=1) 
Stroke(n=14) 
 
of 2.3-6.4 treatments 
a week. 
HEAD/BRAIN INJURY 
Singer et 
al, 2008 
 
 
 
Exp: 17 
Con:10 
Brain injury Stroke Before and 
after design 
(Pilot) 
3 minutes cyclic 
stretching at  (5
o
/s  
and 25
o
/s) 
N/A Passive plantarflexor 
resistive torque (PPRT) 
(Dynamometer) 
Affected limb of hemiparetic 
subjects showed significantly 
greater resistance to fast 
stretches compared to slow 
stretches (p<0.004) 
Significant reduction in PPRT 
observed in all limbs post cyclic 
stretching (p<0.005) (no 
difference between stretch 
velocity )  
3/9 
SPINAL CORD INJURY 
Harvey et 
al, 2009 
Exp:20 Spinal cord injury Randomised 
controlled trial 
2x 10 minutes  
(am/pm) of passive 
movement 5x a 
week for 6 months  
1.Experimental group 
passive stretching of 
ankle 
2.Control group no 
stretch applied to 
opposite ankle 
-Passive ankle dorsiflexion 
range (mechanical device) 
-Ankle(PF)/knee 
(Hamstring) spasticity 
(MAS) 
-Participant perception of 
change(15 point Llikert 
scale (-7) very great deal 
worse (0) no change  (+7) 
very great deal better 
ROM 
Experimental: increased from 
88
o
  to 91
o 
post intervention 
Control: decreased from 89
o
 to 
87
o
.  
Overall between group mean 
difference was 4
o
 (p=0.002) 
MAS 
Not statistically significant 
Participant perception of 
change 
Experimental: 2-4 
Control: 0-0 
8/9 
 
Ben et al, 
2005 
 
 
 
 
Exp:20 Spinal cord injury Within subject 
design 
1X 30 minute weight 
bearing stretch on 
tilt table/wedge 3x 
per week for 12 
weeks 
1.Experimental group 
weight bearing and 
stretch 
2.Control group non 
weight bearing and no 
stretch 
-Ankle mobility  
(ROM mechanical device) 
-Bone mineral density 
(Dual energy X-ray 
absorptiometry) 
 
Ankle mobility 
Experimental ankles: decrease 
by 4
o
  
Control ankle: decreased by 1
o 
. Mean effect of stretching on 
ankle mobility 4
o 
(95% CI 2to6 
degrees) 
Bone mineral density 
Experimental ankles: mean 
loss of 6.0%  
Control ankle: mean loss of 
6.6%.  
Mean effect of standing to 
reduce bone loss was 0.5% 
(95% CI -1.8% to 2.9%) of 
initial values.  
8/9 
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
Overall treatment effect 
expressed as % of the loss in 
control leg was 9.2%. 
 
Harvey et 
al, 2000 
 
Exp:14 Spinal cord injury Randomised 
controlled trial  
Within-subject 
design 
1x 30 minutes 
stretch 5-7 days a 
week for 4 weeks 
1.Experimental group 
stretching randomly 
allocated ankle 
2.Control group no 
stretching of opposite 
ankle 
Ankle stiffness (slope of 
torque angle curve) 
(Mechanical device) 
Ankle ROM (Mechanical 
device) 
Knee extended 
Difference between stretch 
and control leg from baseline 
to post stretch periods  
Slope- 2 weeks: -0.01 
(p=0.31)  4 
weeks:0.01(p=0.50)            
5 weeks:0.00(p=0.24) 
ROM-  2 weeks:1
o
 (p=0.68) 
4 weeks: 0
o
 (p=0.99)           
5 weeks:0
o
 (p=0.95) 
Knee flexed 
Slope- 2weeks: 0.00 (p=0.85)   
4 weeks: 0.01 (p=0.17)           
 5 weeks: 0.01 (p=0.19)   
ROM- 2 weeks: 2
o
 (p=0.13)   
4 weeks: 0
o
(p=0.92)             
5 weeks: 0
o
 (p=0.77)   
8/9 
Kunkel et 
al, 1993 
Exp:6 Spinal cord trauma 
(n=4) 
Multiple sclerosis 
(n=2) 
 
Before after 
design 
-Progressive from 3x 
10 minutes to 3x 30 
minutes for 4 weeks. 
-Then 2x 45 minutes 
daily standing for 5 
months 
N/A  Spasticity: deep tendon 
reflexes (percussion 
hammer); muscle tone and 
clonus (manual testing via 
therapist on  0-5 VAS) 
H-reflexes (EMG) 
Fracture risk (0-4 VAS) 
Joint ROM (Goniometer) 
Hip contracture(Thomas 
test) 
Bone density (Dual photon 
absorptiometry) 
(Mean + SE) 
Lumber bone density: pre – 
1.26(0.12) post: 1.19(0.10) 
Femoral neck bone density: 
pre- 0.51(0.08) post: 
0.56(0.06) 
H-reflex 
Amplitude(mV) pre: 
1.78(0.28) 
Post: 1.93(0.32) p=0.74 
Latency(sec) pre: 34.5(1.05) 
post: 35.8(0.91) p=0.37 
 Spasticity 
Patellar reflex pre:1.90(0.45) 
post:1.60(0.41) 
Ankle reflex pre: 1.20(0.32) 
post:1.00(0.42) 
Muscle tone knee: 
pre:3.20(0.36) post: 3.00(0.42) 
Ankle clonus pre: 1.00(0.57) 
post:1.40(0.57) 
Rom knee pre: 110.00(7.40) 
post: 114.00(9.10) 
Rom ankle pre: 28(3.10) post: 
34(2.90) 
Hip contracture- 
pre:7.40(2.10) post: 4.50(0.80) 
3/9 
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
Fracture risk 
Tibia- pre: 1.58(0.33) post: 
1.5(0.32) p= 0.59 
Fibula- pre: 1.58(0.33) post: 
1.58(0.33) p=0.50 
Calcaneus- pre: 2.33(0.33) 
post: 1.6(0.24) p=0.07 
Odeen & 
Knutsson, 
1981 
Exp:9 Spinal cord injury Before after 
design 
-4x 30 minutes 
weight load on legs 
in standing with feet 
in DF 
-2x 30 minutes 
weight load on legs 
in standing with feet 
in PF 
-2x 30 minutes calf 
stretch in supine 
N/A Ankle stiffness (Rotational 
potentiometer) 
% change and range 
0.25 cycles/s 
DF standing:-15 (+16 to-
33)(p<0.001) 
PF standing:-11(+14 to -33) 
(p>0.05) 
DF supine: -14 (0 to -40) 
(p<0.01) 
1.0 cycle/sec 
DF standing:-32 (+10 to-70) 
(p<0.001) 
PF standing:-26(+26 to -65) 
(p<0.01) 
DF supine: -17 (+3 to -25) 
(p<0.001) 
4/9 
MULTIPLE SCLEROSIS 
Baker et al, 
2007 
Exp: 6 Multiple sclerosis Randomised 
controlled 
single blind 
crossover 
design 
1) 30 minutes daily 
standing for 3 weeks 
 
2) Home exercise 
program including 8 
exercises 5 x 
repetitions daily for 3 
weeks. 
 
 
Group A: Standing 
week 1-3,  home 
exercise programme 
week 4-6 
Group B:Home 
exercise programme 
week 1-3,  Standing 
week 4-6. 
 
Spasticity (Ashworth 
scale) 
Spasm(Self-reported 
spasm frequency scale) 
Passive 
ROM(Goniometer) 
Ashworth (Mean(IQR) 
Hip flexion right – 
pre:1.5(1.0) 
Exercise:1.5(1.0) Standing: 
1.0(2.25) 
Hip flexion left- pre: 2.0(1.0) 
Exercise: 2.0(2.0) Standing: 
2.0(2.5) 
Hip abduction right– 
pre:1.0(2.0) 
Exercise:2.0(1.5) Standing: 
2.0(1.0) 
Hip abduction left– 
pre:2.0(1.0) 
Exercise:2.0(1.0) Standing: 
2.0(1.5) 
5/9 
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
Knee flexion right– 
pre:1.5(1.5) 
Exercise:1.5(1.0) Standing: 
1.0(2.25) 
Knee flexion left– pre:2.0(2.0) 
Exercise:3.0(2.0) Standing: 
1.0(0.5) 
Ankle dorsiflexion right– 
pre:2.0(2.0) 
Exercise:2.0(1.25) Standing: 
1.5(1.25) 
Ankle dorsiflexion left– 
pre:2.0(0.5) 
Exercise:1.5(2.0) Standing: 
1.0(0.5) 
Penn spasm 
Spasm frequency right– 
pre:2.0(1.7) 
Exercise:2.5(2.5) Standing: 
1.0(3,2) 
Spasm frequency left– 
pre:2.0(2.2) 
Exercise:2.0(2.2) Standing: 
2.0(3.2) 
ROM 
Hip right– pre:10(2.5IQR) 
Exercise:10(7.5)  Standing: 
0.0(5.0) p=0.038 
Hip left– pre:20(5.5) 
Exercise:10(3.7) Standing: 
5.0(2.5)p=0.059 
Ankle right– pre:10(2.0) 
Exercise:10(1.2) Standing: 
5.0(0.5) p=0.026 
Ankle left– pre:13.5(3.5) 
Exercise:10(1.2) Standing: 
2.5(5.5) p=0.027 
CEREBRAL PALSY 
Cadenhead 
et al, 2002 
Exp:6 Cerebral palsy A single 
subject design 
and 2 multiple-
baseline 
design 
Passive ROM 
exercises 5x 20-60 
second stretches 3 x 
per week for 
hip(extension, 
abduction, lateral 
rotation), 
knee(extension) and 
ankle(dorsiflexion) 
joints 
Phase A 
Group 1 n=3: receiving 
PROM exercises 
Group 2 n=3: no 
PROM exercises 
Phase B 
Group 1:  no PROM 
exercises 
Group 2:  receiving 
PROM exercises 
Hip joint PROM 
Knee joint PROM 
Ankle joint PROM 
(Goniometer) 
Group1: Showed no change 
in 28 out of 36 joints and a 
decrease in 8 joints when 
PROM exercises were 
discontinued 
Group 2: Showed no change 
in 23 of 36 joints, an increase 
in 3 joint measurements and a 
decrease in 10 measurements 
3/9 
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Study Participants Study Characteristics 
No. Condition Study 
Design 
Stretch 
Intervention 
Groups Outcome measures Results Score 
 
Table 3.1: Details of studies included in literature review 
Exp- experimental group, Con-control group, PROM-passive range of movement
when PROM exercises were 
provided 
 
Tremblay 
et al, 1990 
Exp:12 
Con:10 
Cerebral palsy Before and 
after design 
1 x 30 minutes 
triceps surae stretch 
with ankle 
dorsiflexed on a tilt 
table 
Experimental:30 
minutes  triceps surae 
stretch on a tilt table 
Control: 30 minutes 
session in a seated 
position 
Stiffness (resistive torque) 
(Dynamometer) 
Muscle activity (EMG) 
MVC (Dynamometer) 
Stiffness: reduced post 
stretch in experimental group 
(p<0.01) change= -0.51 at 
60
o
/s Significant reductions 
present 35 minutes later 
(p<0.05) 
EMG: reduced (p<0.05) at 
60
o
/s 
Change =0.66(uv.s) and 
remained reduced 35minutes 
post stretch 
MVC: 7 out of 8 children in 
experimental group had 
increased activation (p<0.5) 
1.67(uv.s) 
4/9 
Tardieu et 
al, 1988 
Exp:10 
Con:5 
Cerebral palsy Before and 
after design 
Variable stretching 
times from 1hour 50 
minutes to 7 hours 
10 minutes per day 
for 7 months. 
Group 1: Non-
handicapped: n=5 
7hours and 10 minutes 
of stretch per day for 7 
months 
Group2a: CP: n=4 
6 hours of stretching 
per day for 7 months 
Group 2b: CP:n=6  
1hour and 50 minutes 
per day for 7 months 
Ankle ROM (soleus) 
(Mechanical Device) 
Group1:  Mean range of 
passive muscle stretch 26.4
o
 
Pre-post measurements <4
o 
= 
no contracture 
Group2a: No mean indicated. 
Pre-post measurements<4
o 
= 
no contracture 
Group2b: No mean indicated. 
Pre-post measurements>4
o 
= 
progressive contracture 
present 
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Table 3.2: Methodological Quality Assessment  
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STROKE 
Geo et al, 2011 N N N N Y Y N Y Y 
Yeh et al, 2007 N N N N Y Y N Y Y 
Tseng et al, 2006 Y N N Y Y Y N Y Y 
Wu et al, 2006 N N N N Y Y N Y Y 
Selles et al, 2005 N N N N Y Y N Y Y 
Chung et al, 2005 N N N N Y Y N Y Y 
 Yeh et al, 2005 Y N N N Y Y N Y Y 
Bakheit et al, 2005 Y N N N Y Y Y N Y 
Yeh et al, 2004 N N N N Y Y N Y Y 
Bressel and McNair, 2002 Y N N N Y Y Y Y Y 
Zhang et al, 2002 N N N N Y Y N N Y 
Tsai et al, 2001 N N N N Y Y N Y Y 
Bohannon & Larkin , 1985 N N N N Y N N Y Y 
HEAD INJURY 
Singer et al, 2008 N N N N Y Y N N Y 
SPINAL CORD INJURY 
Harvey et al, 2009 Y Y N Y Y Y Y Y Y 
Ben et al, 2005 Y Y N Y Y Y Y Y Y 
Harvey et al, 2000 Y Y N Y Y Y Y Y Y 
Kunkel et al 1993 N N N N Y Y N N Y 
Odeen & Knutsson, 1981 N N N N Y Y N Y Y 
MULTIPLE SCLEROSIS 
Baker et al, 2007 Y N N Y Y Y N N Y 
CEREBRAL PALSY 
Cadenhead et a l, 2002 N N N N Y N N N Y 
Tremblay et al, 1990 N N N N Y Y N Y Y 
Tardieu et al, 1988 N N N N Y Y N N Y 
Study Randomised 
allocation? 
Allocation 
concealment? 
Blinding 
(Subjects)? 
Blinding 
(Assessors)? 
Accurate 
Outcome 
measures? 
Appropriate 
statistical tests? 
Sufficient 
power 
calculation? 
Free of 
selective 
reporting? 
Data 
Dredging? 
 69 
 
3.2.4 Study Evaluation: Assessment of Different Stretching Effects 
Studies were separately evaluated for their effects on passive stiffness, spasticity, 
range of motion and function. Studies that evaluated passive stiffness had to impose a 
stretch whose peak velocity was <7.5 o/s as past literature has shown that above this 
velocity stretch reflexes can be elicited in people with spasticity (Lorentzen et al. 2010). 
When evaluating spasticity, if several different speeds of movement / frequencies of 
movement were applied then the highest speed / frequency was chosen.  
 
Where possible the data was reported in the units used and then converted into a 
common unit. This allowed an evaluation of the clinical relevance of any statistically 
significant changes reported and for comparison with the results of the studies 
presented in chapters 6 and 7. For range of motion the common unit was degrees; for 
experimental measures of passive stiffness and spasticity the common unit was 
Nm/deg. In many cases, due to differences in the type of outcome measures, 
expression of the results in a common unit could not be reported and effect sizes were 
evaluated.  
3.2.5 Study Evaluation: Calculation of Effect Sizes and Meta-Analysis 
Effect sizes and their 95% confidence intervals were calculated where sufficient data 
was presented in the article. Many studies did not have a control group and evaluated 
the effects of stretching in a single patient group. In these cases effect sizes were 
calculated as: 
Effect Size =
                        
                          
 
In studies that had an intervention (int) and a control (cont) group the effect size was 
calculated as: 
Effect Size =
(                                 ) (                                  )
                               (        )
 
Mean values were used where possible. Where medians and inter-quartile ranges 
(IQR) only were reported, the mean was estimated as being half way between the IQR. 
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If the IQR was symmetrical around the reported median/mean, the standard deviation 
was estimated as: SD= IQR X 1.35 (Higgins & Green 2009) (Table 3.3). If only the 
range was reported then the standard deviation was estimated using the following 
correction factors that depended on the number of subjects included in the study: 
 
Subject Numbers in Study Correction Factor 
2 0.0886 
3 0.5908 
4 0.4857 
5 0.4299 
6 0.3946 
7 0.3698 
8 0.3512 
9 0.3367 
10 0.3249 
11 0.3152 
12 0.3069 
>12 0.25 
 
Table 3.3: Correction factor applied to studies of different sample size to achieve an 
estimate of the standard deviation 
 
Where z scores were provided the effect size was calculated as: 
Effect size= 
 
  
 
Where n= number of participants in the study. 
A meta-analysis was performed where comparable data for three or more studies was 
available. Data were pooled in statistical meta-analysis using a random effects model 
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using exploratory software for confidence intervals (ESCI) (Cumming 2012). Due to 
software requirements only studies with sample sizes greater than six were included.  
Heterogeneity between studies was compared using I2., calculated as:  
I2=
    
 
      . 
Where Q is the total weighted sum of squares between studies and df is the number of 
degrees of freedom (study number-1). The higher the percentage the greater the 
degree of heterogeneity between studies. Studies with a control group were assessed 
separately from studies without a control group as the use of a control group reduces 
potential bias. A comparison of the effects of stretching (ie pre-post stretching) was 
then analysed. These studies included those without control groups and data from the 
intervention arm of control groups. Where statistical pooling was not possible findings 
are presented in narrative summary form.      
3.3 Results 
3.3.1  Study Selection Process 
Based on the pre-defined search criteria a total of 1289 reference articles were initially 
identified. All 1289 article titles and abstracts were screened and 1188 were excluded 
as they did not meet the inclusion criteria. Additionally, a further 62 duplicate articles 
were removed, leaving 39 articles which were potentially eligible for inclusion. The full 
text articles for all 39 studies were inspected in detail along with the bibliography 
citations, leading to the exclusion of 22 articles and the inclusion of six new studies. 
Consequently, the literature review of stretch based interventions for the treatment and 
management of hypertonia included 23 articles (Figure 3.1).  
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Study selection flowchart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Flow chart of literature selection 
 
 
Initial database 
search results 
N=1289 
Articles screened 
N=1289 
Articles excluded 
based on abstract 
and title 
N=1188 
Duplicates removed 
N=62 
Full text articles 
assessed based on 
inclusion criteria 
N=39 
Articles excluded 
based on review of 
full text article 
N=22 
Articles included 
based on full text 
bibliography search 
and screening 
N=6 
Articles included in 
the review 
N=23 
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3.3.2 Study Samples  
The 23 articles included in the literature review reported experimental work in a variety 
of neurological conditions: 12 studies were conducted with stroke patients, five with 
SCI,  three in cerebral palsy, one in MS, one with head injury  and one article with 
participants of variable pathologies including stroke, head injury, brain hypoxia and 
transverse myelitis. In total 493 participants were assessed within the 23 studies (Table 
3.1).  
3.3.3  Main Purpose of Studies 
The majority of studies included in the review focused primarily on the effects of varied 
stretching paradigms on stiffness, spasticity and ROM.  Other factors investigated 
included the effect of stretching on pain (Tseng et al. 2006), activity limitations (Tseng 
et al. 2006; Bressel & McNair 2002; Wu et al. 2006), depression (Tseng et al. 2006), 
joint/muscle flexibility (Tseng et al. 2006), stress relaxation (Bressel & P. J. McNair 
2002), muscle activity (Godelieve Nuyens et al. 2002; Tremblay et al. 1990) and bone 
density (Ben et al. 2005; Kunkel et al. 1993). 
3.3.4 Outcome Measures and Measurement Tools 
A variety of outcome measures were used to assess specific dependent variables. For 
all studies using a dynamometer, motor or mechanical driven equipment, measures of 
passive stiffness, spasticity, ROM, and stress relaxation were conducted using these 
devices. Other assessment methods used to measure spasticity included: Ashworth 
scale; modified Ashworth scale; Hmax:Mmax ratio; and F wave:M response ratio. 
Additionally, ROM in some instances was assessed with the use of a goniometer.   
Other variables assessed included: pain via a visual analogue scale; activity limitations 
using the Functional Independence Measure Activities of Daily Living sub-scale (FIM-
ADL)  and Brunnstrom stage; depression using the geriatric depression scale; muscle 
activity using EMG; bone density using duel energy x-ray absorptiometry; gait with 
combinations of the 10 meter timed walk test, timed up and go, and cadence; tendon 
reflexes using a reflex hammer; and muscle tendon length with ultrasound.   
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3.3.5 Quality of the Evidence 
Table 3.2 details the assessments undertaken of methodological quality. The risk of 
bias was found to be variable, with non-randomised trials scoring lowest indicating a 
greater risk of bias. Studies fell short, most commonly, in areas associated with subject 
blinding, assessor blinding, randomised allocation of participants, allocation 
concealment  and the provision of sufficient power calculation.   
 
Studies poor in internal validity included: (Tardieu et al. 1988), scoring two out of nine; 
and (Bohannon & Larkin, 1985; Cadenhead et al., 2002; Kunkel et al., 1993;  Singer et 
al., 2008;  Zhang et al., 2002) all scoring three out of nine. Studies with moderate 
internal validity included: (Chung et al., 2005; Gao et al., 2011; Odeen & Knutsson, 
1981; Selles et al., 2005; Tremblay et al., 1990; Tsai et al., 2001; Wu et al., 2006; Yeh 
et al., 2004; Yeh et al., 2007) all scoring four  out of nine ; (Baker, Cassidy, & Rone-
Adams, 2007; Bakheit et al., 2005;  Yeh et al., 2005) scoring five  out of nine and 
(Tseng et al. 2006; Bressel & McNair 2002) scoring six out of 9. Studies high in internal 
validity included: (Ben et al., 2005; Harvey et al., 2000, 2009) all scoring eight  out of 
nine. 
3.3.6 Types of Intervention Used 
A variety of stretching interventions were implemented in the studies included in this 
review: it is possible to broadly subdivide these treatment interventions into two 
categories; static stretching and cyclic stretching. Static stretching methods were 
carried out in 14 of the 23 studies and applied either at a constant angle with the use of 
a tilt table (Ben et al., 2005; Bohannon & Larkin, 1985; Kunkel et al., 1993;  Odeen & 
Knutsson, 1981;Tremblay et al., 1990; Tsai et al., 2001; Bakheit et al. 2005);  
dynamometer or mechanical device (Yeh et al., 2004,2005,2007; Harvey 2000; Tardieu 
et al. 1988; Bressel & McNair 2002) or with the application of a constant force using a 
motorised device. Cyclic stretching interventions were implemented in 9 studies and 
applied either manually by a therapist (Tseng et al. 2006; Cadenhead et al. 2002; 
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Harvey et al. 2009), via intelligent control using a motor (Gao et al. 2011; Chung et al. 
2005; Selles et al. 2005; Zhang et al. 2002) or with a standard dynamometer or 
mechanical device (Singer et al. 2008;   Wu et al. 2006). 
3.3.7 Stretch Dosage  
Stretch duration ranged from 60 seconds to 7 hours per day; durations of 30 minutes 
was used in 13 of the 23 studies. Stretch frequency varied from a single session to 
between three to seven days per week for a minimum of three weeks to a maximum of 
seven months. A single session for 30 minutes duration was the most commonly used 
stretching protocol.  
3.4 Meta-Analysis 
3.4.1 Effects of Stretch on Passive Stiffness 
3.4.1.1 Studies with a control group: 
The three studies  included in this analysis  showed minimal variability (Q =0.29; 
I2=0.0%) (Chung et al. 2005; Singer et al. 2008; Odeen & Knutsson 1981). The forest 
plot shown in Figure 3.2 indicates that although a decrease in passive stiffness favours 
treatment (Overall effect size: -0.295); (CI -0.706 to 0.117) overlaps zero in all 
instances. Differences in the units used to measure passive stiffness prevented mean 
differences being described except  for Chung et al, 2005 (Table 3.4) 
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Figure 3.2. Forest plot showing 95% confidence intervals (CI) for the effect of: 
intelligent stretching (Chung et al. 2005); cyclic stretching (Singer et al. 2008); tilt table 
standing with ankle dorsiflexion verses tilt table standing in ankle plantarflexion (Odeen 
& Knutsson 1981 (a)); supine ankle dorsiflexion stretch verses tilt table standing with 
ankle dorsiflexion (Odeen & Knutsson 1981(b)) on passive stiffness;  all studies had a 
control group.  
 
 
 
 
 
 
 
 
 
 
 
 
Favours 
Treatment 
Favours 
Control 
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Study Experimental 
Group 1 
Experimental 
Group 2 
Control 
 Baseline  Post Baseline Post Baseline Post 
Chung et al, 2005 
(mean+/-SD) 
(Nm/deg) 
0.54 +/- 
0.25 
0.43 +/-
0.19 
NA 0.37 +/-
0.23 
0.38 +/- 
0.23 
Singer et al, 2008 
(mean+/-SD) 
(Nm) 
9 +/- 4.5 8 +/- 4.5 6 +/- 3.0 5.9 +/-
3.0 
7.9 +/- 
4.5 
7 +/- 4.5 
Odeen & 
Knutsson, 1981 
(mean % 
change+/-SD) 
(Nm) 
-15+/- 16.49 -14+/- 13.47 -11+/- 15.8 
 
Table 3.4. Experimental data results for control studies investigating the effects of 
stretching on passive stiffness.  
 
3.4.1.2 Pre-Post Intervention comparison 
Six studies including two that compared two different stretching interventions were 
included in this analysis resulting in eight comparisons. There was minimal variability 
(Q=4.46 I2=0.0%) among the included studies. The forest plot is shown in Figure 3.3, 
indicating an effect that favors treatment in reducing passive stiffness (Overall effect 
size: -0.559); ( CI -0.778 to -0.331). 
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Figure 3.3. Forest plot showing 95% confidence intervals (CI) for the effect of: cyclic 
stretching (Gao et al. 2011; Singer et al. 2008; Bressel & McNair 2002 (a)); intelligent 
stretching (Chung et al. 2005; Selles et al. 2005); tilt table standing with ankle 
dorsiflexion verses tilt table standing in ankle plantarflexion (Odeen & Knutsson 1981 
(a)); supine ankle dorsiflexion stretch verses tilt table standing with ankle dorsiflexion 
(Odeen & Knutsson 1981(b)); stretching at a constant angle (Bressel & McNair 2002 
(b)) on passive stiffness.    
 
In three studies passive stiffness was measured in Nm/O (Chung et al. 2005; Gao et 
al.2011; Selles et al. 2005). A combined mean difference of -0.09Nm/o (CI-0.05 to  
-0.14) was observed with stretching (Figure 3.4).  
 
 
 
 
 
 
 
Favours 
Treatment 
Favours 
Control 
Gao et al, 2011 
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Figure 3.4. Forest plot showing change in passive stiffness in Nm/o and the 95% 
confidence intervals (CI) for the effect of: intelligent stretching (Chung et al. 2005; 
Selles et al. 2005) and cyclic stretching (Gao et al. 2011)  interventions.  
 
3.4.2 Effects of Stretch on Spasticity: Biomechanical and Electrophysiological 
Measures 
3.4.2.1  Studies with a control group: 
Three studies investigated the effects of stretching on spasticity (Tremblay et al. 1990; 
Bakheit et al. 2005; Chung et al. 2005). One compared three different stretching 
interventions in both stroke participants and a control group; giving a total of five 
comparisons. The studies showed minimal variability (Q =3.20; I2=0.0%). The forest 
plot is shown in Figure 3.5, once again indicating an effect that favours treatment for 
reducing spasticity (overall effect size:-0.218); (CI -0.601 to 0.166) overlaps zero. 
Differences in the units used to measure spasticity prevented mean differences being 
described expect for Chung et al, 2005 (Table 3.5). 
Favours 
Treatment 
Favours 
Treatment 
Favours 
Control 
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Figure 3.5. Forest plot showing 95% confidence intervals (CI) for the effect of: constant 
angle stretch on a tilt table (Tremblay et al. 1990); cyclic stretching (Bakheit et al. 2005 
(a)); isotonic non-weight bearing (Bakheit et al. 2005 (b)); isotonic weight bearing 
(Bakheit et al. 2005 (c)) and intelligent control stretching (Chung et al. 2005); on 
spasticity. All studies had a control group.    
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 81 
 
 
Table 3.5. Experimental data results for control studies investigating the effects of 
stretching on spasticity.  
 
3.4.2.2 Pre-post Intervention Comparison 
 
Nine studies were included in the following analysis, of which two compared three 
different stretching interventions and one compared two different stretching techniques; 
giving a total of 14 comparisons. The studies were heterogeneous (Q=102.8 I2=87.4%) 
in nature. The results of the meta-analysis are displayed on the forest plot in Figure 
3.6. This indicates an effect that favours treatment on reducing spasticity (overall effect: 
-0.398);( CI -0.726 to -0.070). 
 
 
 
 
 
 
 
 
Study Experimental Group 1 Control 
 Baseline  Post Baseline Post 
Tremblay et al, 1990 
(mean +/- SD)(Nm/rad) 
-0.67 (+/- 0.84) -0.12(+/- 0.58) 
Bakheit et al, 2005 (a) 
(mean +/- SD) (H:M) 
0.66(+/-0.27) 0.59(+/-0.25) 0.37(+/-0.13) 0.39(+/-0.11) 
Bakheit et al, 2005 (b) 
(mean +/- SD)(H:M) 
0.46(+/- 0.14) 0.45(+/-0.15) 0.41(+/-0.08) 0.37(+/-0.1) 
Bakheit et al, 2005 (c) 
(mean +/- SD)(H:M) 
0.58(+/-0.25) 0.53(+/-0.22) 0.41(+/-0.21) 0.39(+/-0.2) 
Chung et al, 2005 
(mean+SD) (Nm/deg) 
4.41(+/-2.97) 4.03(+/-2.93) 2.93(+/-1.59) 2.69(+/-1.53) 
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Figure 3.6. Forest plot showing 95% confidence intervals (CI) for the effects of: 
constant angle and constant torque stretching (Tsai et al, 2001; Yeh et al, 2004; Yeh et 
al, 2005 (a)/(b); Yeh et al 2007 (a)/(c)); constant angle stretch on a tilt table (Tremblay 
et al. 1990); cyclic (Yeh et al, 2007 (b); (Bakheit et al. 2005 (a)); isotonic non-weight 
bearing stretches (Bakheit et al. 2005 (b)); Isotonic weight bearing stretches (Bakheit et 
al. 2005 (c)); standing (Kunkel et al, 1993) and intelligent control stretching (Chung et 
al. 2005; Selles et al, 2005) on spasticity in studies with no control groups. 
 
In three studies spasticity was measured in Nm/O or Nm/rad and so could be converted 
to common units. These showed a combined overall effect of -0.124Nm/o; CI-0.768 to 
0.319 with stretching and a mean difference of -0.18 Nm/o (CI 0.59 TO -0.94) (Figure 
3.7). 
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Figure 3.7. Forest plot showing 95% confidence intervals (CI) for the effects of: 
constant angle and constant torque stretching (Yeh et al, 2004; Yeh et al, 2005 (a)/(b); 
and intelligent control stretching (Chung et al. 2005) on spasticity. 
3.4.3 Effects of Stretch on Spasticity: Clinical Measures 
3.4.3.1 Studies with Control Group: 
Two studies compared the effects of stretching on spasticity as measured using the 
Modified Ashworth scale. Baker et al (2007) had an effect size of -0.656 (CI -1.8 to 
0.53) and Harvey et al 2009 had an effects size of -0.19 (CI -0.99 to 0.62), both 
demonstrating a reduction in spasticity with the stretching intervention. 
3.4.3.2 Pre-post Intervention Comparison 
Seven studies were included of which one compared three different types of stretches 
and one compared two types of stretches; giving a total of 10 comparisons. The studies 
were heterogeneous (Q=105.79 I2=91.5%). The forest plot is shown in Figure 3.8 
indicating an effect that favours treatment in reducing spasticity (overall effect size:  
1.072; CI -1.748 to -0.395).  
Favours 
Control Favours 
Treatment 
Favours 
Control 
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      Figure 3.8. Forest plot showing 95% confidence intervals (CI) for the effects of: 
constant angle and constant torque stretching (Tsai et al, 2001; Yeh et al, 2005 (a)/(b); 
Yeh et al 2007 (a)/(c)); cyclic (Wu et al, 2006; Yeh et al, 2007 (b); Harvey et al, 2009); 
and standing ( Baker et al, 2007; Kunkel et al, 1993) on spasticity in studies with no 
control groups. 
 
3.4.4  Effects of Stretch on Range of Movement 
3.4.4.1 Studies with Control Group: 
Six studies compared the effects of stretching on range of movement. The studies 
showed heterogeneity (Q =12.91; I2=61.3%). The forest plot is shown in Figure 3.9. 
The overall effect size for this group of studies was 0.782 with a 95% CI ranging from 
(CI 0.286 to 1.277), demonstrating an effect in favour of stretching for increasing ROM. 
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Figure 3.9. Forest plot showing 95% confidence intervals (CI) for the effects of: ROM 
exercises (Tseng et al 2006 (a)/(b)); cyclic (Harvey et al, 2009); intelligent control 
stretching (Chung et al. 2005);  standing (Ben et al, 2005; Baker et al, 2007);  
stretching on ROM in studies with a control group. 
 
3.4.4.2 Pre-post Intervention Comparison 
Twelve studies were included of which one compared three different types of stretches 
and two compared two types of stretches; giving a total of 16 comparisons. The studies 
were heterogeneous (Q=74.02 I2=79.7%). The forest plot is shown in Figure 3.10 
indicating an effect that favours treatment on increasing ROM (overall effect size: 0.75; 
CI 0.487, 1.016). 
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Figure 3.10.  Forest plot showing 95% confidence intervals (CI) for the effects of: 
constant angle and constant torque stretching (Tsai et al, 2001;Yeh et al, 2004; Yeh et 
al, 2005 (a)/(b); Yeh et al 2007 (a)/(c); cyclic stretching (Yeh et al, 2007 (b); Harvey et 
al, 2009); intelligent control stretching (Chung et al. 2005; Selles et al, 2005); ROM 
exercises (Tseng et al 2006 (a)/(b)) and standing (Bohannon & Larkin, 1985; Ben et al, 
2005; Baker et al, 2007; Kunkel et al, 1993) on ROM in studies with no control group. 
 
 
All studies measured ROM in degrees. When studies comparing intervention with a 
control group were compared the overall mean difference was 5.97o (CI 3.3 to 8.62) 
favouring stretching (Figure 3.11).When studies without a control group were compared 
the mean difference was 5o (CI 9.65 to 0.28). 
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Figure 3.11. Forest plot showing 95% confidence intervals (CI) and mean difference in 
ROM in studies with a control group: ROM exercises (Tseng et al 2006 (a)/(b)); cyclic 
stretching (Harvey et al, 2009); intelligent control stretching (Chung et al. 2005) and 
standing (Ben et al, 2005; Baker et al, 2007). ROM increase over the control group is 
indicated.  
 
3.4.5 Effects of Stretch on Functional Mobility 
In some of the papers that met the inclusion criteria the effects of stretching on 
functional ability were also reported. In these papers functional ability was assessed 
using the FIM ADL scale, TUG, and the cadence and 10 meter timed walk. Bressel & 
McNair (2002) reported no significant improvements in the 10 meter timed walk test 
with the application of a single session of 30 minutes static or cyclic stretching. 
However, Wu et al. (2006) reported a significant increase in the TUG (p<0.01), 10 
meter timed walk (p<0.01) and cadence (p<0.05) following 15 minutes of dynamic 
repeated ankle ROM exercises in a standing position. Similarly, Selles et al (2005) 
reported a significant increase in comfortable walking speed from 0.52(m/sec) to 
0.60(m/sec) after 45 minutes of stretching three times a week for four weeks (Selles et 
Favours 
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Favours 
Treatment 
Favours 
Treatment 
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al. 2005).  
3.4.6 Comparing Different Stretching Interventions 
Two studies compared different stretching interventions. Yeh et al (2007) compared the 
application of a constant torque, constant angle and cyclic stretching.  Bressel and 
McNair (2002) compared constant angle and cyclic stretching.  
The stretching intervention implemented with a constant torque was shown to be more 
effective at increasing ROM and decreasing spasticity when compared to constant 
angle and cyclic interventions (p<0.001) (Yeh et al, 2007, Figure 3.12a). No significant 
difference was found between constant angle and cyclic stretching treatments 
(p=0.071, Figure 3.12a).  
  
Figure 3.12a. Comparing the treatment effect of: constant torque, constant angle and 
cyclic stretches on ROM (Yeh et al, 2007). More positive values indicate a greater 
increase in ROM with constant torque treatment being the most favourable. 
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No statistically significant difference in the change in passive stiffness was found 
between a constant angle and cyclic stretch (Bressel & McNair 2002, Figure 3.12b).   
 
 
Figure 3.12b. Comparing the treatment effect of: constant angle and cyclic stretches 
on passive stiffness (Bressel & McNair, 2002). More negative values indicate a greater 
reduction in passive stiffness. Constant angle stretching was the more favourable of 
the two treatment options.  
 
 
There was a significant reduction in spasticity that was greater with a constant angle 
stretch compared to a cyclic stretch. A constant torque stretch produced a greater 
reduction in spasticity compared to both a constant angle and cyclic stretch (Yeh et al 
2007, Figure 3.12c) 
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Figure 3.12c. Comparing the treatment effect of: constant torque, constant angle and 
cyclic stretches on spasticity (Yeh et al, 2007). More negative values indicate a greater 
reduction in spasticity. Constant torque stretching was the more favourable of the three 
treatment options.  
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3.5 Discussion  
There has been recent speculation in clinical practise regarding the on-going 
implementation of stretching regimes for patients with hypertonia secondary to a 
neurological insult. It is evident that this uncertainty has, in part, stemmed from a recent 
systematic review which broadly concludes that stretching interventions are ineffective 
for the treatment and prevention of contractures and spasticity (Katalinic et al. 2012). 
As discussed in chapter one section 2.5.2.3 this review has potential flaws and may 
have overlooked some key issues; therefore the purpose of this literature review was to 
ascertain the efficacy of stretching interventions for the treatment and or management 
of ankle plantarflexor hypertonia in people with neurological disorders.  
 
In response to criticisms of previous reviews that only included randomised controlled 
trials (Weppler 2011) the current review additionally included experimental trials with no 
control group. As can be seen from the forest plots and meta-analysis these trials 
demonstrated larger effects sizes with 95% confidence intervals that tended to favour 
treatment compared to studies that used a control group. The higher effect size with 
non-controlled trials has been reported previously and reflects potential bias effects 
that can affect serial measures, such as fatigue, and an outcome measurement 
practice effect (Wang & Bakhai 2006).  Although fatigue could be a compounding factor 
in the studies reviewed, many of the outcome measures use perturbations/ passive 
movements and electrical stimulation to assess passive stiffness, spasticity and ROM. 
In these cases the participant was essentially passive suggesting that there would be 
little opportunity for participant-driven practice effects as could be seen, for example, in 
some measures of gross function such as walking speed or timed up and go.  
The lack of a control group does not always reflect poor experimental methodology. 
Some of the studies were specifically designed to compare the effects of different types 
of stretching in the same patient population. In these cases there was not a true control 
group but rather different comparator groups. The findings of the review undertaken for 
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this thesis are broadly in agreement with previous reviews (Katalinic et al. 2012). It is 
acknowledged that this thesis review was only conducted by one person and therefore 
there was potential for bias in the articles chosen compared to one  undertaken using 
Cochrane criteria (Higgins & Green 2009).  
3.5.1 Effects on ROM: 
When both controlled and uncontrolled trials were assessed there was an effect size 
that favoured treatment in increasing ROM with 95% confidence intervals that did not 
overlap zero. Therefore, it can be concluded that stretching can improve ROM.  As 
highlighted by Katalinic’s review the question then remains as to whether this 
statistically significant improvement is clinically useful (Katalinic et al. 2012).  Katalinic 
et al 2009 chose 5o as their cut off for a minimally significant clinical difference. In this 
current review the size of the effect was 5.97o (95% CI 3.3 o to 8.62 o) when the 
controlled trials were assessed and, as the lower 95% CI goes down to 3.3 o, one could 
argue that the effects of stretching on ROM are inconclusive.  However, it remains 
unclear what does constitute a minimally significant clinical difference. This could 
potentially vary depending on the part of the range that is gained and the function of 
the participant.  For instance, a 3.3 o improvement that allows a person to achieve 
plantargrade with their ankles at 90 o could be highly clinically significant as this would 
in turn affect the posture of more proximal joints and potentially aid transfers. Similarly, 
an improvement from 0-3 o ankle dorsiflexion in an ambulant participant could 
significantly reduce the risk of tripping while walking. An important proviso here is that 
the person would have to either actively control that range or use aids such as 
functional electrical stimulation to “access” the newly gained range. In summary, this 
review concludes that ROM can be significantly improved with stretching and that, as 
well as trying to optimise these effects; future work should be directed towards 
understanding the clinical utility of these improvements.  
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3.5.2 Passive Stiffness and Spasticity: 
When relying on only controlled trials to assess the effects of stretching on passive 
stiffness and spasticity (as measured using biomechanical, electrophysiological and 
clinical measures) the effect size was smaller and overlapped zero compared to non-
controlled trials. In light of this the conclusion at present is that the effects of stretching 
on passive stiffness and spasticity are inconclusive. 
One reason for a lack of a conclusive improvement with stretching could be that this 
intervention is ineffective in reducing stiffness and spasticity. Another reason, however, 
could be due to the variable stretching parameters used in the studies. For instance, 
from the studies described to date there is evidence that a constant torque stretch is 
more effective than stretching at a constant angle or cyclic stretching. For the most 
promising of these stretches, a constant torque stretch, it is unclear what the optimal 
torque is or what is the optimal duration of stretching. Variation in the level of torque 
applied throughout the stretch may also impact on effectiveness. In the study by Yeh et 
al (2007) stretching force was shown to gradually decrease over the duration of a 30 
minute treatment session by 46.57 +/- 4.79% (mean +/- SD) and by 36.82 +/- 2.25% 
with application of a stretch at a constant angle and cyclic stretching respectively. It is 
possible that the decrease in the applied force affected the efficiency of both these 
interventions.   Looking into the effect of these parameters will be the main aim of the 
thesis. 
Inconclusive findings about the effectiveness of stretching in reducing passive and 
stretch reflex mediated stiffness could also reflect variability in the outcome measures 
used to quantify these parameters. Changes in spasticity were measured using a 
variety of techniques including clinical and laboratory measurement tools. However, in 
most instances the modified Ashworth scale was used to characterise changes with an 
intervention. Significant reductions in spasticity as measured by the modified Ashworth 
scale were reported in  four studies  ( Wu et al., 2006;  Yeh et al., 2004;  Yeh et al., 
2007, 2005).  Contrary, to these findings both Baker et al (2007) and Harvey et al, 
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(2009) observed no significant changes in spasticity with this measurement tool. 
Interpretation of these findings is however problematic due to the number of recognised 
flaws of the modified Ashworth scale with regard to its validity, reliability and 
responsiveness (refer to Section 2.4.1.1.) Additionally, clinical enhancements of muscle 
tone in spastic paretic patients have been observed at night (Odeen, 1981) questioning 
the efficacy of interventions during the day when patients are most active; and it is 
speculated that degree of activity is correlated to a reduction in hypertonus (Odeen, 
1981).     
Seven of the studies included in the review reported that stretching had no significant 
effect on clonus, Achilles and knee tendon reflexes, H-reflex amplitude and latency and 
spasm frequency (Baker, Cassidy, & Rone-Adams, 2007; Bakheit et al., 2005; Chung 
et al., 2005; Kunkel et al., 1993; Selles et al., 2005; Wu et al., 2006; Zhang et al., 
2002). Contrary to the above, Tasi et al. (2001) observed significant change in 
Fwave:Mwave response ratio and Hmax:Mmax ratio following their constant angle 
stretching protocols. Additionally, Trembley et al (1990) demonstrated significant 
reductions in EMG activity in the plantarflexors following 30 minutes of stretching on a 
tilt table. Spasticity can be very variable and it is thought that EMG signals from 
different measurement sessions can often demonstrate inconsistency (Cadenhead et 
al., 2002; Odeen, 1981; Selles et al., 2005). In addition, it has been postulated that test 
repetitions may complicate the assessment of hypertonia (Nuyens et al. 2001).  This 
thesis will measure spasticity by imposing stereotyped stretches using a motor and 
measuring the mechanical response and the EMG response.  This method has the 
advantage that it can measure stretch-evoked stiffness in the same units as passive 
stiffness and gives a direct indication of the opposing torque that can limit functional 
movements (Wood et al. 2005). 
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Passive stiffness can also be difficult to measure and perhaps because of this few 
studies in MS have investigated this as an outcome measure for stretching 
interventions. The use of a motor allows the stiffness of the whole muscle-tendon 
complex to be measured. However, following neurological lesion differential changes in 
the muscle and tendon can occur. For example, following a stroke the gastrocnemius  
muscle body has reported to become short and stiff and the tendon longer and more 
compliant ( Gao & Zhang, 2008; Zhao et al. 2009). Stretching may have differential 
effects on the muscle and tendon depending on the degree of underlying stiffness 
(Abellaneda et al. 2009). Therefore, techniques to measure muscle fibre stiffness and 
tendon stiffness directly may be more sensitive at revealing changes with stretching 
compared to gross measures of the muscle-tendon stiffness. Recently, 
ultrasonography has been used to measure muscle and tendon stiffness  directly (Zhao  
et al. 2009; Kubo et al. 2002)  and this method will be used to explore differences 
between healthy controls and pwMS and the effects of stretching in chapter 8. 
 
3.5.3 Summary 
Although previous research and reviews show many areas of agreement, disparity and 
inconsistencies of findings are present. It is evident that there is still a great deal that is 
unknown and requires further research. Some important questions that have to be 
addressed include; what is the goal directed aim of stretching? Is the main purpose of 
stretch to facilitate functional training by temporarily inhibiting restrictive spastic 
hypertonia? If so the literature lends inconclusive support. Secondly, what is a 
worthwhile treatment effect? While it has been reported that anything below 5o of 
increase in range is not considered worthwhile; this is arguable. It is also not yet known 
if the therapeutic effects of stretching accumulate over time or if they are dose related. 
Similarly, it is not clear what time of day is most effective for stretching or at what stage 
of the disease course stretching should be implemented; is it better to stretch early on 
at disease onset or at a later stage for the purpose of treatment or management? 
Additionally, research on the long term effects of stretching is minimal and therefore 
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requires investigating. Although there is still a lot that is unknown, it is clear from the 
literature reviewed that stretching does have the potential to improve ROM. Further 
work is required to define the parameters of plantarflexor stretches that will provide the 
optimal improvements in passive stiffness and spasticity and ultimately functional 
walking. 
 
3.5.4 Thesis Justification, Aims and Structure 
To date there is evidence that a constant torque stretch produces greater 
improvements in passive stiffness, spasticity and ROM compared to constant angle 
and cyclic stretches.  However, it is unclear, during a constant torque stretch, what the 
optimal applied torque or duration of stretch actually is. This thesis therefore aims to 
assess the effects of different torques applied over different durations on passive 
stiffness, spasticity and ROM.  In keeping with past study designs that have compared 
different types of stretches, a repeated measures design will be used where the same 
participants are seen on different sessions and where in each session a different 
torque is applied for a set duration.  This design does not allow for the long term effects 
of stretching at a particular torque to be assessed. However, monitoring stretch-
induced effects over 30 minutes post stretch will provide information about the 
immediate post-stretch time course. This is important since it is assumed that transient 
stretch mediated effects may be useful for the immediate clinical situation. For 
example, a stretch to decrease stiffness that may limit functional movement would be 
useful prior to performing additional interventions (e.g. strength / task related training) 
that aim to improve that functional movement. It is further assumed that for more long 
term improvements in passive stiffness, spasticity and ROM that any stretch-induced 
effects should last as long as possible following a single stretching session therefore 
providing a long term signal that could drive tissue remodelling.  These assumptions 
will be revisited in the concluding chapter. 
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When applying stretches using a motor no justification has been given in previous work 
as to why a particular torque was chosen. The use of motors to deliver stretches have 
several advantages in that an exact specified torque can be delivered and the motor 
can be used to assess ROM and stiffness pre and post intervention. However, the use 
of motors are expensive and impractical for the majority of clinical stretching regimes 
(eg in the home environment). Therefore, it is important that the torques assessed, in 
this and future studies, include the range of torques that can be applied by patients for 
the purposes of self-management programmes.  This will allow an assessment of 
applied torque delivered using motors to be ecologically valid and relevant to clinical 
practice. 
Finally, it is important to ascertain the exact site of passive stiffness changes following 
a neurological insult and whether stretching specifically targets the sites (eg tendon vs 
muscle) of increased stiffness. This can be done by imaging muscle motion using 
ultrasound during standard ankle perturbations. 
This thesis therefore aims to: 
d) Define the torques that can be applied by pwMS during commonly prescribed 
manual stretches (Chapter 5) 
e) Investigate the effects of different levels of applied torque and durations of 
stretch using a motor on passive stiffness, spasticity and ROM in pwMS 
(Chapter 6 and 7) 
f) Investigate the effects of constant torque stretching on direct measures of 
muscle  strain using ultrasonography (Chapter 8) 
 
Chapter 4 will describe common methods that are used throughout the thesis and 
chapter 9 will provide an overview of the thesis findings an appraisal of the underlying 
study assumptions and their limitations, and directions for future work. 
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4. Chapter Four: Methods 
This chapter describes the recruitment strategy, subject selection and randomisation 
criteria, outcome measures, experimental procedures, data collection and analysis 
methods common to the experimental studies detailed in this thesis. Any specific 
variations in methodological procedures not mentioned here will be subsequently 
detailed in the relevant chapters. 
4.1 Sample Size Calculations 
Study 1:  The aim of study one was to investigate the applied torques achieved during 
four commonly applied stretches of the plantarflexors and explore the relationship 
between the applied torque and the participants’ functional ability and level of stiffness 
(2 predictors). Harvey et al. (2003) previously investigated therapist applied stretches 
of the hamstrings in people with a spinal cord injury. A mean correlation coefficient of 
0.7 (R2=0.49) was found between the applied torque and hamstring extensibility. A 
similar relationship was assumed for patient applied stretches in study one. Thus, for a 
multiple regression with two predictors and 90% power at the 0.05% significance, the 
estimated sample size was 19.2. Therefore the aim was to have a minimal sample size 
of 20 people undertaking all four stretches. It was anticipated that up to 36 people 
would need to be targeted to achieve this minimum sample size since people with an 
Expanded Disability Status Scale (EDSS) ≥6 may not be able to achieve all the stretch 
positions requested.    
Studies 2 and 3: These studies aimed to investigate the effect of different applied 
torques (study 2) and stretch duration (study 3) on the resulting reduction in stiffness. 
Although there was no data in the literature on the effects of applied torque on 
stiffness, previous authors  had compared constant angle with constant torque 
stretches (Yeh et al. 2007). Therefore, sample size calculations were based on an 
assumption that a similar effect size would be found between the different applied 
torques as observed between constant angle and constant torque stretches. Yeh et al. 
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(2007) found that a stretch at a constant angle produced a 29+/-10% change in 
stiffness whilst a constant torque stretch produced a 39+/- 10% change in stiffness. 
Thus the effect size was (39-29)/10 =1. For 90% power at the 0.05% significance level, 
the estimated sample size required to find a difference equivalent to one standard 
deviation between the means of the different stretches is 13 (determined for a paired t 
test). To account for 15% participant drop out per visit (3 visits) the aim was to recruit a 
maximum of 19 people to ensure that 13 people were seen for all three visits. 
4.2 Study Sample 
The combined study sample of the experiments consisted of 54 people clinically 
diagnosed with MS who were mild to moderately disabled (27 study one, 14 study two, 
13 study three) and 15 healthy controls in study one and 13 in study two and three 
(identical sample). All subjects provided informed written consent prior to participation 
in keeping with the declaration of Helsinki (Helsinki, 1996); ethical approval was 
obtained from the National Health Service (NHS) Torbay and Devon Research Ethics 
Committee  and research and development committee approval was granted by the 
Plymouth Hospitals NHS Trust (Ref-09/H0202/42). 
4.3 Recruitment Strategy  
People with MS who were registered on the South West Impact of MS Project (SWIMS) 
database (Zajicek et al. 2010), were invited via letter to volunteer for the studies. 
SWIMS is a population-based natural history database in which longitudinal self-report  
questionnaire data is  collected to assess the impact of MS on over 1100 people in 
Devon and Cornwall.  
The SWIMS Project Coordinator initially identified SWIMS participants who met the 
eligibility criteria (see below). These potential participants had stated that they had 
experienced symptoms of stiffness in the last six months but were not confined to bed 
(EDSS =7) (Goodin 1998). The SWIMS Project Coordinator withheld the identities of 
eligible participants from the research team but a record was made on the SWIMS 
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project database that a participant was eligible to approach for this stretch study.  The 
SWIMS project coordinator then sent a “Stretch Study” information pack directly to 
eligible participants.  The information pack contained a cover letter from the SWIMS 
coordinator to notify participants about the stretch study and explain why they had been 
chosen to take part, an invitation letter from the researcher, participant information 
sheet and stamped addressed reply slip.  
All reply slips were returned directly to the research team. Potential participants were 
then contacted via telephone to ascertain additional information, answer screening 
questions and book appointments for visits to the Human Movement and Function 
Laboratory at the Allied Health Centre, Plymouth. In study one, 30 participants with MS 
were recruited, 27 of which completed the study. In study two, 17 participants with MS 
were recruited, 14 of which completed the study. In study three, 17 participants with 
MS were recruited, 13 of which completed the study. In addition age, height and weight 
matched controls were recruited from friends and spouses of people with MS and local 
staff. In study one, 15 control participants were recruited and for studies two and three 
a single control group of 13 participants was recruited.  
4.4 Eligibility Criteria 
People with MS had to fulfil the following eligibility criteria: 
4.4.1 Inclusion Criteria: 
Participants to: 
(a) Be able to take a minimum of 10 steps with or without the use of a walking aid and 
transfer independently (EDSS upper limit 7.0). 
(b) Be able to self-report the presence of leg stiffness.  
(c) Passively achieve a neutral alignment of the foot between inversion and eversion 
with the foot in 10o plantarflexion. This was required as motor driven stretches and 
measures of stiffness moved the ankle about one axis; any ankle contractures into 
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inversion or eversion would not move in the parasagittal plane, potentially causing 
injury. 
(d) Have at least 90o passive movement at the knee when the hip is extended. 
(e) Live within the Plymouth NHS hospitals catchment area and be willing to travel to 
the Human Movement and Function Laboratory at the Peninsula Allied Health Centre, 
Plymouth. 
4.4.2 Exclusion Criteria: 
(a) Presence of additional neurological or orthopaedic conditions not associated with 
MS. 
(b) Severe cognitive impairment such that they are unable to provide informed consent. 
(c) Upper limb deficits that prevent them from consistently using the manual motor 
safety cut off switch. 
4.5 Measures of Participant Characteristics  
4.5.1 Descriptors of Functional Status 
Barthel Index: a self-report 10 item ordinal scale measuring daily functioning such as 
mobility,  feeding and bathing (van der Putten et al. 1999). The Barthel Index is one of 
the most widely used generic disability measures and scores range form 0-100 with a 
high score indicative of a high level of functioning.  
Multiple Sclerosis Walking Scale: a 12 item self-report MS walking scale that measures 
the impact of MS on walking ability (Hobart et al. 2003). Scores range from 12-54, 
where a high score is indicative of high walking limitation. Scores are transformed to 
give a range of 0-100. 
Expanded Disability Status Scale (EDSS): a 10 item ordinal scale ranging from “no 
disability” to “severe disability” where 4.5 is fully ambulatory without aid and 7.0 is 
unable to walk 5 meters with an aid (Goodin, 1998). The EDSS is very widely used in 
MS studies. The self-report version was used in this study (Goodin, 1998).    
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4.5.2 Clinical and Subjective Measures of Stiffness 
Plantarflexor stiffness was assessed at baseline using both patient report and clinician 
rated methods.  
Multiple Sclerosis Spasticity Scale: an 88 item self-report questionnaire that measures 
the impact of muscle stiffness, pain and spasticity and the impact of spasticity on 
function and social interactions (Hobart et al. 2006).Scores range form 88-352 and a 
high score indicates that the participant is more bothered by the effects of stiffness and 
spasticity on their daily functioning.  
Ashworth Scale: a clinician rated measure of stiffness. Scores range from 0-4 where 
0=normal muscle tone and 4=limb is rigid in flexion or extension.  
4.6 Outcome Method 
4.6.1 Stiffness 
Passive motor driven stretches: 15 degree amplitude, slow (5 o/s) and fast (175 o/s) 
ramp stretches delivered by a servo motor. 
Here participants were placed in a semi-reclined (25o head tilt) position with the right or 
left foot supported in a padded footplate (manipulandum) attached to a BSM Servo 
Motor (8.64 AMPS, 13.3Nm BSM90N,2500 line encoder) in series with a 10:1 low 
backlash gearbox. The motor was driven by a Motiflex e100 brushless drive with three 
phase input (Baldor UK Ltd, Bristol, UK). The drive was controlled by software written 
using the mint workbench programme (Mint programming module OPT-MF-100, Baldor 
UK Ltd, Bristol, UK). In series with the motor was a torque transducer (TLSF-B; IML, 
Derby UK).  Analog outputs were provided via MINT option cards (e100). The motor 
had a resolution of 2.7 x10-4 degrees. Study one participants used the Biodex Systems 
3, IPRS Mediquipe UK motor and participants in study two and three the Baldor Motor. 
In all cases the ankle axis was aligned to the axis of the motor while the foot was in a 
plantagrade position and the thigh was held in place with padded straps with the knee 
 103 
 
in full extension. Padded stops and seatbelt styled supports prevented the body from 
moving longitudinally up the bed.  
 
 
Figure 4.1: Foot position for stiffness assessment: A) starting position 10 o 
plantarflexion; B) 5 o dorsiflexion 
 
The degree of ankle passive stiffness, total stiffness and stretch reflex activity were 
measured by applying a 15-degree amplitude, slow (5 o/s) and fast (175 o/s) stretch 
which consisted of ramps and variable hold periods repeated sinusodally six times 
(Yeh et al. 2004; Gajdosik, 2002) (Figure 4.1). A 5 Volt output signal indicated the time 
of stretch onset. In study two and three, a random two-four second delay was provided 
between hold positions so that the participants could not anticipate the stretch. Torque, 
position and velocity (EMG Analogue interface) were analogue to digital (AD) 
converted at 2KHz (Power 1401, Spike 2, Version 5, CED Electronics Cambridge, UK) 
and stored for off-line analysis (Matlab version R2009b).  
4.6.2 Motor Safety Features 
Extensive safety features were included in the Baldor and Biodex motor design to limit 
the maximal applied torque, joint position and to enable the user to immediately stop 
the motor (Yeh et al. 2004). The safety features included: 
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 (a) Mechanical stops that limit movement and shear pins that limit applied force above 
150 Nm. 
 (b) Software features that limit applied force and motion specific to the person being 
studied.  
(c) Hand held immediate cut off safety device for the operator and the participant.   
4.6.3 Strength and Muscle Activity 
Isometric Maximal Voluntary Contraction (iMVC): a maximum isometric voluntary 
ankle plantar- and dorsi-flexion contraction was recorded with the ankle in 10o 
plantarflexion. Participants were instructed to pull their foot up toward their head as 
hard as possible, relax then push their foot against the foot plate as hard as possible. 
Participants received visual feedback of the applied torque throughout the study as well 
as verbal encouragement.  
Muscle activity was recorded during the stretches and iMVC measured from the tibialis 
anterior, medial gastrocnemius and soleus muscles via surface electromyography 
(EMG 2.5 cm inter-electrode distance, MT8, MIE, UK); signals were sampled at 2KHz 
and AD converted for off line analysis (Power 1401, Spike 2, Version 5, CED 
Electronics Cambridge, UK). EMG signals were subsequently processed by removing 
any DC offset, filtering the data using a 1st order 30 Hz low pass butterworth zero 
phase and rectifying the data filter in MATLAB. 
4.6.4 Safety and Strength of the Stretch 
Visual analogue scale for safety and strength of stretch (study one):  
Participants were asked to score the perceived strength and safety of each stretch 
using a six point visual analogue scale (VAS) from 0 – 5 (strength: 0= no stretch, 5= 
very strong stretch; safety: 0= not safe at all, 5= very safe). 
 
Visual analogue scales from 0-10 for strength of stretch (studies two and three): 
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Participants were asked to score their perceived strength of stretch on a VAS from 0 –
10; where 0 = no stretch and 10 = a very strong stretch. It was felt that a scale of 0-5 
may not be broad enough for participants to accurately indicate the strength of the 
constant torque stretch applied using the Biodex motor.  
4.7 Analyses 
4.7.1 Analysis of Motor Driven Stretches 
Data files for the fast and slow stretches collected using Spike2 (CED Electronics 
Cambridge,UK) were assessed visually to determine that muscles were relaxed prior to 
the stretch and that there was no muscle activation during the slow stretches. Data was 
then exported as ascii text files in a standard format at 2000 Hz using a script program. 
Text files were then imported into MATLAB (Mathworks, UK). 
Individual stretches were aligned to stretch onset and then the average of stretch two-
six was calculated.  In study one stretch onset was defined as the point at which the 
acceleration/velocity trace rose above the pre-stretch mean baseline + 4SD for at least 
five milliseconds. In study two and three, stretch onset was aligned around a 5V signal 
that defined the onset of the stretch.  
Stretches were excluded in the slow stretch if the EMG values rose above a level 
defined as the mean + 4SD of the period prior to stretch onset. This ensured that the 
slow stretch was measuring the effects of passive limb stiffness rather than any 
volitional or reflex-related muscle activity. 
Stiffness values (slow and fast stretch data) were then calculated by entering the 
subject’s demographic data: mass, length of manipulandum, gender and side 
assessed. Torque (Torque total) and position were measured over a 300-350 ms period 
prior to stretch onset and immediately following stretch offset (Figure 4.2). 
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Figure 4.2:  Raw data from the fast (A) and slow (B) stretch. The average of five 
stretches for a participant with MS and a control is shown. Note the large response in 
soleus and subsequent resistance to movement in the pwMS in B (blue trace) 
The torque due to the weight of the foot (Torque foot weight) at each time point was 
estimated as: dmgTorque footweight sin     
Where θ = ankle angle relative to vertical (Figure 4.3), g = acceleration due to gravity, 
m = mass of the foot estimated from anthropometric data based on the subject’s mass 
and gender (De Leva 1996) and d = the manipulandum length. 
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Figure 4.3 Position of foot in manipulandum. θ= angle relative to vertical  
The change in torque due to the manipulandum (Torque manipulandum) was measured 
directly by re-playing the same computer controlled stretch when only the 
manipulandum was attached and without the foot inserted. The torque due to stiffness 
in the ankle-foot complex (Torque ankle-foot) was defined as: 
ummanipulandfootweighttotalfootankle TorqueTorqueTorqueTorque   (2.9) 
Stiffness was calculated as:  
Stiffness = ∆ Torque / ∆ Position (Nm/radians) 
Differences in all stiffness measures between groups were compared using a student t-
test. 
4.7.2 Definitions of Stiffness Used in the Thesis 
Total stiffness:  the fast stretch elicits a stretch reflex and so the resultant stiffness 
observed is a combination of both the neural and non-neural components (Stevenson 
2006). This will be referred to as the total stiffness. 
Passive stiffness: changes in visco-elastic properties (non-neural) including connective 
tissues within and surrounding muscles, joints and intramuscular proteins. The slow 
stretch allows an assessment of the passive component in isolation as it is slow 
enough not to elicit a stretch reflex (Stevenson, 2006). Pilot work has shown that 
stretch reflexes can be elicited in patient groups at speeds as low as 8 o/s. 
θ 
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Spasticity: a velocity-dependent increase in tonic stretch reflex with exaggerated 
tendon jerks, resulting from hyperexcitability of the stretch reflex (Lance, 1980). This is 
represented by the difference between the fast and slow stretches applied. 
4.7.3 Analysis of Isometric MVC 
The MVC was defined as the difference between the maximal applied torque and the 
baseline torque when the participant was resting. 
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5. Chapter Five: Factors Influencing the Applied Torque During 
Manually Applied Plantarflexor Stretches in People with 
Multiple Sclerosis 
5.1 Introduction 
Previous studies assessing stretching regimes have used motors to apply controlled 
stretches (Bressel & McNair, 2002; Yeh et al. 2004). Whilst the use of a motor has the 
advantage of providing consistency of stretching and the ability to monitor changes in 
stiffness, it is unclear whether the torques applied and the durations of stretching relate 
to clinically prescribed stretches. Therefore, the applied torques that can be produced 
with commonly applied manual stretches was investigated and the relationship 
between the applied torque, the severity of passive stiffness, spasticity and functional 
ability was explored.  
5.2 Materials and Methods 
5.2.1 Participants and Recruitment 
Participants with MS (n = 27) were recruited from the SWIMS database.  Participants 
were included if they met the eligibility criteria (see chapter 4 section 4.4 for details). 
PwMS were compared with 15 age, height and weight matched healthy controls. 
Written informed consent was obtained from all participants and the study was 
conducted with approval from the NHS Torbay and Devon Research Ethics Committee 
(Ref-09/H0202/42). 
5.2.2 Demographics and Self-Report Measures of Spasticity and Function 
Demographic information (gender, age, weight, height, type and duration of diagnosis, 
anti-spastic medication) was collected and self-report EDSS (Goodin, 1998) was 
recorded at the beginning of the study. During seated rest periods throughout the test 
session, participants completed self-report questionnaires to evaluate: function, the 
Barthel Index (BI, Putten et al., 1999); walking ability, the 12-item Multiple Sclerosis 
Walking Scale (MSWS-12, Hobart et al., 2003); and spasticity, the Multiple Sclerosis 
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Spasticity Scale (MSSS-88, Hobart et al., 2006) (refer to Chapter 4 , section 4.5 for 
details).  
5.2.3 Measurement of Stiffness, Strength and Muscle Activity 
Ankle stiffness: Plantarflexor stiffness was measured on the right leg as described in 
chapter 4 (Biodex Systems 3, IPRS Mediquipe UK).   
Isometric MVC: A maximum isometric voluntary ankle plantar- and dorsiflexion 
contraction (iMVC) was recorded with the right ankle in 10O plantarflexion; participants 
received visual feedback of the applied torque throughout. 
Muscle Activity: Surface EMG was recorded from the tibialis anterior, medial 
gastrocnemius and soleus muscles via surface electromyography (EMG 2.5 cm inter-
electrode distance, MT8, MIE, UK). The position of the surface electrodes was constant 
throughout the study; that is during measures of stiffness, strength and manually 
applied stretches. 
5.2.4 Manually Applied Stretches 
Four stretches of the right plantarflexor muscles were assessed in a consistent order 
(Figure 5.1): stretching in step standing (WALL); stretching off a step (STEP); pulling 
the ankle into dorsiflexion (PULL); and standing in an oswestry standing frame 
(FRAME). All stretches were demonstrated by the researcher using standardised 
instructions and each condition was practiced prior to measurement. Participants were 
not required to perform any stretch that could not be safely maintained and they wore a 
safety harness attached to an overhead gantry if their balance was compromised. The 
stretch duration for all positions was 15 seconds and each stretch was repeated three 
times. A five minute rest was given between each group of stretches during which 
participants were asked to score the perceived strength and safety of the stretch 
immediately using a visual analogue scale (VAS) from one – five (strength: 1= minimal 
stretch, 5= strong stretch; safety: 1= feel very unsafe, 5= feel very safe). 
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Figure 5.1: Stretch conditions: A) Wall stretch, B) Step stretch, C) Pull stretch (showing 
the ankle move into dorsiflexion from top to bottom), D) Frame stretch. 
Following the four stretch conditions and a five minute rest period, the MS participants 
performed a constant sustained stretch in order to determine the length of time that 
they could hold a stretch (up to a cut off of 10 minutes) and the limiting factors. One 
stretch position out of the four stretching conditions was selected; the stretch selection 
was based on the highest VAS score reported for perceived strength of stretch if it had 
a safety score of three or more.  Participants were asked to stretch for as long as they 
felt comfortable and to apply a force that did not cause discomfort and was similar to 
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the forces they typically applied while stretching. The duration of this stretch was 
recorded and the participants were asked to report why they had stopped stretching. 
5.2.5 Measurement of Gastrocnemius Length ,Torque and Muscle activity 
Gastrocnemius length was estimated from the position of Coda markers (Figure 5.2) 
placed on the muscles’ distal attachment (the tubercle of the calcaneus) and proximal 
attachment (posterior lateral femoral condyle) (Lichtwark et al. 2007).  
 
 
Figure 5.2: Tibial (TB) and Hindfoot (HF) diagram with Coda marker placement: 
(a) TB: Frontal plane through the malleoli and fibula head; sagittal plane through the 
tibial tuberosity and midpoint between the two malleolar markers (MMAL, LMAL); (b) 
HF: Sagittal plane aligned with markers along the vertical axis of the calcaneus; 
transverse plane is taken parallel to the floor (Carson et al. 2001).Abbreviation include: 
proximal femur (PFEM), middle of thigh (MID THIGH), knee axis (KAXIS), distal femur 
(DFEM), tibial tuberosity (TTUB), head of fibular (HFIB), lateral malleolus (LMAL), 
medial malleolus (MMAL), medial calcaneus (MCAL), lateral calcaneus 
(LCAL),posterior calcaneus (CAL1), marker placed on Achilles tendon in line with top of 
malleolus (CAL2), additional marker placed on external ankle device in line with 
posterior calcaneus (CPEG), distal first metatarsal (D1MT),proximal first metatarsal 
(P1MT), distal second metatarsal (D2MT),distal fifth metatarsal (D5MT), proximal fifth 
metatarsal (P5MT.)  
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Gastrocnemius length was calculated using pythagoras’ theorem: 
Length2= (proximal x – distal x)2 + proximal y-distal y)2+ (proximal z-distal z)2 
Where: 
proximal = position of the proximal marker on the posterior lateral femoral condyle  
distal= position of the distal attachment on the  tubercle of the calcaneus  
x= marker position in the antero-posterior direction 
y=marker position in the medio-lateral direction  
z= position in the vertical direction.  
Gastrocnemius length was normalised to body height. Additional markers were placed 
over bony landmarks that defined the longitudinal axis of the foot, shank and thigh and 
from this the ankle and knee angle in the sagittal plane was calculated.  Two calibration 
trials with the ankle at 90o and knee at 0 o were taken at the start to standardise the 
neutral ankle and knee position between participants. 
For stretches in a standing position the direction, magnitude and point of application of 
the applied torque was measured via force plates (9286AA Kistler, Instruments Ltd, 
Hampshire, UK) that the participant stood on (WALL, STEP AND FRAME). For the 
STEP and WALL stretches only the leg of interest was in contact with the force plate. 
For the FRAME stretch both feet were in contact with the force plate and the load 
through each foot was measured directly (FMAT, TEKSCAN, Biosense MedIcal UK). 
For the PULL stretch applied torque was measured via a torque transducer in series 
with the strap; markers were positioned along the strap to define the direction of pull 
and point of application of the torque. Body segment mass and the centre of mass 
were estimated from anthropometric data. Muscle activity was measured throughout 
the stretch using surface EMG.  
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A      B 
Figure 5.3: A) Codamotion analysis sagittal plane stick figure showing the Coda 
marker placement, B) Free body diagram of the forces acting on the foot when the 
body is stationary. 
As the participant was stationary during the stretch, the net ankle torque produced 
during the stretches was estimated as the cross product of the following vectors (Figure 
5.3) (Robertson et al., 2004):  
12 rgmFrM footGRFa

.  
Where:  
aM

 = unknown net ankle torque 
1r
 = vector from the ankle joint centre to the centre of mass 
2r
 = vector from the ankle joint centre to the point of application of the ground reaction 
force vector  
.gm foot = weight of the foot vector 
r1
r2
mfootg
T GR
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GRT

 = ground reaction force vector 
The net ankle torque was normalised by the participants’ body mass. The applied 
torque in the FRAME condition was adjusted according to the percentage of load 
through the right leg.  
EMG signals from the tibialis anterior and gastrocnemius were processed by removing 
any DC offset, filtering the data using a 1st order 30 Hz low pass butterworth zero 
phase and rectifying the data filter in MATLAB. The mean EMG activity over the 5-15 
period was then calculated. The EMG level was then normalised to the mean EMG 
level calculated over a 500 ms period centred on the point of maximal torque output. 
  
5.2.6 Analyses 
Normalised mean ankle torque and gastrocnemius length and EMG activity over the 5-
15 second period of the stretch were compared between the MS and control groups 
using a between groups repeated measures ANOVA (SPSS 17.0, IBM). Factors were 
STRETCH CONDITION N=4 (WALL, STEP, PULL, FRAME). A priori contrast 
compared the difference between the WALL Vs STEP; STEP Vs PULL and PULL Vs 
FRAME conditions. Differences in plantarflexor and dorsiflexor isometric muscle 
strength and stiffness between the groups were compared using a paired student t-test. 
The relationships between i) muscle strength ii) limb stiffness iii) functional ability (as 
measured by the Barthel Index and the MSWS12) and the applied torque were 
determined using a Pearson’s rank correlation; a Bonferroni correction was made to 
account for the multiple comparisons (n=16 significance taken P<0.05/16=0.003). For 
all other statistical tests, the level of significance was set at P<0.05.    
5.3 Results 
The study population comprised 27 pwMS (age 54 ± 8.08 yrs) and 15 healthy 
volunteers (53.4 ± 6.5 yrs). PwMS had a median EDSS score of 5.5 (IQR 1.8, range 
4.5-7.0) and a median Barthel Index of 90 (IQR 20, range 0-100). All participants could 
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achieve plantargrade (90o) at the ankle. Tables 5.1 and 5.2 provide a summary of the 
demographic characteristics and self-report questionnaire scores for the sample. 
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PwMS                N=27 
  
 F=20 
  M=7 
 
Mean:54 
SD ± 8.08 
 
Mean:168 
SD ±10.47 
 
Mean:77 
SD ± 19.27 
      
     Mean:9.83 
     SD ± 9.34 
       
   N=4 
 
Mean:5.50 
SD ± 1.88 
        
 
 
 
Subject    Group Gender Age(years) Height(cm) Weight(kg) MS Type Duration 
of MS 
(years) 
Anti-spastic 
medication 
EDSS 
1 MS M 61 180.9 129 PPMS 3 NO 6.0 
2 MS F 48 169.7 64 RRMS 0.50 NO 4.5 
3 MS F 45 151.5 104 RRMS 14 NO 4.5 
4 MS F 49 155.5 95 RRMS 7 NO 4.5 
5 MS M 51 188.0 120 RRMS 1 NO 6.0 
6 MS F 43 175.2 70 RRMS 3 NO 5.5 
7 MS F 76 165.2 65 PPMS 5 NO 6.0 
8 MS F 54 168.0 66 PPMS 1 NO 4.5 
9 MS F 65 154.1 55 PPMS 3 NO 6.0 
10 MS M 51 171.5 90 PPMS 8 NO 7.0 
11 MS M 55 174.6 100 PPMS 5 NO 7.0 
12 MS F 54 164.9 68 RRMS 3 NO 4.5 
13 MS F 57 170.4 66 RRMS 13 NO 6.5 
14 MS F 47 169.0 80 SPMS 14 NO 6.5 
15 MS F 61 165.1 76 SPMS 4 NO 5.0 
16 MS M 45 178.0 80 RRMS 12 NO 4.5 
17 MS F 52 166.8 55 RRMS 4 NO 5.5 
18 MS F 65 168.7 69 RRMS 21 NO 5.5 
19 MS F 52 153.0 70 RRMS 1 NO 4.5 
20 MS F 63 158.5 70   SPMS 20 NO 6.0 
21 MS F 52 154.0 50 RRMS 5 NO 4.5 
22 MS F 63 157.5 65   SPMS 32 Baclofen 7.0 
23 MS F 47 157.5 64   SPMS 20 Baclofen 6.5 
24 MS F 51 169.7 83   SPMS 28 Baclofen 6.0 
25 MS M 60 185.0 85 Unknown 28 Baclofen 7.0 
26 MS M 41 187.4 83 RRMS 1 NO 4.5 
27 MS F 50 163.0 58 RRMS 9 NO 4.5 
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Table 5.1. Participant demographics columns 1-6 contain information about each individual belonging to the patient or control groups, 
gender, age, height and weight. Columns 7-10 contain information regarding MS participants, including MS type: relapsing remitting MS 
(RRMS), primary progressive (PPMS), secondary progressive MS (SPMS), duration of MS, the use of anti-spastic medication and EDSS.  
Subject    Group Gender Age(years) Height(cm) Weight(kg) MS Type Duration 
of MS 
(years) 
Anti-spastic 
medication 
EDSS 
28 CON F 44 165.0 57 NA N/A N/A N/A 
29 CON F 63 169.0 57 NA N/A N/A N/A 
30 CON M 48 165.0 69 NA N/A N/A N/A 
31 CON F 47 167.0 65 NA N/A N/A N/A 
32 CON M 54 175.5 76 NA N/A N/A N/A 
33 CON F 54 170.0 140 NA N/A N/A N/A 
34 CON m 50 178.5 76 NA N/A N/A N/A 
35 CON F 56 179.0 100 NA N/A N/A N/A 
36 CON M 47 169.0 60 NA N/A N/A N/A 
37 CON M 62 171.5 76 NA N/A N/A N/A 
38                    CON F 62 163.9 63 NA N/A N/A N/A 
39                    CON M 51 177.5 75 NA N/A N/A N/A 
40                    CON M 56 176.8 102 NA N/A N/A N/A 
41                    CON M 46 166.5 106 NA N/A N/A N/A 
42                    CON M 61 172.0 89 NA N/A N/A N/A 
 Controls             N=15            F=6 
           M=9 
      Mean:53 
     SD ± 6.46 
      Mean:171 
      SD ± 5 .25 
    Mean:81 
    SD ± 22.99 
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Table 5.2 Clinical descriptors of people with MS: Barthel Index (Median, Inter Quartile 
Range (IQR)); Transformed MSWS12 (Mean ± Standard deviations, (IQR)); MSSS88 
(Median, (IQR)); plantarflexor Ashworth scores (Median, (IQR)).  
 
5.3.1 Stiffness and Muscle Strength 
Plantarflexor (t=-2.2 P=0.03) and dorsiflexor isometric strength (t=-4.0 P=0.0002, 
Figure 5.4a) was significantly reduced in pwMS. Slow (5 o/s) stretches did not elicit any 
EMG activity. The passive stiffness in the plantarflexors measured during the slow 
stretch was not significantly different between the groups (t=0.43 P=0.67).  Fast (175 
o/s) stretches resulted in EMG activation in all pwMS. The difference between the slow 
and fast stretch, indicative of the size of the stretch reflex, was significantly higher in 
pwMS  (t=2.05 P=0.04, Figure 5.4b). 
 
 
 
 
OUTCOME MEASURES SCORE 
Barthel index (range 0-100) 90.0 (20.0)  
MSWS12(t)(range 0-100) 48.42  ± 21.64  (38.89) 
MSSS88 (range 0-352) 153.0 (83.5) 
Ashworth ankle (range 0-4) 2(1) 
Ashworth knee extensors  1( 1) 
Ashworth knee flexors  1(1) 
Ashworth hip extensors  1(2) 
Ashworth hip flexors  1(2) 
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Figure 5.4: A) Maximum voluntary contraction recorded in Nm/kg (PF = Plantarflexor 
DF= Dorsiflexor strength), B) Average plantarflexor stiffness. Standard error of the 
mean (SEM) is indicated.  
5.3.2 Mean Ankle Torque 
There was a significant difference between the conditions (CONDITION F (3,120) = 
33.9 P=0.000); a priori contrasts revealed that the mean torque decreased significantly 
between the STEP and PULL conditions (F(1,40)=100.8 P<0.001) then increased 
significantly between the PULL and FRAME conditions (F(1,40)=40.7 P<0.001, Figure 
5.5a). There was no significant GROUP X CONDITION interaction (F(3,120)=0.6 
P=0.51 ) and no significant effect of group (GROUP F(1,40)= 1.5; P=0.22).  
5.3.3 Gastrocnemius Length 
There was a significant effect of group, with the controls showing a longer 
gastrocnemius length compared to the pwMS (GROUP F(1,40) = 7.2 P=0.01, Figure 
5.5b). There was no significant difference between the conditions (CONDITION 
F(3,120)= 2.4 P=0.09, Figure 5.5b). There was a significant GROUP X CONDITION 
interaction (F(3,120)=9.1 P<0.001). Contrasts revealed that there was a large decrease 
in gastrocnemius length between the STEP and PULL condition in the MS group whilst 
the muscle length stayed approximately the same in the controls (F(1,40)=7.9 P=0.008, 
Figure 5.5b).  There was greater gastrocnemius lengthening in the MS group during the 
FRAME condition compared to the PULL condition, in contrast to controls where 
lengthening was greater in the PULL compared to the FRAME condition (F(1,40)=10.5 
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P=0.002). In the FRAME condition muscle length was the same between the two 
groups, in keeping with the fact that all participants stood in a standardised position 
with their foot and knee position constrained by the frame (Figure 5.5b). 
 
 
Figure 5.5:  A) Mean ankle torque normalised to body weight (Nm/kg), B) 
Gastrocnemius length normalised to body height (cm). Standard error of the mean 
(SEM) is indicated.  
5.3.4 Muscle Activation 
Tibialis Anterior: There was a significant difference in normalised tibialis anterior 
activation between the conditions (CONDITION F(3,117)= 6.0 P<0.001). There was 
higher muscle activation in the PULL condition compared to the STEP (F(1,40)=6.4; 
P<0.05) and FRAME (F(1,40)=16; P<0.001) conditions (Figure 5.6a). There was no 
significant GROUP X CONDITION interaction (F(3,117)=0.99 P=0.4). Normalised EMG 
was higher in the MS group (GROUP F(1,40)=6.7 P=)< 0.05 ). 
Gastrocnemius and Soleus: Muscle activation in the two plantarflexor muscles during 
stretching showed identical trends and therefore only the gastrocnemius activity is 
reported.  There was a significant difference in gastrocnemius activation between the 
conditions (CONDITION F(3,117)=5.0 P<0.01) with activation being higher in the STEP 
compared to the WALL (F(3,40)=8.6 P=0.005) and PULL (F(3,40)=5.1 P=0.03) 
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conditions (Figure 5.6b). There was a significant GROUP X CONDITION interaction 
(F(3,117)=3.0  P=0.03) with a larger increase in activation in the STEP condition 
compared to the WALL condition in the MS group (F(1,40)=4.8 P<0.05) (Figure 5.6b).  
Normalised EMG was higher in the MS group (GROUP F(1,40)=5.1 P< 0.05). 
 
 
 
Figure 5.6:  A) Mean normalised tibialis anterior activation B) Mean normalised 
gastrocnemius activation. Standard error of the mean (SEM) is indicated.  
5.3.5 Relationship Between Ankle Torque, Ankle Stiffness and Functional 
Ability 
In pwMS there were weak and/or insubstantial correlations (r<0.3, Cohen 1988) 
between mean ankle torque and functional ability as measured by either the BI or the 
MSWS-12, or between mean ankle torque and stiffness following either a slow or a fast 
stretch (Table 5.3). 
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CONDITION WALL STEP      PULL OSF 
Mean ankle moment –  
Barthel Index 
R= 0.19  
(p=0.34) 
R=0.16 
(p=0.44) 
    R= 0.15  
   (p=0.47) 
 
R= 0.08  
(p=0.71) 
Ankle moment  
– MSWS12 
R= 0.23  
(p=0.27) 
 
R=0.0002 
(p=1.00) 
    R= 0.02  
    (p=0.92) 
R= 0.07  
(p=0.74) 
Ankle moment - 
Stiffness (slow stretch) 
R= 0.36  
(p=0.06) 
 
R=0.12  
(p=0.54) 
 R= 0.18   
(p=0.39) 
R= 0.07 
 (p=0.74) 
 
Ankle Moment - Stiffness 
(fast stretch) 
R= 0.17  
(p=0.40) 
R= 0.06  
(p=0.77) 
R= 0.27  
(p=0.19) 
R= 0.11  
(p=0.60) 
Man ankle moment-Ankle 
PF iMVC                        
R=0.30 
(P=0.11) 
R=0.07 
(P=0.71) 
R=0.22 
(P=0.26) 
R=0.06 
(P=0.75) 
 
 Table 5.3. Relationship between mean ankle moment and function, ankle stiffness and 
iMVC 
R = Pearson’s rank correlation. 
 
5.3.6 Self Report Measures of Strength and Safety of Stretches  
The WALL and the STEP stretch were rated by pwMS as the two strongest stretches 
and were rated equally safe (Figure 5.7). Of the pwMS 61.54% chose the WALL stretch 
as the stretch that gave them the strongest sensation of stretch, 23.08% chose the 
STEP, 11.54% the FRAME and 3.85% chose the PULL. One person chose not to 
perform the long stretch due to fatigue. The pwMS who chose to stretch subsequently 
using the FRAME or PULL conditions had a higher EDSS and lower BI (n=4 Median 
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(Interquartile range) EDSS = 6.5 (1.13), BI = 75 (18.75) compared to those that chose 
the WALL or STEP conditions (n = 22 EDSS= 5.75 (1.5), BI = 95 (15.0). 
 
 
 
 
 
 
 
 
 
 
Figure 5.7:  Self-reported strength and safety of stretch in MS group (mean +/- 
Standard error of the mean (SEM) is indicated.  
PwMS were able to maintain a stretch for 148.4 seconds (s) (±134.7) with longer 
stretch durations being seen in the FRAME and PULL conditions (mean (SD) 
296±419s) compared to the WALL and STEP conditions (118±86s). In the most 
commonly chosen stretch, the WALL stretch, fatigue in the arms was most frequently 
given (42.9% of cases) as the reason for cessation of the stretch, with other reasons 
being fatigue in the stretching leg (28.6%), general fatigue (26.4%) or discomfort in the 
neck region (7.1%). Healthy controls were not assessed in terms of the length of time 
with which a stretch could be sustained.  
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5.4 Discussion 
The overall aim of this study was to enhance understanding of the amplitude of the 
torques that could be achieved using commonly prescribed manual stretches for the 
plantarflexor muscles and the relationship between the torques achieved and the 
presenting level of stiffness and functional ability in pwMS.  
 
5.4.1 Muscle Stiffness in MS 
The 5 o/s stretch did not elicit a stretch reflex and is therefore felt to measure passive 
stiffness. The 175 o/s stretch elicited a stretch reflex in all pwMS.  The difference 
between the fast and slow stretch represents the contribution of spasticity to the overall 
stiffness measure and this was significantly higher in pwMS. In contrast, passive 
stiffness was not significantly different between the groups in keeping with recent work 
by Lorentzen et al. (2010) although changes in passive stiffness have been previously 
reported in this patient population (Sinkjaer et al., 1993). Given that spasticity was the 
main contributor to stretch mediated stiffness in this study sample it will be important to 
explore the clinical impact of stretching on spasticity as well as passive stiffness and 
range of motion in future studies. 
5.4.2 Effect of Stretching on Ankle Plantarflexion Torque and Gastrocnemius 
Length 
The ankle plantarflexor torque produced while stretching significantly varied between 
the different stretching conditions, with both groups producing higher torques in the 
standing conditions. This is supported by the subjective ratings of the pwMS, the 
majority of who rated the standing stretches (particularly the WALL stretch) as those 
which were associated with a strong sensation of stretch. Higher ankle torques in the 
WALL and STEP stretch were probably due to the use of body weight to apply a 
constant torque. In both groups less ankle torque was produced when manually using 
the arms to stretch the ankle. For the pwMS this resulted in less lengthening of the 
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gastrocnemius when compared to other stretches; this may reflect weakness and 
fatigue of the upper limb muscles resulting in an inability to generate a significant force 
to stretch the plantarflexor muscles. Lower net ankle plantarflexor torque in the PULL 
condition may also reflect the observed increase in activation of the tibialis anterior 
muscle. 
The controls were able to produce a significantly longer gastrocnemius muscle length 
than the pwMS, suggesting that they were able to produce a more effective stretch in 
all conditions.  However, the applied ankle torque did not differ between the groups. A 
net plantarflexor ankle torque could be caused by forces associated with passively 
stretching the plantarflexors or actively contracting the plantarflexors; the inverse 
dynamics approach used in the current study to calculate the ankle torque is unable to 
distinguish between these possibilities. While stretching the gastrocnemius and soleus, 
EMG was found to be higher in the pwMS in the WALL, STEP and PULL stretching 
conditions, highlighting that the stretch and generation of ankle torque was not totally 
passive in nature.  The increased muscle activation may reflect postural activity 
resulting from poor standing balance or a stretch–evoked contraction of the muscle.  
Correlations between function, stiffness and torque for all stretch conditions were  
negligible to weak (Cohen, 1988). This suggests that, in this sample of mild to 
moderately disabled pwMS (EDSS 4.5 – 7.0); neither functional capability nor the level 
of presenting stiffness had a significant impact on the torque produced. When asked to 
choose a stretch that was perceived as producing a strong sensation and that was safe 
to implement, people with lower functional ability tended to choose the FRAME and 
PULL conditions whilst participants with higher functional ability tended to choose the 
WALL and STEP stretches. People choosing the FRAME and PULL conditions were 
able to hold the stretch for longer than the other conditions that required standing 
balance and antigravity activity. Thus the PULL and FRAME stretch elicit lower ankle 
torques when measured objectively but can be held for longer. These findings are 
specific to the sample used and future work should explore the relationship between 
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stretch duration and applied torque using clinically achievable stretch durations and 
torques as outlined here in people with MS of varying levels of hypertonia and 
functional ability. This will allow clinicians to ascertain whether longer duration/lower 
torque stretches are as effective as shorter duration/higher torque stretches at reducing 
stiffness in the short and long term and ultimately allow stretch regimes to be tailored to 
the individual. 
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6. Chapter Six: The Effect of Stretching at Different Torques on 
Plantarflexor Stiffness and Range of Motion in People with 
Multiple Sclerosis 
6.1 Introduction 
Chapter five highlighted that  pwMS produce different levels of torque during standing 
and seated manual stretches, with standing stretches generating higher torques, which 
result in greater lengthening of the plantarflexors (Hall et al. 2010). There are currently 
no studies exploring the relationship between the effects of different clinically 
achievable torques on muscle stiffness and joint ROM. Previous work investigating 
sustained muscle stretching interventions have demonstrated that stretching at a 
constant-torque is more beneficial in improving ROM compared to cyclic stretches or 
holding the ankle at a constant angle (Yeh et al. 2007). Therefore, this second study 
aimed to investigate the effects of three constant torque values that were  shown in 
study one to be achievable by pwMS during manual stretches. The torques were 
applied over a 30 minute stretching period and the differing impact of these on passive 
stiffness, spasticity and joint ROM over a 30 minute post stretch period were 
ascertained.  The literature review described in chapter one and two highlights that the 
optimal duration of stretching remains unclear. Although there is still some uncertainty 
around the duration of stretch that is most effective in treating hypertonia, a number of 
studies have demonstrated that 30 minutes of stretching daily alongside routine 
positioning was of significant benefit in  improving ROM in the neurologically impaired 
population (Gorter et al. 2007; Yeh et al. 2004; Yeh et al. 2007; Bressel & McNair, 
2002). Based on this, it was anticipated that this stretch duration would be sufficient to 
show clinical benefits and allow the impact of different applied torques to be 
investigated. 
Determining the change in passive stiffness and spasticity with stretching will provide 
information about the role of the applied torque amplitude in passive stiffness and 
spasticity management and the time course of any changes over the pre- and post-
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stretch period. This will help to inform clinicians about the importance of these specific 
parameters. Further, investigating factors such as the impact of baseline levels of 
stiffness on treatment outcomes will help to tailor interventions to the individual. 
6.2 Materials and Methods 
6.2.1 Participant Recruitment 
Participants with MS (n = 17) were recruited from the SWIMS database (Zajicek et al. 
2010);  eligibility criteria were described in chapter four section 4.4. Baseline 
characteristics were compared to an age, height and weight matched control group 
(n=13) recruited from friends/families of pwMS and via a local advertisement for 
volunteers. Written informed consent was obtained from all participants and the study 
was conducted with approval from the NHS Torbay and Devon Research Ethics 
Committee (Ref-09/H0202/42). 
6.2.2 Demographics and Baseline Characteristics 
During the post stretch period, participants with MS were asked to complete self-report 
questionnaires on function (BI and MSWS-12 (Putten et al. 1999; Hobart et al. 2003)) 
and spasticity (MSSS-88 (Hobart et al. 2006)). Disease severity was rated using the 
EDSS (Goodin, 1998). For both the control group and pwMS demographic information 
including age, weight, height, gender, shank length and thigh length was recorded at 
the beginning of the study. Length of time and type of diagnosis and medication was 
also recorded for participants with MS.  
6.2.3 The Stretching Intervention 
The study aimed to determine the effect of a 30 minute constant torque stretch on 
plantarflexor passive stiffness, stretch reflex-evoked stiffness, ROM, ankle plantar- and 
dorsi-flexor strength and to determine how this varied over a 30 minute post stretch 
period. Three torque levels were assessed over three test sessions, presented in 
random order with each session separated by a minimum of three days.  Factors such 
as bed height, back rest position and motor position relative to the bed were constant 
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for each participant across the three visits to ensure that the ankle starting position was 
standardised. 
 
The high (0.42 Nm/kg), medium (0.30 Nm/kg) and low (0.18 Nm/kg) imposed torques 
calculated from study one (see chapter five) were used to apply a constant stretch; the 
torque applied was scaled according to body weight.  Participants were placed in a 
semi-reclined (25o head tilt) position with their head supported on a pillow. The leg 
reported by participants to be the most affected by stiffness was placed in a padded 
footplate attached to a servomotor (BSM, UK). The ankle axis was then aligned to the 
axis of the motor and the thigh held in place with padded straps with the knee in 
extension and supported by the plinth.  Seat belt styled supports prevented the body 
from moving longitudinally up the bed (Figure 6.1).  
 
A custom-designed servomotor controlled by a digital signal processor, was used to 
measure stiffness and strength and apply a stretch at a constant torque. The 
servomotor was programmed to administer a low, medium or high constant torque over 
the 30 minute stretching period. Ankle position started from a standard position of 10o 
plantarflexion. The required level of torque built up over a 20 second period and 
allowed the muscle to be gradually stretched slowly and safely (Yeh et al. 2004). Safety 
features for the motor were used as indicated in chapter four section 4.6.2. 
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Figure 6.1: Experimental setup: participant in semi-reclined position with the test foot 
attached to a footplate at 0o. 
6.2.4 Measurement of Stiffness, Strength and Range of Motion 
Stiffness: The degree of ankle passive stiffness and stretch reflex activity was 
measured using a servomotor (BSM, UK) by applying a 15-degree amplitude, slow (5 
o/s) and fast (175 o/s) ramp stretch respectively while the participant was relaxed as 
described previously (chapter four, section 4.6.1). Measurements of stiffness were 
recorded using the servomotor at the beginning of the test session (baseline), 
immediately post intervention (post_0) and again at 10 (post_10), 20 (post_20) and 30 
(post_30) minutes post stretch. Surface EMG of the tibialis anterior, medial 
gastrocnemius and soleus muscles was recorded to ensure the participant was relaxed 
prior to the assessment and to measure the presence of any stretch-induced muscle 
activity. Additionally, stiffness was measured by a single rater (JO) in the right and left 
ankle plantar- and dorsi-flexors, knee and hip flexors and extensors using the Ashworth 
scale (Ashworth, 1964) at the beginning of the session.  
Muscle strength: Maximum isometric voluntary ankle contractions (iMVC) were 
recorded with the ankle in 10o plantarflexion at baseline, immediately post-stretch and 
30 minutes post stretch; participants received visual feedback of the iMVC and torque 
applied using a computer monitor.  
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Range of Motion: The range of motion was recorded directly from the BSM 
servomotor encoder. This measured the position of the motor shaft that was bolted to 
the manipulandum to an accuracy of 2.7 x10-40 degrees. The foot at 90o to the shank 
was defined as neutral or 0o, with positive values indicating dorsiflexion and negative 
values indicating plantarflexion. Initial baseline ROM was defined as the ankle range 15 
seconds after application of the low constant torque from a position of 10o 
plantarflexion. ROM was also recorded throughout the stretch and AD converted (200 
Hz sampling rate) by the power 1401 (CED Cambridge UK). 
6.2.5 Subjective Report of Stretch 
At 10 minute intervals during the 30 minute stretch participants were asked to score 
their perceived strength of stretch on a VAS from 0 –10, where 0 = no stretch and 10 = 
a very strong stretch. In addition, participants were asked to describe and locate the 
position of the stretch they were feeling.  
6.2.6 Analyses 
Plantarflexor stiffness and strength were analysed as described previously (chapter 
four, section 4.7). Position signals during the 30 min stretch were exported at 10 Hz 
and low pass filtered (4Hz, 1st order Butterworth) in MATLAB. The position was 
measured every 10 minutes to give an indication of how the ROM changed over time.  
Statistical analysis: Differences in baseline ankle stiffness, strength and ROM 
between the pwMS and the control group was compared using an unpaired t-test. 
In pwMS the effect of applied force on the change in stiffness, ROM, and isometric 
strength after a 30 minute stretch and the post stretch time course was compared using 
a repeated measures analysis of variance (ANOVA). Factors were TIME (five levels: 
baseline, post_0, post_10, post_20, post_30) and TORQUE (3 levels: high, medium, 
low). 
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The relationship between applied torque and the changes in passive and stretch reflex-
mediated stiffness and between the baseline stiffness and the change in stiffness was 
determined using linear regression analysis.  
For all statistical tests, the level of significance was set at P<0.05. 
6.3 Results 
6.3.1 Demographics and Baseline Characteristics 
Seventeen pwMS were assessed. Two of the participants recruited were unable to 
complete the study due to pre-existing recurrent back pain and a reported disc 
prolapse following the first session. One other participant was unable to tolerate the 
high constant torque applied and was therefore unable to complete the study in its 
entirety. 
The sample therefore comprised of 14 pwMS and 13 matched healthy controls, further 
details of the sample can be found in table 6.1 and 6.2 which provides a summary of 
the demographic characteristics and outcomes of the self-report questionnaires for this 
sample. All participants could achieve plantagrade (90o) at the ankle. 
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PwMS              N=14 F=11 
M=3 
Mean:57.21 
SD ± 10.04 
Mean:167.12 
SD ±10.78 
Mean:76.29 
SD ± 22.72 
SPMS =6   Mean :9.70 
RRMS=4   SD ±11.26 
PPMS=4     
             
N=3 
 
 
 
Mean:5.54              Y=8 
SD ± 0.97               N=6 
Controls           N=13 F=11 
M=2 
Mean:55.23 
SD ± 6.00 
Mean:163.35 
SD ± 8.16 
Mean:71.85 
SD ± 19.51 
 N/A       N/A N/A N/A 
 
Table 6.1: Participant Demographics and baseline characteristics CON = Control Group; N/A = not applicable. Columns 1-6 contain 
information about: subject number, each individual belonging to the patient or control group, gender, age, height, weight. Columns 7-10 
Subject    Group Gender Age(years) Height(cm) Weight(kg) MS Type Duration 
of MS 
(years) 
Anti-spastic 
medication 
EDSS Participated 
in S1 
1 MS F 50 164.7 75 SPMS 17 Baclofen 7.0 N 
2 MS M 42 193.0 86 RRMS 1.5 NO 4.5 Y 
3 MS F 57 162.2 68 RRMS 6 NO 4.5 N 
4 MS F 65 154.1 55 PPMS 3 NO 6.0 Y 
5 MS F 68 157.2 61 SPMS 30 Baclofen 6.0 N 
6 MS M 62 181.0 133 PPMS 2 NO 6.5 Y 
7 MS F 49 170.0 64 RRMS 1.2 NO 4.5 Y 
8 MS F 62 157.5 105 SPMS 35 NO 6.0 N 
9 MS F 54 169.0 67 PPMS 1.1 NO 4.5 Y 
10 MS F 61 164.5 75 SPMS 4 NO 4.5 Y 
11 MS F 48 158.0 62 SPMS 20 Baclofen 6.5 Y 
12 MS F 43 164.4 51 RRMS 4 NO 4.5 N 
13 MS M 63 179.0 101 SPMS 4 NO 6.5 N 
14 MS F 77 175.0 65 PPMS 7 NO 6.0 Y 
15 CON M 56 175.0 73 NA NA NA NA NA 
16 CON M 52 177.0 71 NA NA NA NA NA 
17 CON F 49 166.5 66 NA NA NA NA NA 
18 CON F 45 168.0 69 NA NA NA NA NA 
19 CON F 56 168.0 134 NA NA NA NA NA 
20 CON F 64 159.0 60 NA NA NA NA NA 
21 CON F 59 154.5 57 NA NA NA NA NA 
22 CON F 54 154.5 70 NA NA NA NA NA 
23 CON F 55 167.5 65 NA NA NA NA NA 
24 CON F 56 159.5 63 NA NA NA NA NA 
25 CON F 55 153.5 62 NA NA NA NA NA 
26 CON F 50 167.5 78 NA NA NA NA NA 
27 CON F 67 153.5 66 NA NA NA NA NA 
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contain information regarding MS participants including: MS type relapsing remitting MS (RRMS), primary progressive (PPMS), secondary 
progressive MS (SPMS) and duration, the use of anti-spastic medication and EDSS score. Mean ± standard deviations are indicated. 
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OUTCOME MEASURES SCORES 
Barthel Index (score range 0-100) 95  (5) 
MSWS12(t) (score range 0-100) 45 ± 23 (30) 
MSSS88 (score range 0-352) 139 (86)  
Ashworth right ankle plantarflexors (score range 0-4) 1 (2) 
Ashworth left ankle plantarflexors (score range 0-4) 1 (1) 
Ashworth right knee extensors (score range 0-4) 1(1) 
Ashworth left knee extensors (score range 0-4) 1 (1) 
Ashworth right knee flexors (score range 0-4) 1 (2) 
Ashworth left knee flexors (score range 0-4) 1 (2) 
Ashworth right hip extensors (score range 0-4) 0 (1) 
Ashworth left hip extensors (score range 0-4) 1 (1) 
Ashworth right hip flexors (score range 0-4) 0 (1) 
Ashworth left hip flexors (score range 0-4) 0 (1) 
 
Table 6.2: Clinical descriptors of people with MS: Barthel Index (Median (IQR); 
Transformed MSWS12(t) (Mean ± Standard deviations, (IQR)); MSSS88 (Median 
(IQR));  Ashworth scores (Median, (IQR)) are indicated.  
6.3.2 Comparison of Baseline Characteristics with Control Participants 
6.3.2.1 Stiffness and Muscle Strength 
Dorsiflexor isometric strength was significantly reduced in pwMS (t=-2.70 P=0.01) 
compared to the matched control group. However, although the plantarflexor muscles 
were weaker in pwMS this was not statistically significant (t=-1.28 P=0.21, Figure 6.2a). 
Slow (5o/s) stretches did not elicit any EMG activity. The passive stiffness in the 
plantarflexors measured during the slow stretch was significantly higher in pwMS (t= 
2.47 P= 0.02). Fast (175 o/s) stretches resulted in EMG activation in all pwMS. The 
difference between the slow and fast stretch, indicative of the size of the stretch reflex, 
was  not significantly different between the groups (t=-0.39 P=0.70, Figure 6.2b). 
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Figure 6.2: A) Maximum voluntary contraction (MVC) recorded in Nm/kg (PF = 
Plantarflexor DF = Dorsiflexor strength), B) Average plantarflexor stiffness in 
Nm/rad./kg. Standard error of the mean (SEM) is indicated.  
 
6.3.2.2 Range of Movement  
Initial baseline ROM was significantly lower in pwMS compared to the matched control 
group (t=-2.32 P = 0.04, Figure 6.3). This may be due to the significantly increased 
level of passive stiffness present in the pwMS at baseline.  
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Figure 6.3: Initial baseline ankle ROM for MS and control group from a position of 10o 
plantarflexion (start position) to 15s after application of the low constant torque (end 
position). Standard error of mean (SEM) indicated.  
 
6.3.3 Subjective Report of Stretch in pwMS (n=14) 
A Kolmogorov-Smirnov test revealed that the VAS data was not normally distributed. 
The data was therefore analysed using a Friedman non-parametric test after averaging 
across torque or time.  There was a significant difference in perceived strength of 
stretch with torque (P=0.01); with the largest difference occurring between the medium 
and low torques (Figure 6.4). There was no significant difference in the perceived 
strength of stretch reported over time (P=0.24). Of the participants, 81% reported 
feeling the stretch sensation in their calf, 9% in the back of the knee, 2% in the 
hamstring muscle and 8% were unsure. These results are general and not specific to 
the applied torque. 
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Figure 6.4: Self-reported strength of stretch on a visual analogue scale ranging from 0-
10. Mean +/- standard error of the mean (SEM) indicated. H = high torque M = medium 
torque L = low torque. 
6.3.4 Change in Stiffness with Applied Torque in pwMS 
Stiffness data were obtained at five time intervals; base= baseline; post_0= 
immediately post stretch; post_10= 10 minutes post stretch; post_20= 20 minutes post 
stretch; post_30= 30 minutes post stretch. 
6.3.4.1 Changes with Stretch  
Total Stiffness: There was no significant difference in total plantarflexor stiffness with 
torque (TORQUE F(2,26)=0.062 p=0.940). However, there was a significant difference 
in total plantarflexor stiffness over time (TIME F(4,52)=17.1 p=0.001), with a significant 
reduction in stiffness between baseline and post_0 (TIME F(1,13)=25.7 p=0.001); the 
stiffness then increased between post_0 and post_10 (TIME F(1,13)=14.6 p=0.002)  
and then it slightly decreased between post_10 to post_20 (TIME F(1,13)=11.5 
p=0.005) (Figure 6.5). There was no significant TORQUE X TIME interaction 
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(F(8,104)=0.32 p=0.80). The overall decrease in stiffness from the start of application 
of the stretch to the end of monitoring (60 minutes later) is given in table 6.3.  
 
Table 6.3: Average total stiffness for pwMS during and after stretches with different 
torques. Mean (Nm/rad.kg) ± standard deviation is indicated. 
 
 
Figure 6.5: Change in total stiffness in pwMS between (i) baseline and post stretch 
(Post_0 Base), (ii) immediate post stretch and 10 minutes post stretch (Post_10-
Post_0), (iii) 10 minutes post stretch and 20 minutes post stretch (Post_20-Post_10); 
20 minutes post stretch and 30 minutes post stretch (Post_30-Post_20) time period, 
were compared against the applied torque. Standard error of mean (SEM) indicated. H 
= High torque M = Medium torque L = Low torque. Negative values indicate a reduction 
in stiffness. 
 
Total Stiffness (Nm/rad.Kg) 
 
  Base Post_0 Post_10 Post_20 Post_30 
H  0.74±0.49 0.52±0.29 0.57±0.34  0.58±0.32 0.58±0.32 
M  0.69±0.49 0.52±0.46 0.55±0.44 0.55±0.45 0.54±0.40 
L 0.65±0.32 0.53±0.23 0.55±0.23 0.51±0.22  0.54±0.23 
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Passive Stiffness: There was no significant difference in passive stiffness with torque 
(TORQUE F(2,26)=0.16 p=0.86). However, there was a significant difference in 
passive stiffness over time (TIME F(4,52)=11.9 p=0.003), with a significant reduction in 
passive stiffness post stretch  (post_0-Base) (TIME F(1,13)=14.6 p=0.002);  stiffness 
then significantly increased 10 minutes post stretch (post_10 – post_0) (TIME 
F(1,13)=9.0 p=0.010) were it remains constant 20 minutes post stretch and further 
drops 30 minutes post stretch.  There was no significant TORQUE X TIME interaction 
(F (8,104) =0.24 p=0.63) (Figure 6.4). The overall decrease in passive stiffness from 
the start to the end of monitoring (60 minutes later) is given in table 6.6. 
 
 
Table 6.4:  Average passive stiffness in pwMS during and after different stretches. 
Mean ± standard deviation is indicated 
 
 
 
 
 
 
 
 
Passive Stiffness (Nm/rad.Kg) 
  Base Post_0 Post_10 Post_20 Post_30 
H 0.60±0.58  0.40±0.42 0.41±0.36 0.41±0.35 0.40±0.34 
M 0.60±0.58 0.40±0.42 0.41±0.36 0.41±0.35 0.40±0.34 
L 0.50±0.31 0.37±0.18 0.39±0.18 0.38±0.18 0.37±0.17 
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Figure 6.6: Change in passive stiffness in pwMS between (i) baseline and post stretch 
(Post_0-Base), (ii) immediate post stretch and 10 minutes post stretch (Post_10-
Post_0), (iii) 10 minutes post stretch and 20 minutes post stretch (Post_20-Post_10), 
20 minutes post stretch and 30 minutes post stretch (Post_30-Post_20) time periods 
were compared against the applied torque. Standard error of mean (SEM) indicated.  
 
Stretch Reflex Associated Stiffness: There was no significant difference in stretch 
reflex associated stiffness with applied torque (TORQUE F(2,26)=2.29 p=0.12) and no  
significant difference seen over the observed time frame (TIME F(4,52)=1.70 p=0.21). 
There was no significant TORQUE X TIME interaction (F(8,104)= 0.37 p=0.81 ( Figure 
6.7 ). The overall decrease in stretch reflex associated stiffness from the start of the 
stretch application to the end of monitoring (60 minutes later) is given in table 6.5. 
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Table 6.5: Average stretch reflex associated stiffness in pwMS during and after 
different stretches. Mean ± standard deviation is indicated 
 
 
 
Figure 6.7:  The difference in associated stretch reflex associated stiffness between 
baseline and post stretch (Post_0-Base), immediate post stretch and 10 minutes post 
stretch (Post_10-Post_0), (iii) 10 minutes post stretch and 20 minutes post stretch 
(Post_20-Post_10), 20 minutes post stretch and 30 minutes post stretch (Post_30-
Post_20) time periods were compared against the applied torque. Standard error of 
mean (SEM) indicated.  
 
 
 
 
Stretch Reflex Associated Stiffness (Nm/rad.Kg) 
  Base Post_0 Post_10 Post_20 Post_30 
H 0.15±0.17 0.13±0.15 0.17±0.15 0.19±0.13 0.20±0.12 
M 0.10±0.17 0.11±0.12 0.14±0.11 0.14±0.14 0.14±0.12 
L 0.15±0.11 0.16±0.10 0.16±0.10 0.13±0.08 0.17±0.11 
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6.3.5 Changes in Strength with AppliedTorque in pwMS (n=14) 
6.3.5.1 Isometric Dorsiflexor Strength  
There was no significant difference in isometric strength with torque (TORQUE 
F(2,26)=1.46 p=0.25). There was no significant difference over time (TIME 
F(2,26)=0.77 p=0.48). There was no significant TORQUE X TIME interaction 
(F(4,52)=0.85 p=0.46) (Figure 6.8). 
 
 
Figure 6.8: Change in isometric dorsiflexor strength in pwMS between (i) baseline and 
post stretch (Post_0-Base), (ii) immediate post stretch and 30 minutes post stretch 
(Post_30-Post_0), (iii) 30 minute post stretch and baseline (Post_30-Base) time 
periods were calculated and compared against the applied torque. Standard error of 
mean (SEM) indicated.  
6.3.5.2 Isometric Plantarflexion Strength  
There was no significant difference in isometric plantarflexor strength with torque 
(TORQUE F( 2,26)=0.47 p=0.63), no significant change in isometric strength over time 
(TIME F(2,26)=0.008 P=0.99) and no significant TORQUE X TIME interaction 
(F(4,52)=1.39 p=0.25) (Figure 6.9).    
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Figure 6.9: Change in isometric plantarflexor strength in pwMS between (i) baseline 
and post stretch (Post_0-Base), (ii) immediate post stretch and 30 minutes post stretch 
(Post_30-Post_0), (iii) 30 minute post stretch and baseline (Post_30-Base) time 
periods were calculated and compared against the applied torque. Standard error of 
mean (SEM) indicated.  
 
6.3.6 Changes in Range of Movement with Applied Torque in pwMS (n=13) 
For one participant we were unable to record changes in position in one condition due 
to technical difficulties. In this participant the changes in ROM for the other two applied 
torques were similar to the remaining participants. 
6.3.6.1 Effect of Applied Torque on End Range Ankle Position 
There was a significant effect of torque on end ankle position (29 minutes after stretch 
onset) (TORQUE F(2,24)=34.87 p<0.001) with a significant increase in range observed  
with application  of a HIGH torque compared to MEDIUM (TORQUE F (1,12)=49.96 
p<0.001) and MEDIUM compared to LOW (TORQUE F(1,12)=27.92 p<0.001) (Figure 
6.10). 
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Figure 6.10: End foot position (29 minutes post stretch) with the application of a high, 
medium or low torque in pwMS. Standard error of mean (SEM) indicated.  
 
6.3.6.2 Changes in Range of Movement during the Stretch 
As expected there was a significant effect of time on the position of the ankle (TIME 
F(1,14)= 108.45 p=0.001); a priori contrasts revealed a significant increase in position 
as the duration of the stretch increased (p<0.001).   There was a significant effect of 
torque on the position of the ankle at 30 seconds, 10 minutes, 20 minutes and 29 
minutes post stretch onset (TORQUE F(2,24)= 40.69 p=0.001); a priori contrasts 
revealed a significant  increase in  ankle position between LOW and MEDIUM (F= 
(1,12)= 49.52 p =0.001) and MEDIUM and HIGH (F(1,12)= 35.96 p=0.001).  
There was a significant TORQUE X TIME interaction (TORQUE X TIME F(2,22)=13.15 
p<0.001). This indicated that with a  higher applied torque the ROM tended to increase 
across the whole course of the stretch period whilst with the low torque stretch the 
ROM tended to plateau after 15-20 minutes  (p<0.001); this is illustrated in Figure 6.11. 
Figure 6.12 shows the grand average change in position across time with data being 
sampled every 0.5 minutes; this and Figure 6.11 highlight that the rate of change of 
ankle position with applied torque starts to decrease around 7.5-10 minutes. 
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Figure 6.11: Position achieved from 30 seconds to 29 minutes of stretch at a constant 
torque with the application of a high, medium or low torque in pwMS. Standard error of 
mean (SEM) indicated. 
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Figure 6.12: Grand average of position data with the application of a constant torque 
over 25 minutes in pwMS. I = low torque; m = medium torque; h = high torque. 
 
6.3.7 Relationship between Applied Torque and Stiffness in pwMS 
The application of a 30 minute stretch using the applied low, medium and high constant 
torques did not produce a statistically significant difference in total stiffness reduction in 
pwMS (see section 6.3.4.1).  However, the relationship between the low absolute 
applied torque (ie not normalised to body weight) and the change in total stiffness (post 
stretch-baseline) revealed a significant moderate correlation  (0.3 ≤ r ≤0.6, Cohen, 
1988) and a trend towards significance for the high and medium torques (see Table 
6.6) potentially suggesting a relationship between absolute applied torques and change 
in stiffness. 
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Table 6.6. Relationship between absolute applied torque and change in total stiffness 
in pwMS. Change in total stiffness = post stretch – baseline. R = Pearson’s rank 
correlation 
 
6.3.8 Relationship between Baseline Stiffness and Change in Stiffness in pwMS 
To explore the relationship between the baseline stiffness and the change in stiffness 
the grand average stiffness across the three applied torque conditions were calculated. 
The difference in stiffness with stretching (post-pre) was calculated where negative 
values indicate a reduction in stiffness.  There was a strong (r ≥0.8, Cohen 1988) 
significant relationship between the baseline passive stiffness and the change in 
passive stiffness (Table 6.7, Figure 6.14A); this is dominated by one participant who 
had a baseline stiffness that was 1.3Nm/rad.Kg.  However without this participant the 
relationship was still significant (R2=0.48) There was also a moderately strong (r ≥0.6, 
Cohen 1988) significant relationship between the baseline stretch reflex-related 
stiffness and the change in stretch reflex-related stiffness (Table 6.7, Figure 6.13 B). 
This suggests that higher levels of baseline stiffness were associated with greater 
reductions in stiffness with stretching. 
 
 
   
CONDITION  R  value P value 
 
High torque – change in total stiffness 
 
0.49 
 
0.072 
 
Medium torque – change in total stiffness          
 
0.49 
 
0.073 
 
Low torque – change in total stiffness                  
 
0.56 
 
0.046 
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Table 6.7 Relationship between baseline passive stiffness and change in passive 
stiffness in pwMS; baseline stretch reflex related stiffness and change in stretch reflex 
related stiffness across all torques.  R = Pearson’s rank correlation 
 
 
 
 
Figure 6.13: Correlation between baseline passive stiffness and stretch reflex related 
stiffness and the change in these measures post stretch in pwMS, across all applied 
torques. There was still a significant relationship in both A and B when the outliers 
indicated by a circle were omitted.  
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CONDITION  R  value P value 
Baseline passive stiffness Vs change in  
passive stiffness 
 
0.74 <0.005 
Baseline stretch reflex associated 
stiffness Vs change in stretch reflex-
associated  stiffness 
 
0.69 0.006 
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6.4 Discussion 
The overall aim of this second study was to understand the impact of 30 minutes of 
stretching at three different constant torque levels on stiffness, muscle strength, and 
ROM, and how this varied in the 30 min period post stretch.    
6.4.1 Change in Stiffness with Applied Torque 
In this study there was no significant effect of torque on reductions in total stiffness, 
passive stiffness or stretch-reflex associated stiffness. It is possible that no significant 
effect of torque was found due to the variability (as indicated by the high SD’s and 
SEM’s) among the participants; it is also possible that the sample size may not have 
been large enough to observe an effect. For example, for the measures of total 
stiffness with a sample size of 14 and the SD  observed in the study (0.19 on average) 
and power=0.85 there would need to be a 70% difference in the reduction in stiffness 
with stretching between torque conditions to reach statistical significance. In this study 
there was a 50% difference in stiffness change following the high and low torque 
stretch; this would require a sample size of 28 to detect a significant difference. In 
addition, the torques selected and used in this current study were based on those 
produced by pwMS when performing commonly prescribed clinical stretches over 15 
seconds (Hall et al., 2010). However, the high torque (0.66 Nm/Kg) observed in this 
study was not tolerated by early participants when applied in the current non-weight 
bearing position for up to 30 minutes. Therefore, to ensure participation by all subjects 
a middle value between the original high (0.66 Nm/Kg) and medium (0.30 Nm/Kg) 
torque found in chapter five was calculated and used as the new high torque 
(0.42Nm/Kg). It is possible that differences in the change in stiffness may have been 
detected with a higher applied torque.  
There was a moderate statistically significant correlation between the low absolute 
torque applied and the change in total stiffness and a trend toward significance for the 
medium and high applied torque (section 6.3.7). This potentially suggests that absolute 
torque levels may be important. This study applied torques shown to be producible by 
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people with MS that was scaled to their body weight, on the assumption that this 
reflects the torques that would be able to be typically applied by pwMS during a home 
programme, i.e. people use their body weight as the constant torque. However, the 
body weight range of the participants was large (51-133 Kg). This meant that for the 
low torque stretch the heaviest participant was stretched with a torque of 133Kg x 
0.18Nm/Kg = 23.94Nm, whilst at the high torque level the lightest participant was 
stretched with a torque of 51 Kg x 0.42Nm/Kg=21.42 Nm. This overlap in the absolute 
levels of applied torque between different conditions may be why no effect of torque 
was found when it was normalised to body weight, that is it may be the absolute torque 
level applied that is important. This is however speculative and absolute torque may 
not have an influence on change in stiffness.  
6.4.2 Change of Stiffness over Time 
There was a significant reduction in total stiffness (18-25%) and passive stiffness (30-
40%) measures with stretching. This is in keeping with work by Yeh et al. (2005)   who 
looked at the effects of 30 minutes of stretching at a constant torque on ankle 
hypertonia in stroke patients, where a significant reduction in immediate elastic and 
viscous component of the hypertonic muscle was found. However, it is not evident from 
the study how long this benefit was maintained for.  This current study found that the 
gains made in reduced stiffness during the stretch period were generally well 
maintained, with only a 4% increase in stiffness relative to baseline over the 
subsequent 30 minute post stretch period.  
It was observed that passive stiffness continued to decrease between 20-30 minutes 
post stretch. The low torque applied in the intervention tended to only achieve a 
maximum end position of 3o plantarflexion whereas the stiffness assessment procedure 
undertaken at regular 10 minute intervals post stretch moved the ankle between -10o of 
plantarflexion through to 5o of dorsiflexion, therefore achieving a greater ROM and 
degree of stretch than that seen during the intervention.  It is therefore possible that the  
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administration of this method of assessing stiffness may have resulted in further 
reductions in stiffness during the rest period. Muscles behave in a thixotropic manner in 
that their stiffness is dependent on movement (Nuyens et al. 2002). When stretch is 
applied to a relaxed muscle that has been maintained in a lengthened position the 
initial resistance is lower (Lakie & Robson, 1988). It is possible that the innate 
thixotropic properties of muscle may have resulted in a further reduction in stiffness 
post stretch due to a decrease in viscosity and muscle stiffness. 
There was no effect of stretching on stretch-reflex associated stiffness. Both passive 
stiffness and spasticity are common problems in MS. However, our objective measures 
suggest that while passive stiffness and spasticity are both evident, in this second 
study it is the passive element that is particularly high in this sample;  ~84% of the total 
stiffness was explained by the passive stiffness element. This is in contrast to the first 
study’s sample (chapter five) in whom only 53% of the total stiffness was explained by 
the passive stiffness element. This is not felt to be due to the different motors used to 
deliver the perturbations; the manipulandum used and the peak velocities achieved and 
amplitude moved were identical. This is supported by the fact that, in the seven 
participants who completed both studies, there was no significant difference in passive 
stiffness measured using the different devices.  
MS is a disease in which the clinical presentation of individuals is markedly variable; 
this discrepancy may have therefore occurred because of the natural heterogeneity of 
this disease group.  It is possible that the reductions in passive stiffness seen in this 
second study are a direct result of a high baseline level of passive stiffness. 
Furthermore that the lack of effects of the 30 minute stretch on spasticity may be 
because this sample was predominately comprised of people with only mild reflex 
mediated stiffness (spasticity), rather than a lack of effect of stretch on spasticity per 
se.  
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6.4.3 Change in Strength with Stretching 
There was no significant difference in isometric plantarflexor or dorsiflexor strength in 
pwMS with applied torque and no effect of time. Compared with pre-stretch, 
dorsiflexion strength (as determined by maximal isometric contractions) decreased post 
stretch by 9% and this remained below the baseline value by 2% at 30 minutes post-
stretch. In contrast plantarflexor maximum isometric strength was not reduced with the 
application of a stretch and remained relatively constant throughout the experimental 
period.  
 
Reductions in maximal muscle strength following stretching have been reported in 
healthy participants (Fowles et al. 2000). In keeping with the explanations of the 
previous study it is possible that the sustained shortened position of the dorsiflexors 
during the stretching of the plantarflexors may have altered the force-length 
characteristics of the muscle. The assessment of length tension relationships was not 
carried out in this study. Future work will look at the relationship between isometric 
strength with the ankle in different positions. 
6.4.4 Dorsiflexion Range  
Muscle stretching regimes are based on the assumption that stretching increases 
muscle extensibility and preserves/improves joint ROM for functional movement.  It is 
thought that impaired mobility and prolonged spasticity lead to structural changes in 
muscle fibers and connective tissue, resulting in a reduction in joint ROM (Zhang et al. 
2002). This is reflected by the baseline characteristics of this study sample wherein 
high levels of passive stiffness were observed, compared to the healthy controls. In 
addition, the pwMS had an average baseline dorsiflexion range of 1o compared to 5o 
dorsiflexion in the healthy controls, when measured 15s after the application of a low 
torque. It is postulated that this reduced range is due, in part, to the enhanced level of 
passive stiffness observed.   
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This study indicates that ROM increases with stretching and that this is greater with 
higher applied torques. This result is similar to work by Yeh in people with stroke who 
reported that the average ROM of ankle dorsiflexion increased significantly after a 
single sustained muscle stretching session for 30 minutes at a constant torque (Yeh et 
al. 2007). This was significantly higher than the improvements in range obtained when 
stretching at either a constant angle or cyclically (Yeh et al. 2007).  
 
The time taken to achieve a similar percentage of the maximal achieved ROM varied 
with different levels of applied torque. With higher torques it took longer to achieve the 
same percentage in ROM due to the fact that the end positions varied and stretching 
continued throughout the application of the higher torques. This gradual increase in 
ROM over time is interpreted as being due to tissue creep. When connective tissues 
are stretched under a constant load there is a time dependent deformation (Bressel 
and McNair, 2002). The slow deformation is due to the viscosity of the tissue whilst the 
end range achieved is an indicator of the elasticity (stiffness) of the tissue (Gajdosik 
2001). With higher applied loads the rate of deformation is initially high and this 
decreases the time for the viscous component to dissipate, resulting in a longer time 
period to achieve maximal ROM. Thus, in tissues that have a large viscous component 
(e.g. spastic muscle), higher forces applied for a short period of time may not provide 
the most effective stretch for increasing ROM. However, from Figure 6.10 it is clear that 
ROM traces for different applied torques diverge after  the first minute so this may only 
apply to a very short duration stretch (i.e. <30s). 
 
Figure 6.11 illustrates that in this study a large majority of the end range achieved was 
obtained after only 10 minutes of stretching: ~95% of the maximal range with the 
application of the low torque and ~65% of the maximal range with the application of the 
medium and high torques. A similar study assessing the time course of 
musculotendinous stiffness responses following different durations of passive 
stretching found that, in healthy participants, stretching for eight minutes reduced 
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musculotendinous stiffness and this remained reduced for 20 minutes post stretch 
(Ryan et al. 2008).  Thus it can be seen that, at least in healthy individuals, similar 
increases in ROM and reductions in stiffness may be achieved with much shorter 
duration stretches than those applied in this MS study. Whether this is also the case in 
people with MS is important to establish since shorter duration stretches are clinically 
more feasible. Currently it is unclear whether the immediate effects of stretching over 
this shorter duration would be maintained over the post stretch period or whether this 
only occurs with longer durations of stretch. Subsequent work in chapter 7 will 
therefore establish if stretching for 10 minutes at a constant torque is able to reduce 
passive stiffness and improve ROM in pwMS and for what length of time any 
reductions are maintained.  
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7. Chapter Seven: The Effect Duration of Stretch  and Applied 
Torque on Plantarflexor Stiffness in People with Multiple 
Sclerosis.  
7.1 Introduction 
The previous study (chapter 6) found that ankle plantarflexor stiffness significantly 
reduced following a 30 minute constant torque stretch. Three different torque levels 
were applied: a high, medium and low which were scaled relative to the participants’ 
body weight. While there was no observable effect of applied torque on either measure 
of plantarflexor stiffness (passive and stretch-reflex mediated), there was an effect of 
applied torque on the range of motion gained during the stretch. Analysis of the change 
in ROM during the stretch suggested that increases in range started to plateau after 10 
minutes of stretching especially for the low applied torque.  
The possibility of short duration stretches achieving similar effects on stiffness and 
ROM would be clinically more convenient for therapists and patients alike. However, 
with shorter durations of stretch it is possible that there may be an effect of applied 
torque on plantarflexor stiffness; this needs to be considered.   Therefore, the aim of  
this third study was to assess the effects of a 10 minute stretch, applied on three 
separate occasions at the same levels of torque that were applied in study two (chapter 
six).  A description of the effects of a 10 minute stretch on stiffness, strength and ROM 
is followed by a comparison of the effects of a 30 minute and 10 minute stretch.   
7.2 Materials and Methods  
7.2.1 Participant Recruitment  
MS participants were recruited through the SWIMS database as outlined previously 
(section 4.3). Of those recruited, 10 MS participants had also undertaken the 30 minute 
stretch study described in chapter six. In this third study 13 pwMS were compared to 
13 healthy controls recruited from local advertisement at Plymouth University and 
friends/families of pwMS. Written informed consent was obtained from all participants 
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and the study was conducted with approval from the NHS Torbay and Devon Research 
Ethics Committee (Ref-09/H0202/42). 
7.2.2 Demographics and Baseline Characteristics 
In line with studies one and two, the following baseline characteristics were taken: self-
report questionnaires on function (BI and MSWS-12); spasticity (MSSS-88 and 
Ashworth scale) and disease severity (EDSS). Demographic information including age, 
weight, height, gender, shank length and thigh length was gathered on all participants. 
Additionally length of time and type of diagnosis and anti-spasticity medication was 
recorded at the beginning of the study for pwMS.  
7.2.3 Intervention 
This third study aimed to identify the effect of a 10 minute constant torque stretch on 
plantarflexor passive stiffness, stretch reflex excitability, ROM and ankle planter- and 
dorsi- flexor strength and to determine how this varied over a 30 minute post stretch 
period. In line with the previous two studies, three torque levels were assessed low 
(0.18Nm/Kg), medium (0.30 Nm/Kg) and high (0.42 Nm/Kg)) over three test sessions 
with each session separated by a minimum of three days.  Constant torque stretches 
were applied using the apparatus described in chapter 6 (section 6.2.3). The order of 
the applied torque was randomised between participants using codes generated in 
MATLAB. 
7.2.4 Measurement of Stiffness and Strength 
Outcome measures were taken immediately before and after the intervention and at 10 
minute intervals for 30 minutes post stretch. The measures used, which are listed 
below, are described in detail in chapter five: 
1) Ankle plantarflexor total stiffness 
2) Ankle plantarflexor passive stiffness 
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3) Ankle plantarflexor stretch reflex-associated stiffness 
4) Range of motion during the stretch 
5) Ankle dorsi- and plantar-flexor isometric strength   
7.2.5 Subjective Report of Stretch 
The subjective rating of the applied stretch was determined using a VAS from 0 –10, 
where 0 = no stretch and 10 = a very strong stretch; participants were also asked to 
describe and locate the position of the stretch they were feeling. 
7.2.6 Measurement of ROM 
The range of motion was recorded directly from the BSM Servomotor Encoder as 
detailed in chapter six (section 6.2.4). Initial baseline ROM was defined as the ankle 
range 15 seconds after application of the low constant torque from a position of 10o 
plantarflexion. ROM was also recorded throughout the stretch at 10 seconds, 3.25 
minutes and 7.75 minutes post stretch onset and AD converted (200 Hz sampling rate) 
by the power 1401 (CED Cambridge UK). 
7.2.7 Analyses 
Plantarflexor stiffness and strength were analysed as described previously (chapter 
four, section 4.7); and initial baseline stiffness, strength and ROM between groups 
were analysed using an unpaired t-test. The effect of applied torque on the change in 
stiffness, ROM, and isometric strength after a 10 minute stretch and the post stretch 
time course were analysed using an repeated measures ANOVA with factors being 
TIME (base,post_0,post_10,post_20,post_30) and TORQUE (low, medium and high).  
The 30 minute (study two) and 10 minute (study three) stretch results were then 
compared using a between groups repeated measures ANOVA. For all statistical tests, 
the level of significance was set at P<0.05. 
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7.3 Results 
7.3.1 Patient Demographics and Baseline Characteristics   
Seventeen pwMS were recruited. Two of the participants recruited were unable to 
complete the study due to a change in their personal circumstances; two other 
participants were unable to tolerate the high constant torque applied as they indicated 
the stretch they were experiencing was beginning to cause pain in the calf and were 
therefore unable to complete the study in its entirety. 
The study sample therefore comprised 13 pwMS, ten of whom had completed both this 
and the second study described in chapter six. Table 7.1 and 7.2 provides a summary 
of the demographic characteristics and outcomes of the self-report questionnaires for 
the sample. 
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Table 7.1: Participant demographics columns 1-6 contain information about: each individual belonging to the patient or control group, 
gender, age, height, weight and duration of MS. Columns 7-11 contain information regarding MS participants including: MS type relapsing 
remitting MS (RRMS), primary progressive (PPMS), secondary progressive MS (SPMS) and duration, the use of anti-spastic medication, 
EDSS score and if the participants were involved in experiment 2. Mean ± standard deviations are indicated. 
Subject    Group Gender Age(years) Height(cm) Weight(kg) MS Type Duration of 
MS (years) 
Anti-spastic 
medication 
EDSS Participated in 
Study 2 
1 MS F 77 165.0 64 PPMS 17 NO 6.0 Y 
2 MS F 55 169.0 71 PPMS 1.5 NO 4.5 Y 
3 MS F 62 164.5 72 SPMS 6 NO 4.5 Y 
4 MS F 67 154.1 55 RRMS 3 NO 6.0 Y 
5 MS F 58 162.2 68 RRMS 30 NO 4.5 Y 
6 MS F 49 170.0 62 RRMS 2 NO 4.5 Y 
7 MS F 55 164.5 71 RRMS 1.2 NO 6.0 N 
8 MS F 43 164.4 52 RRMS 35 NO 4.5 Y 
9 MS F 58 168.0 61 RRMS 1.1 Baclofen 6.0 N 
10 MS F 49 160.3 83 RRMS 4 Baclofen 4.5 N 
11 MS F 51 164.7 72 SPMS 20 Baclofen 7.0 Y 
12 MS M 64 179.0 104 SPMS 4 NO 6.0 Y 
13 MS F 69 157.2 60 SPMS 4 Baclofen 6.0 Y 
14 CON M 56 175.0 73 NA NA NA NA NA 
15 CON M 52 177.0 71 NA NA NA NA NA 
16 CON F 49 166.5 66 NA NA NA NA NA 
17 CON F 45 168.0 69 NA NA NA NA NA 
18 CON F 56 168.0 134 NA NA NA NA NA 
19 CON F 64 159.0 60 NA NA NA NA NA 
20 CON F 59 154.5 57 NA NA NA NA NA 
22 CON F 54 154.5 70 NA NA NA NA NA 
22 CON F 55 167.5 65 NA NA NA NA NA 
23 CON F 56 159.5 63 NA NA NA NA NA 
24 CON F 55 153.5 62 NA NA NA NA NA 
25 CON 
F 50 167.5 78 
NA 
NA NA NA 
NA 
26 CON F 67 153.5 66 NA NA NA NA NA 
          
PwMS                   N=13  F=12 
 M=1 
 Mean:58 
 SD ± 9 
 Mean:165 
 SD ± 6 
   Mean:69                 PPMS=2 
   SD ± 13                  SPMS=4 
     Mean:8 
     SD ± 8 
                                     Mean:5                   N=10 
 N=4                 SD ± 1 
Controls                N=13  F=11 
 M=2 
 Mean:55.23 
 SD ± 6.00 
Mean:163.35 
SD ± 8.16 
   Mean:71.85            RRMS=7 
   SD ± 19.51 
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Table 7.2: Clinical descriptors of people with MS; Barthel Index (Median (IQR); 
Transformed MSWS12 (Mean ± Standard deviations, (IQR)), MSSS88 (Median (IQR)); 
plantarflexor Ashworth scores (Median, (IQR)).  
7.3.2 Comparison of Baseline Characteristics with Control Participants 
7.3.2.1 Muscle Strength and Stiffness  
Dorsiflexor and plantarflexor isometric strength was significantly reduced in pwMS (DF 
t=-3.06 P=0.009); (PF t=-2.52 P=0.03) when compared to the healthy control group 
(Figure 7.1a). Slow (5o/s) stretches did not elicit any EMG activity in participants of 
either group. The passive stiffness in the plantarflexors measured during the slow 
stretch was not significantly different between the pwMS and the control group (t= 1.43 
P= 0.18). Fast (175 o/s) stretches resulted in EMG activation in all participants. The 
difference between the slow and fast stretch, indicative of the size of the stretch reflex, 
was  not significantly different between the two groups (t=1.57 P=0.14, Figure 7.1b). 
OUTCOME MEASURES SCORES 
Barthel Index (score range 0-100) 90  (10) 
MSWS12(t) (score range 0-100) 39 ± 24 (35) 
MSSS88 (score range 0-352) 145 (48)  
Ashworth right ankle (score range 0-4) 1 (0) 
Ashworth left ankle (score range 0-4) 1 (1) 
Ashworth right knee extensors (score range 0-4) 1(1) 
Ashworth left knee extensors (score range 0-4) 1 (2) 
Ashworth right knee flexors (score range 0-4) 1 (2) 
Ashworth left knee flexors (score range 0-4) 1 (2) 
Ashworth right hip extensors (score range 0-4) 0 (1) 
Ashworth left hip extensors (score range 0-4) 0 (1) 
Ashworth right hip flexors (score range 0-4) 0 (1) 
Ashworth left hip flexors (score range 0-4) 0 (1) 
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Figure 7.1: A) Maximum voluntary contraction (MVC) recorded in Nm/kg (PF = 
Plantarflexor; DF = Dorsiflexor strength), B) Average plantarflexor stiffness in 
Nm/rad.kg. Standard error of the mean (SEM) is indicated.  
 
7.3.2.2 Range of Movement (n=11pwMS, n = 13 healthy controls) 
Initial baseline ROM was not significantly different between the pwMS and matched 
control group (t=0.54 P =0.60) (Figure 7.2). This may potentially be due to the 
similarities observed between these groups as indicated in the baseline comparison of 
passive stiffness and stretch reflex mediated stiffness described above. Two MS 
participant’s data could not be incorporated within this analysis due to an error in the 
data collection.    
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Figure 7.2: Initial baseline ankle ROM for pwMS and the control group from a position 
of 10o plantarflexion (start position) to 15s after application of the low constant torque 
(end position). Standard error of mean (SEM) indicated. 
7.3.3 Subjective Report of Stretch in pwMS 
A Kolmogorov-Smirnov test revealed that the VAS data was not normally distributed. 
The data was therefore analysed using a Friedman non-parametric test after averaging 
across torque or time.  There was a significant difference in perceived strength of 
stretch with torque (P=0.01); with the largest difference occurring between the medium 
and low torques (Figure 7.3). There was no significant difference in the perceived 
strength of stretch reported over time (P=0.56).   
Seventy nine per cent of MS participants reported feeling the stretch sensation in their 
calf; 3% in the back of the knee; 6% in the hamstring muscle and 12% were unable to 
locate a specific stretch sensation. These results are not specific to an applied torque 
and encompass results from all three visits. 
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Figure 7.3: Self-reported strength of stretch on a visual analogue scale ranging from 0-
10 in pwMS. Mean +/- standard error of the mean (SEM) indicated. H = high torque M 
= Medium torque L = low torque 
7.3.4 Change in Stiffness with Applied Torque in pwMS (n=13)  
Total Stiffness: There was no significant difference in total plantarflexor stiffness with 
torque (TORQUE F(2,24)=0.279 p=0.759). Plantarflexor stiffness significantly reduced 
over the observed time frame (F(4,48)=6.222 P=0.001). There was no significant 
TORQUE X TIME interaction (F(8,96)=0.918 p=0.442) (Figure 7.4). The overall 
decrease in stiffness from the start of the stretch to the end of monitoring (40 minutes 
later) is given in Table 7.3. Table 7.3 and Figure 7.4 illustrate that the reduction in total 
stiffness did not last for more than 10 minutes post stretch. The increase in stiffness 20 
minutes post stretch following the low torque stretch is dominated by one participant. 
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Total Stiffness (Nm/rad.Kg) 
  
Base Post_0 Post_10 Post_20 Post_30 
H 0.55±0.33 0.43±0.33 0.55±0.34 0.55±0.33 0.54±0.35 
M 0.56±0.32 0.45±0.31 0.53±0.33 0.53±0.32 0.52±0.26 
L 0.47±0.24 0.44±0.36 0.53±0.33 0.72±0.94 0.51±0.25 
 
Table 7.3: Average total stiffness at baseline, immediate post stretch and then at 10 
minute intervals until 30 minutes post stretch in pwMS. Mean (Nm/kg) ± standard 
deviation is indicated. H = High torque M = Medium torque L = Low torque. 
   
 
Figure 7.4: Change in total stiffness between (i) baseline and post stretch (Post_0 
Base), (ii) immediate post stretch and 10 minutes post stretch (Post_10-Post_0), (iii) 10 
minutes post stretch and 20 minutes post stretch (Post_20-Post_10); 20 minutes post 
stretch and 30 minutes post stretch (Post_30-Post_20) time periods, were compared 
against the applied torque. Standard error of mean (SEM) indicated. H = High torque M 
= Medium torque L = Low torque. 
 
Passive Stiffness: There was no significant difference in passive stiffness with torque 
(TORQUE F(2,24)=1.331 p=0.283). However, there was a significant difference in 
passive stiffness over time (TIME F(4,48)=3.933 p=0.026); with a significant reduction 
in stiffness post stretch  (TIME F(1,12)=7.693 p=0.017). There was no significant 
TORQUE X TIME interaction (F (8,96) =0.662 p=0.586, Figure7.5).  Changes in 
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stiffness over time are given in Table 7.4. Reductions in passive stiffness were small 
and lasted for 10 minutes for the low force but remained lower than baseline values for 
the medium and high force. 
 
 
Table 7.4: Average passive stiffness during and after high (H), medium (M) or low (L) 
torque stretches in pwMS. Mean ± standard deviation is indicated. 
 
 
 
Figure 7.5: Change in passive stiffness between (i) baseline and post stretch (Post_0-
Base), (ii) immediate post stretch and 10 minutes post stretch (Post_10-Post_0), (iii) 10 
minutes post stretch and 20 minutes post stretch (Post_20-Post_10), 20 minutes post 
stretch and 30 minutes post stretch (Post_30-Post_20) time periods were compared 
against the high (H), medium (M) or low (L) applied torque. Standard error of mean 
(SEM) indicated.  
 
Passive Stiffness (Nm/rad.Kg) 
  Base Post_0 Post_10 Post_20 Post_30 
H 0.34±0.27 0.31±0.27 0.32±0.29 0.32±0.29 0.32±0.28 
M 0.37±0.25 0.32±0.26 0.34±0.25 0.33±0.26 0.34±0.26 
L 0.31±0.21 0.29±0.23 0.31±0.23 0.31±0.23 0.31±0.21 
 168 
 
Stretch Reflex Associated Stiffness: There was no significant difference in stretch 
reflex associated stiffness with torque (TORQUE F(2,24)=0.880 p=0.428) and no  
significant difference seen over the observed time frame (TIME F(4,48)=3.18 p=0.08). 
There was no significant TORQUE X TIME interaction (F (8,96) =1.02 p=0.35, (Figure 
7.6 and Table 7.5).  It is interesting to note that stretch reflex mediated stiffness 
increased to above baseline levels between 10-20 minutes post stretch. In the case of 
both the high and low torque stretches, these higher levels remained for the rest of the 
30 minute assessment period (Table 7.5). 
 
 
Table 7.5: Average stretch reflex associated stiffness during and after high (H), 
medium (M) or low (L) torque stretches in pwMS. Mean ± standard deviation is 
indicated 
 
 
 
 
 
 
 
 
 
Stretch Reflex Associated Stiffness(Nm/rad.Kg) 
  Base Post_0 Post_10 Post_20 Post_30 
H 0.20±0.10 0.12±0.13 0.23±0.10 0.23±0.09 0.23±0.12 
M 0.19±0.10 0.13±0.10 0.19±0.13 0.20±0.14 0.18±0.11 
L 0.16±0.13 0.15±0.16 0.22±0.16 0.41±0.72 0.20±0.11 
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Figure 7.6: The difference in stretch-reflex associated stiffness between baseline and 
post stretch (Post_0-Base), immediate post stretch and 10 minutes post stretch 
(Post_10-Post_0), (iii) 10 minutes post stretch and 20 minutes post stretch (Post_20-
Post_10), 20 minutes post stretch and 30 minutes post stretch (Post_30-Post_20) time 
periods were compared against the applied torque. Standard error of mean (SEM) 
indicated.  
 
7.3.5 Change in Strength with Applied Torque in pwMS (n=13)  
7.3.5.1 Isometric Dorsiflexor Strength Normalised to Body Weight 
There was no significant difference in isometric dorsiflexor strength with torque 
(TORQUE F m( 2,24)=1.491 p=0.248) ; no significant change in isometric strength over 
time (TIME F(2,24)=3.226 P=0.088) and no significant TORQUE X TIME interaction 
(F(4,48)=0.870 p=0.442) (Figure 7.7 and Table 7.6).    
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Isometric  Dorsiflexor Strength(Nm/kg) 
  Base Post _0 Post_30 
H 0.25±0.04 0.24±0.04 0.27±0.04 
M 0.21±0.03 0.23±0.04 0.25±0.04 
L 0.23±0.04 0.23±0.04 0.26±0.04 
 
Table 7.6: Average isometric dorsiflexor strength at baseline, immediately post stretch 
and 30 minutes post high (H), medium (M) or low (L) torque stretches in pwMS. Mean ± 
standard deviation is indicated. 
 
 
 
 
 
 
 
 
Figure 7.7: Change in isometric dorsiflexor strength between (i) baseline and post 
stretch (Post_0-Base), (ii) immediate post stretch and 30 minutes post stretch 
(Post_30-Post_0), (iii) 30 minute post stretch and baseline (Post_30-Base) time 
periods were calculated and compared against the applied torque. Standard error of 
mean (SEM) indicated.  
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7.3.5.2 Isometric Plantarflexor Strength Normalized to Body Weight 
There was no significant difference in isometric plantarflexor strength with torque 
(TORQUE F( 2,24)=0.672 p=0.520); no significant change in isometric strength over 
time (TIME F(2,24)=3.235 P=0.080) and no significant TORQUE X TIME interaction 
(F(4,48)=2.012 p=0.108) (Figure 7.8 and Table 7.7).    
 
Isometric Plantarflexor Strength(Nm/kg) 
  Base Post _0 Post_30 
H 0.41±0.06 0.30±0.05 0.34±0.05 
M 0.32±0.04 0.29±0.05 0.30±0.05 
L 0.33±0.04 0.32±0.05 0.32±0.04 
 
Table 7.7: Average isometric Plantarflexor strength at baseline, immediately post 
stretch and 30 minutes post high (H), medium (M) or low (L) torque stretches in pwMS. 
Mean ± standard deviation is indicated. 
 
 
 
 
 
 
 
 
 
Figure 7.8: Change in isometric plantarflexor strength between (i) baseline and post 
stretch (Post_0-Base), (ii) immediate post stretch and 30 minutes post stretch 
(Post_30-Post_0), (iii) 30 minute post stretch and baseline (Post_30-Base) time 
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periods were calculated and compared against the applied torque. Standard error of 
mean (SEM) indicated.  
 
7.3.6 Effect of Applied Torque on End Range Ankle Position in pwMS (n=12)  
There was a significant effect of torque on end ankle position recorded nine  minutes 
after stretch onset (TORQUE F(2,20)=33.097 p=0.001) with a significant increase in 
range observed  with application  of a HIGH torque compared to MEDIUM (TORQUE F 
(1,10)=41.641 p=0.001) and MEDIUM compared to LOW (TORQUE F(1,10)=19.369 
p=0.001) (Figure 7.9). 
 
 
 
 
 
 
 
Figure 7.9: End ankle position (nine minutes post stretch) with the application of a 
high, medium or low torque. Standard error of mean (SEM) indicated. 
 
7.3.7 Range of Movement During the Stretch in pwMS(n=12)  
There was a significant effect of torque on the position of the ankle at 10 seconds, 3.25 
minutes, 6.50 minutes and 9.75 minutes post stretch onset (TORQUE F(2,20)= 34.592 
p=0.001); a priori contrasts revealed a significant  increase in  ankle position between 
LOW and MEDIUM (F(1,10) = 19.354 p = 0.001) and MEDIUM and HIGH (F(1,10) = 
45.050 p=0.001). There was a significant effect of time on the position of the ankle 
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(TIME F(3,30)= 52.492 p=0.001); a priori contrasts revealed a significant increase in 
position as the duration of the stretch increased (p<0.001).    
There was a significant TORQUE X TIME interaction (TORQUE X TIME 
F(6,60)=11.816 p<0.001). This indicated that with a  higher applied torque the ROM 
tended to increase across the whole course of the stretch whilst with the low torque 
stretch the ROM tended to plateau after 6.5 minutes  (p<0.001); this is illustrated in 
Figure 7.10 and Table 7.8. Figure 7.11 shows the grand average change in position 
across time with data being sampled every 0.5 minutes, this and Figure 7.10 highlights 
that the rate of change of torque was initially high and then starts to decrease around 7 
minutes. 
 
  
0.5 minutes 
post stretch 
3.25 minutes 
post stretch 
6.5 minutes 
post stretch 
9.75 minutes 
post stretch 
L 4.43±1.94 6.64±2.51 6.89±3.03 6.98±3.07 
M 10.37±1.47 14.61±2.05 15.55±2.01 16.07±2.01 
H 16.56±1.25 23.43±1.44 25.74±1.42 27.16±1.37 
 
Table 7.8: Average ROM during stretch at 0.5, 3.25, 6.5 and 9.75 minutes post high 
(H), medium (M) or low (L) torque stretches in pwMS. Mean ± standard deviation is 
indicated. 
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Figure 7.10: Position achieved from 0.5 minutes to 9.75 minutes of stretch at a 
constant torque with the application of a high (H), medium (M) or low (L) torque. 
Standard error of mean (SEM) indicated. 
 
 
Figure 7.11: Grand average of range of motion (ROM) data with the application of a 
high, medium or low torque over 9.75 minutes. Standard error of mean (SEM) 
indicated. 
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7.3.8 Comparison of 30 Verses 10 Minutes Duration Stretches on Stiffness and 
Range of Motion  
7.3.8.1 Effects on Stiffness  
Total Stiffness: There was no significant effect of torque on the percentage change in 
total stiffness (TORQUE F(2,50)= 0.196 p=0.823) and no significant interaction 
between TORQUE x DURATION (F(2,50) 0.005 P=0.99). Additionally, there was no 
significant effect of stretch duration on change in total stiffness (DURATION F(1,25) 
1.044 P=0.317). However, there was a significant effect of time on change in total 
stiffness (TIME F(4,100)= 15.4 p<0.001); a priori contrast revealed a significant 
decrease in stiffness between baseline and immediately post stretch (F(1,25) 33.92 
(p<0.001). Furthermore, a significant interaction was observed between  stretch 
duration and time on the reduction in stiffness achieved (TIME x DURATION F(4,100) 
9.62 P<0.001); a priori contrast revealed a significantly greater decrease in stiffness 
over a 30 minute post stretch period for the 30 minute stretch compared to a 10 minute 
stretch (Figure 7.13). This was evident between baseline and immediately post stretch 
(base and post_0) (F(1,25) 7.53 P=0.011); immediately post stretch and 10 minutes 
post stretch (post_0 and post_10) (F(1,25) 21.20 P<0.001); 10 minutes and 20 minutes 
post stretch (post_10 and post_20) (F(1.25) 12.29 P=0.002) (Figure 7.12).  There was 
no significant TORQUE x TIME interaction (F(8,200) 0.685 P=0.704) and no significant 
TORQUE x TIME x DURATION interaction observed (F(8,200) 0.310 P=0.968).   
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Figure 7.12: Percentage change in total stiffness with the application of a stretch 
between: baseline (Base), immediately post stretch (Post_0), 10 minutes post stretch 
(Post_10), 20 minutes post stretch (Post_20) and 30 minutes post stretch (Post_30) 
collapsed across all applied torques over a 10 and 30 minute duration. Standard Error 
of Mean (SEM) indicated.  As there was no effect of torque an average of the response 
to the low, medium and high torque stretches is provided.  
 
Passive Stiffness: There was no significant effect of torque on the percentage change 
in passive stiffness (TORQUE F(2,50) 0.422 p=0.658) and no significant interaction 
between TORQUE x DURATION (F(2,50) 0.065 P=0.937).  Additionally, there was no 
significant effect of stretch duration on change in passive stiffness (DURATION F(1,25) 
1.590 P=0.219). However there was a significant effect of time on change in passive 
stiffness (TIME F(4,100) 12.886 p<0.001); a priori contrast revealed a significant 
decrease in stiffness between base and immediately post stretch (base-post_0) 
(F(1,25) 17.845 (p<0.001); immediately post stretch and 10 minutes post stretch 
(post_0 and post_10) (F(1,25) 6.983 P=0.014); 10 and 20 minutes post stretch 
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(post_10 and post_20) (F(1.25) 7.986 P=0.009); 20 and 30 minutes post stretch 
(post_20 and post_30) (F(1,25) 8.466 P=0.007) (Figure 7.13). Furthermore, a 
significant effect of stretch duration on the reduction in stiffness achieved over time was 
observed (TIME x DURATION F(4,100) 8.036 P<0.001); a priori contrast revealed a 
significantly greater decrease in stiffness over a 30 minute post stretch period for the 
30 minute stretch compared to a 10 minute stretch. This was evident between baseline 
and immediately post stretch (base and post_0) (F(1,25) 9.182 P=0.006); immediately 
post stretch and 10 minutes post stretch (post_0 and post_10) (F(1,25) 6.875 
P=0.015); 10 and 20 minutes post stretch (post_10 and post_20) (F(1.25) 6.365 
P=0.018); 20 and 30 minutes post stretch (post_20 and post_30) (F(1,25) 7.183 
P=0.013) (Figure 7.14). There was no significant TORQUE x TIME interaction 
(F(8,200) 0.372 P=0.724) and no significant TORQUE x TIME x DURATION interaction 
observed (F(8,200) 0.147 P=0.997).   
Figure 7.13: Percentage change in passive stiffness with the application of a stretch 
between: baseline (Base), immediately post stretch (Post_0), 10 minutes post stretch 
(Post_10), 20 minutes post stretch (Post_20) and 30 minutes post stretch (Post_30) 
collapsed across all applied torques over a 10 and 30 minute duration. SEM indicated.   
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Stretch Reflex Associated Stiffness: There was no significant effect of torque on the 
percentage change in stretch reflex associated stiffness (TORQUE F(2,50) 2.853 
p=0.067) and no significant interaction between  TORQUE x DURATION (F(2,50) 
30.684 P=0.761) (Figure 7.14). Additionally, there was no significant effect of stretch 
duration on the reduction in stretch reflex associated stiffness (DURATION F(1,25) 
0.033 P=0.858). However, there was a significant effect of time on the change in 
stretch reflex associated stiffness (TIME F(4,100) 3.858 p=0.018); a priori contrast 
revealed a significant increase in stiffness between post stretch_0 and post stretch_10 
(F(1,25) 8.098 (p=0.009); this increase resulted in a stretch-mediated stiffness that was 
higher than the initial baseline stiffness.  There was no significant TIME x DURATION 
interactions (F(4,100) 1.243 P=0.298) (Figure 7.15); no significant TORQUE x TIME 
interaction (F(8,200) 0.721 P=0.609) and no significant TORQUE x TIME x DURATION 
interaction observed (F(8,200) 0.872 P=0.541).  
 
Figure 7.14: Percentage change in stretch reflex associated stiffness with the 
application of a stretch between: baseline (Base), immediately post stretch (Post_0), 10 
minutes post stretch (Post_10), 20 minutes post stretch (Post_20) and 30 minutes post 
stretch (Post_30) collapsed across all applied torques over a 10 and 30 minute 
duration. SEM indicated.   
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Absolute End Point ROM: There was a significant effect of torque on the end ROM 
achieved with stretch (TORQUE F(2,48) 75.430P<0.001); a priori contrast revealed a 
significant  increase in  ankle  absolute end point ROM between LOW and MEDIUM (F 
(1,24)= 74.595 P<0.001) and MEDIUM and HIGH (F(1,24) 75.852 P<0.001) (Figure 
7.16). There was no significant effect of stretch duration on the absolute end point 
ROM achieved (DUATION F(1,24)=1.467 P=0.238) and no significant TORQUE x 
DURATION interactions (F(2,48) 1.447 P=0.245) (Figure 7.15).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.15: Absolute end point ankle ROM achieved with the application of a low, 
medium and high force over a 10 and 30 minute duration stretch. Standard Error Mean 
(SEM) indicated. 
 
Percentage Change in ROM: As there was a difference between the groups 
participating in the 30 minute and 10 minute studies in terms of their baseline ankle 
ROM, (study two =1.10 DF) and (study three =5.70 DF ) the percentage change in ROM 
relative to their initial baseline range was assessed.  
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There was a significant effect of torque on the percentage change in ROM achieved 
with stretch (TORQUE F(2,46) 10.975 p=0.003); a priori contrast revealed a significant  
increase in  ankle ROM between LOW and MEDIUM (F= (1,23) 9.209 p =0.006) and 
MEDIUM and HIGH (F(1,23) 24.471 p<0.001) (Figure 7.16). There was also a 
significant effect of stretch duration on the percentage change in ankle ROM achieved; 
with the 30 minute duration achieving a greater change in ROM compared to 10 minute 
duration (DUATION F(1,23) 15.207 p=0.001). However, there was no significant 
TORQUE x DURATION interactions (F (2,46) 0.614 P=0.545).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.16: Percentage change in ankle ROM with the application of a low, medium 
and high force over a 10 and 30 minute duration. Standard Error Mean (SEM) 
indicated. 
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7.3.9 Comparison to Previous Work in the Literature 
The mean differences and effect sizes for passive stiffness (Table 7.9 and 7.10); 
stretch reflex associated stiffness (Table 7.11 and 7.12) and ROM (Table 7.13 and 
7.14) are detailed below using common units of Nm/O. The results for study two and 
three detailed in chapters six and seven are compared to the findings from previous 
work in the area of stretching for the treatment of hypertonia detailed in the literature 
review (see chapter three). Data from the literature comparing measures pre and post 
intervention (i.e. not including control group data), were included to allow a more direct 
comparison with the current studies.   
Although there are similarities in the experimental procedure and sample 
demographics detailed in this thesis and the compared literature it is important to note 
that the studies detailed in the literature consist of a variety of disease pathologies in 
addition to MS including: stroke, SCI, head and brain injury. Additionally, the level of 
disability is variable with some participants being functionally mobile without the use of 
a walking aid and others being wheelchair users. Further, the degree of passive 
available ROM ranged from -30 to +100 and baseline levels of passive stiffness were 
variable.  
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Passive Stiffness 
Mean difference (Nm/O): 
Condition Mean difference Lower Limit Upper limit 
30 minutes  -0.25 -0.73 0.23 
10 minutes -0.04 -0.15 0.06 
Previous studies in 
literature (n=3) (30-
60 minutes) 
-0.09 -0.16 -0.02 
 
Table 7.9: Mean difference and confidence intervals are indicated for passive stiffness; 
a negative mean difference indicates a reduction in stiffness. 
 
Effect Size: 
 
Condition Effect Size Lower Limit Upper limit 
30 minutes  -1.03 -1.67 -0.36 
10 minutes -0.77 -1.38 -0.14 
Previous studies in 
the literature (n=3) 
(30-60 minutes) 
-0.29 -0.71 0.12 
 
Table 7.10: Effect size and confidence intervals for passive stiffness; a negative effect 
size indicates that stiffness decreases. 
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Stretch reflex associated stiffness 
Mean difference (Nm/O): 
Condition Mean difference Lower Limit Upper limit 
30 minutes  0.01 -0.26 0.28 
10 minutes -0.05 -0.21 0.12 
Previous studies in 
the literature (n=3) 
(30 minutes) 
-0.18 -0.54 0.59 
 
Table 7.11: Mean difference and confidence intervals are indicated for stretch reflex 
associated stiffness; a negative mean difference indicates a reduction in stiffness. 
Effect Size: 
Condition Effect Size Lower limit Upper Limit 
30 minutes  0.08 -0.45 0.60 
10 minutes -0.55 -1.13 0.05 
Previous studies in 
literature(n=3) 
(30 minutes) 
-0.12 -0.77 0.32 
 
Table 7.12: Effect size and confidence intervals for stretch reflex associated stiffness; 
a negative effect size indicates that stiffness decreases. 
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Range of Motion (Degrees) 
Mean difference: 
Condition Mean difference Lower limit Upper Limit 
30 mins High 22.2 5.41 38.94 
10 mins High 21.2 3.44 38.93 
30 mins Medium 15.4 1.73 29.03 
10 mins Medium 10.4 -1.20 21.96 
30 mins Low 2.2 -2.48 6.85 
10 mins Low 1.2 -2.28 4.71 
Previous studies in 
the literature (n=12) 
(10-45 minutes) 
5.0 0.28 9.65 
 
Table 7.13: Mean difference and confidence intervals are indicated for range of motion 
at high, medium and low torques; positive results demonstrate an increase in range. 
Mins = minutes.   
 
Effect Size: 
Condition Effect size Lower limit Upper Limit 
30 mins High 2.59 1.42 3.74 
10 mins High 2.34 1.21 3.45 
30 mins Medium 2.20 1.16 3.21 
10 mins Medium 1.75 0.82 2.65 
30 mins Low 0.91 0.25 1.55 
10 mins Low 0.68 0.04 1.30 
Previous (N=12) 
(10- 45 minutes) 
0.75 0.49 1.02 
 
Table 7.14:  Effect size and confidence intervals for range of motion; a positive effect 
size indicates that the ROM increases and a negative value indicates a decrease. 
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7.4 Discussion 
Study two detailed in chapter six indicated a significant effect of time in the changes 
observed in passive stiffness. In addition a significant effect of torque and time was 
observed with increases in ROM. It is more clinically feasible to implement a stretching 
regime for 10 minutes as opposed to 30 minutes; therefore this third study aimed to 
establish what the effects were of 10 minutes of stretching on change in stiffness (total, 
passive and stretch reflex associated), strength and ROM. The results demonstrate 
that the effects were notably reduced after 10 minutes of stretching in comparison to 30 
minutes of stretching. Passive stiffness reduced immediately following 10 minutes of 
stretching but the effects were not maintained over the 30 minute post stretch period. 
Further, the percentage change in ROM was significantly less after a 10 minute stretch. 
The effects of stretch duration and applied torque are summarized in Table 7.15. 
 
Table 7.15:  Diagrammatical representation of the effect of stretch duration and applied 
torque on ROM, passive stiffness and stretch reflex associated stiffness. A tick () 
indicates that this parameter has a significant effect on the variable measured 
 
It has been established in studies two and three that the level of applied torque during 
the stretch has no significant effect on change in passive stiffness or stretch reflex 
associated stiffness (spasticity).  Similarly the level of applied torque has no effect on 
plantarflexor or dorsiflexor isometric strength. However, a statistically significant effect 
of the level of applied torque on end ROM was observed, with higher torques achieving 
greater ROM. This implies that for participants with reduced ROM, such as those in 
study two, that both stretch duration and applied torque have to be considered in order 
 Duration of stretch Level of Torque 
ROM   
Passive Stiffness  X 
Stretch Reflex 
Associated Stiffness 
X X 
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to attain an optimal improvement in ROM immediately post intervention. The data 
suggests that people with reduced ankle ROM may benefit more from stretches that 
utilize both gravity and body weight when standing and are applied for a minimum of 30 
minutes.  Similarly, a significantly greater decrease in passive stiffness was achieved 
with 30 minutes of stretch compared to 10 minutes, regardless of the level of applied 
torque, suggesting that patients with enhanced passive stiffness would potentially 
benefit from longer duration stretches irrespective of the level of applied torque. It is 
important to note that the participants in study two had significantly higher passive 
stiffness and a significantly greater reduction in ankle ROM compared to those in study 
three. It is therefore, possible that the mild baseline presentation of the group in the 
third study may have potentially contributed to the reduced efficacy of the 10 minute 
stretching intervention.   
The application of a 30 minute stretch at a high torque applied in study two achieved 
significantly larger increases in ROM of up to 22o post stretch compared to the 5o 
reported in the literature; this further indicates the relative importance of the level of 
applied torque in improving ROM. However, the current study did not have an MS 
group acting as a control (i.e. no stretch). Therefore the treatment effect reported in 
Table 7.14 may be an over estimation. As highlighted in chapter 3, treatment effects 
tended to be lower for studies that had a control group.  
Overall, the results from both study two and three regarding change in passive stiffness 
with stretch are in line with the literature in this area. However, the application of 30 
minutes of passive stretch at a constant torque (study two) was able to achieve a -0.25 
Nm/o decrease in passive stiffness which is higher than what has been previously 
reported; leading to a higher treatment effect than in other stretching studies. It is 
possible that this finding may be due to differences in the intervention protocols or the 
variability in the sample populations such as disease type and severity, however in 
study one we found no significant correlation between level of passive stiffness and 
functional ability.  
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It is not yet completely clear what the clinical relevance of this reduction in stiffness is, 
work in stroke patients, showing similar levels of ankle stiffness to the MS participants 
in these studies, found a relationship between ankle stiffness and the degree of 
dorsiflexion while walking  (R2=0.35) (Lamontagne et al. 2002). However, the 
regression equations were not published and so the effects of the current reduction in 
stiffness could not be ascertained.  Unpublished work by Marsden and colleagues in 
people with Hereditary Spastic Paraparesis (HSP) also looked at the relationship 
between ankle stiffness and ROM while walking (Marsden et al. 2012). They found a 
significant relationship between stiffness measured following a fast stretch (i.e. stretch 
reflex and passive stiffness combined) and maximal dorsiflexion angle while walking 
(R2 =0.39) (Marsden et al. 2012). The equation was Y=-5.56x +15.56, where X is the 
stiffness in Nm/o and y is the range in degrees while walking. This means that for a -
0.25 Nm/o change in stiffness there is a 1.33o increase in range while walking. The 
participants with HSP had much higher levels of stiffness than the MS participants in 
this study (Total stiffness HSP =1.9 (±0.4) Nm/rad MS=0.56 Nm/rad(±0.32)). Further, 
the increase in range achieved was during a functional activity as opposed to passive 
ROM therefore the direct applicability is unknown. However, with such a small potential 
increase in ankle dorsiflexion range it does suggest that functional benefits of the 
observed reduction in passive stiffness (e.g. on reduction in foot drop and tripping, 
balance confidence and walking speed) may be small.  
Reductions in stretch reflex associated stiffness were a lot smaller than what has 
previously been reported. It is also interesting to note that all confidence intervals for 
both the mean difference and effect sizes cross zero. Therefore, it is difficult to state 
where the true treatment effect lies; it is also possible that stretching has no effect and 
may even lead in some cases to a transient increase in stretch reflex mediated 
stiffness. When the two studies (30 minutes and 10 minutes stretch duration were 
compared) a significant increase in stretch evoked stiffness was seen in the 10 minute 
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post stretch period indicating that constant torque stretching may lead to temporary 
increases in spasticity.  
The effect of stretching on spasticity is thus inconclusive; increases and decreases 
have both been seen using both electrophysiological (H/M max) and biomechanical 
measures in MS and other neurological conditions. Five other  studies have also shown 
an increase in spasticity with stretching  (see Figure 3.6); like the studies in this thesis 
all used a constant torque stretch, either delivered via a motor (Chung et al, 2005; Yeh 
et al, 2004; Selles et al 2005; Bahkeit et al, 2005) or using body weight (Kunkal et al 
1993). It may be that other stretching methods such as hold-relax are either effective at 
reducing spasticity, or at least do not increase it post stretch. Future work should use 
combined electrophysiological and biomechanical measures to further assess the 
effects of different stretching regimes on the time course of spasticity. 
In summary, constant torque stretching reduces passive stiffness and improves ROM 
in people with MS. The duration of the stretching intervention and the level of torque 
applied are key components to consider when implementing this intervention. The 
studies conducted in this body of work looked solely at the immediate and short term 
(up to 30 minutes post stretch) effects of stretching and it is therefore still not known 
what the long term benefits of these interventions are. It also remains unclear as to the 
role of viscose deformation in the observed findings. Further, although a change in the 
overall passive stiffness of the ankle plantarflexors has been seen it is unclear where 
these changes occur, namely whether this is in the tendon and/or the muscle. Given 
that differential changes in stiffness in the tendon and muscle have been seen after 
stroke (Gao & Zhang, 2008; Zhao et al. 2009) it is important to ascertain whether 
stretching indeed targets the most affected/stiffest structure. This will be explored using 
ultrasonography in chapter eight. 
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8. Chapter Eight: Changes in Measures of Muscle Stiffness 
Using Ultrasound in People with Multiple Sclerosis and 
Following Stretching 
 
8.1 Introduction 
 
The symptomatic effects of MS are very variable but limb stiffness, or hypertonia, is 
said to affect 85% of the MS population (Nielsen et al., 2007). Hypertonia, a product of 
altered levels of passive and stretch reflex mediated stiffness, can lead to marked 
functional limitations and contributes considerably to the presenting level of disability 
(Barber et al. 2011;  Gao et al. 2011).  
It is thought that the predominant contributing factors in the development of the passive 
stiffness component of hypertonia are changes in the extracellular matrix (ECM) of both 
tendon and muscle, and reductions in muscle length (Gracies, 2005). Fundamentally, 
stretching programmes are implemented to maintain or prevent loss of ROM, to 
prevent or minimise muscle shortening and to reduce hypertonia; these programmes 
are often an integral part of rehabilitation (Hass & Crow, 1995; Bovend’ Eerdt et al. 
2008).  
More recent studies in patients with an upper motor neuron lesion have used a 
combination of motorised devices and servomotors to implement different stretching 
techniques  and to assess biomechanical measures of passive stiffness and spasticity 
(Wu et al. 2011; Nakamura et al. 2011; Zhao et al. 2011). However, the disadvantage 
of these measures is that the passive stiffness measures are all-encompassing, 
including contributions from muscle, tendon (internal and free tendon) and connective 
tissue elements. It is important to have an understanding of the mechanical and 
architectural composition of the structures contributing to the overall stiffness (Lieber & 
Friden, 2001) and how these may be affected by pathology and interventions such as 
stretching.  
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It remains unclear whether ECM changes following a neurological lesion occur in the 
tissues within and surrounding the muscle and/or the tendon. It has been postulated 
that in the stroke population the increase in passive ankle stiffness was due to an 
increase in Achilles tendon stiffness (Thilmann et al. 1991). In contrast, Winters 
suggested that in the stroke population the ECM surrounding muscle is stiffer than 
normal and lies in series with a more compliant tendon (Winters et al. 2009; Zhao et al. 
2011).  
More recently developments in the use of ultrasonography have aided further 
understanding of the muscle and tendon structure and how they adapt to applied 
forces. With B-mode ultrasonography, the mechanical properties of human muscle and 
tendon can be evaluated in vivo and non-invasively (Fukunaga et al. 1996). Two main 
techniques have been used to assess muscle and tendon properties using ultrasound 
to date. In one technique the ankle is fixed in a dynamometer. The dynamometer 
measures the applied torque while the participant isometrically contracts their ankle 
plantarflexors. The change in length of the Achilles tendon is measured using 
ultrasound and the resulting stress (torque/length) and strain (elongation / original 
length) calculated (Sugisaki et al. 2011; Arampatiz et al. 2005; Magnaris & Paul 2002; 
Gao et al. 2011). In the second technique the elongation of the muscle fascicle and / or 
Achilles tendon is measured using ultrasound during imposed stereotyped mechanical 
stretches (Morse et al. 2008; Loram et al. 2006; Nordez et al. 2009).  
Using these techniques it has been shown that the passive mechanical properties of 
muscle and tendon are different in people with neurological lesions compared to 
healthy controls. People with cerebral palsy have significantly shorter muscle fascicles 
(Mohagheghi et al. 2007) and the muscle fibres of stroke patients are shorter and stiffer 
than healthy controls, with an associated longer more compliant Achilles tendon (Gao 
& Zhang, 2008; Zhao et al. 2009). Ultrasonography is thus fast becoming a common 
addition to experimental studies which measure the biomechanical changes in stiffness 
(Kubo et al. 2000; Shortland et al. 2002).  
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As well as investigating whether there are differences with pathology and determining 
the site of any changes, the use of ultrasonography can help to determine whether 
stretching targets this site effectively. For example, it has been shown in healthy 
subjects that the relative change in length of the Achilles tendon following a stretch in 
subjects with low overall passive stiffness was minimal and that greater elongation was 
noted in the muscle fascicles compared to participants with a higher level of stiffness 
(Abellaneda et al. 2009). This suggests that the site and underlying degree of stiffness 
affects the relative degree of lengthening in the muscle and tendon with stretching.  
Therefore, the objectives were to investigate: 
(a) differences in overall muscle and tendon length in pwMS and healthy controls 
(b) differences in muscle fibre lengthening and strain following a stereotyped 
perturbation in pwMS and healthy controls 
(c) the effect of the application of a constant torque stretch for 10 minutes on 
muscle fibre properties. 
8.2 Materials and Methods 
8.2.1 Participants and Recruitment 
Thirteen participants with MS were initially assessed for details (see Chapter 7 section 
7.3.1). However, in three cases missing data prevented the full analysis of results from 
these individuals. Therefore 10 people with MS were included in the final data analysis. 
MS participants were compared to 12 healthy matched controls. Participants with MS 
were recruited from the SWIMS database, and the controls were work associates and 
friends and family members of MS participants (for further details regarding recruitment 
please see Chapter four, section 4.3). All participants met the inclusion criteria (detailed 
in Chapter four, 4.4.1) and gave written informed consent to participate. The study was 
conducted with approval from the NHS Torbay and Devon Research Ethics Committee 
(Ref-09/H0202/42). 
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8.2.2 Experimental Setup 
Participants were placed in a semi-reclined 25o head tilt position, with the leg most 
affected by stiffness supported in a footplate with an attached non-slip mat and padded 
Velcro supports. The footplate was attached to a purpose-built dynamometer (Baldor 
UK) and the ankle axis was aligned to the axis of the motor shaft (Figure 7.1). The 
knee was in full extension and the thigh supported and restrained using straps. 
Seatbelt styled supports and a backrest prevented the body from moving longitudinally 
up the bed.  
The participants with MS were then stretched (“the intervention”) on three separate 
occasions at low, medium and high torques for 10 minutes (see Chapter seven for 
details). Control participants were seen on one occasion where the low torque was 
applied over a 10 minute stretching period and baseline and immediate post stretch 
measures of stiffness, strength and ROM were collected. 
8.2.3 Application of Ankle Perturbations to Monitor Limb Stiffness 
Limb stiffness was measured by applying a 15o amplitude ramp stretch at 5o/second 
from -10o plantarflexion to 5o dorsiflexion. This is termed the ankle perturbation. This 
was repeated six times with a variable one-three second delay between stretches. 
Participants were instructed to remain relaxed throughout the perturbation periods.  
Torque, position and velocity data was obtained via the motor and a torque transducer 
in series with the motor (TLSF transducer, Industrial measurements UK).  Muscle 
activity was recorded from the tibialis anterior, gastrocnemius and soleus muscle, using 
surface EMG (EMG 2.5 cm inter-electrode distance, MT8, MIE, UK). Signals were 
sampled at 2kHz and AD converted using a power 1401. Spike 2 software (version 5, 
CED Electronics Cambridge, UK) was used for initial visual analysis and to export data 
to MATLAB for further analysis. This data was used to calculate passive stiffness after 
checks were made to ensure participants were relaxed prior to and during the stretch 
(see Chapters six and seven). 
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8.2.4 Ultrasound Setup 
A diagnostic ultrasound machine (Sonoace PICO, Medison Ltd, Korea) with a single 
38mm wideband linear array probe and a centre frequency of 7.5 MHz was used to 
collect ultrasound video footage of the gastrocnemius muscle/aponeurosis, soleus 
aponeurosis and free tendon movement with the application of the ankle perturbation 
before and after the intervention (Figure 8.1). The initial ultrasound setup had the 
following characteristics: depth 3cm, density FPA 49. These parameters were adjusted 
where necessary to optimise the image quality. 
A video and audio capture device (EasyCAP DC60 – USB version 2.0) was used to 
connect the ultrasound video display to a laptop so that the ultrasound video data could 
be recorded via Ulead video studio editor (Ulead video studio version 9.0) and stored 
offline for later analysis. Ultrasound gel was placed on the transducer head and once 
the location of the musculotendinous junction (MTJ) was established its position was 
marked on the overlying skin using a marker pen. The ultrasound transducer was kept 
in a stationary position using a flexible mechanical arm (Manfrotto Magic Arm, 
Manfrotto UK) with Manfrotto super clamps that were fixed to an extension frame 
attached to the base of the plinth and locked in place once the desired position was 
achieved (Figure 8.2 B)  
8.2.5  3D Motion Analysis 
Three-dimensional motion analysis was used to estimate the total, proximal and distal 
length of the gastrocnemius muscle tendon complex before and after the stretching 
intervention (Figure 8.1). Four light emitting markers (Codamotion, UK) were placed on 
the motor’s vertical shaft and the horizontal axis of the foot plate attachment. With the 
footplate vertical, the co-ordinate frame for 3D motion data collected was defined so 
that the longitudinal axis of the shank was defined as the x direction; the antero-
posterior axis of the shank was the y axis and the medio-lateral axis of the shank was 
the z axis.  
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Further light emitting markers were placed on the proximal gastrocnemius attachment 
at a position 10 cm distal from the muscle origin on the anterio-medial aspect of the 
tibia shaft (Figure 8.2 B). Two markers were placed on an extension device attached to 
the calcaneus, the tip of which was aligned to the insertion of the gastrocnemius 
(Figure 8.2 A). Pilot work showed that these adjustments ensured that the markers 
indicating the proximal and distal attachment of the gastrocnemius were always in 
view. Additionally, four markers were placed on the transducer head (located at the 
position of the MTJ), top left, top right, bottom left and bottom right (Figure 8.2 C).  
 
 
Figure 8.1: A) Ultrasound transducer location at MTJ (image edited from (Sugisaki et 
al. 2011)); B) Diagrammatical representation of total length, proximal and distal length 
measures of gastrocnemius.   
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Figure 8.2: A) Location of calcaneus heel device with foot in neutral position; B) 
position of markers and EMG and diagrammatic representation of position of 
ultrasound probe relative to the MTJ; C) Ultrasound probe and location of coda 
markers/marker boxes. 
8.2.6 Synchronisation 
The onset of the ankle perturbation was indicated by a 5V signal elicited by the 
software that controlled the BSM servomotor. This signal was AD converted by a power 
1401 (CED, UK) simultaneously with the torque, position, velocity and EMG signals. 
The power 1401 in turn elicited a 5V output signal 1ms later that was used to 
synchronise the 3D motion analysis and ultrasound recordings; this signal was 
collected via the audio input of the EasyCAP device and via the CODA motion analysis 
system. In this way it was possible to locate the same position within the ankle 
perturbation data in the three data collection systems in order to calculate muscle 
length changes pre and post intervention accurately.  
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8.2.7 Signal Processing  
8.2.7.1  Gastrocnemius Muscle and Tendon Length  
The motion analysis data was sampled at 200 Hz for 115 seconds. This data was 
exported to MATLAB (Mathworks UK) for processing using programmes written in-
house. 
 
Total Gastrocnemius Length: gastrocnemius length was calculated using the proximal 
shank markers and the markers on the calcaneal extension. A correction was made for 
the 10cm distal displacement of the marker indicating the proximal attachment of the 
gastrocnemius and the offset imposed by the markers on the extension device that 
aligned with the distal attachment of the gastrocnemius.  Marker position longitudinal to 
the shank (defined as the x direction) and in an antero-posterior direction (defined as 
the y direction) were used to calculate the total length of the muscle and tendon 
complex using Pythagoras’ theorem (Figure 8.3). 
Total Length = √(proximal marker x – distal marker x)2 +(proximal marker y – distal 
marker y)2  
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Figure 8.3: A) Diagrammatical image of marker calculations of gastrocnemius muscle 
length in PF at start of perturbation and B) DF at end of perturbation. Note the change 
in the footplate and heel marker orientation from A to B as the ankle moves into 
dorsiflexion. 
 
Gastrocnemius Muscle and Tendon Length: video imaging software (VirtualDub 
version 1.9.6) was used to export the first frame of the slow ankle perturbation applied 
pre and post intervention. This image file was then opened using Image J software and 
the distance of the MTJ from the centre of the screen (the “correction factor”) was 
calculated using the equation:  
Correction factor = (length of half screen width-X)/pixels per mm,  
where X = distance measured from the left side of the screen to the MTJ.  
This correction factor meant that images to the left of the screen midline were positive 
and those to the right of screen midline were negative. This correction factor was later 
used in the calculation of the gastrocnemius muscle and tendon length (see below).   
The position of the MTJ, relative to the markers indicating the distal and proximal 
gastrocnemius attachment, was then calculated as follows. The mid-position of the 
ultrasound head was calculated from the attached markers. A correction factor was 
added to account for the exact position of the MTJ image relative to the middle of the 
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ultrasound head, as described previously. This made allowances for the fact that the 
MTJ could be to the left or right of the mid-position of the ultrasound head. The 
distance from the MTJ, in coda motion co-ordinates and the distal gastrocnemius 
attachment point was then calculated using Pythagoras’ theorem providing an estimate 
of the tendon length.  
Tendon Length = √(MTJ marker x – distal marker x)2 +(MTJ y – distal marker y)2 
The gastrocnemius muscle length was determined by subtraction of the tendon length 
from the total length.  All length measures were normalised to the participants’ height. 
8.3  Calculation of Muscle Fibre Length Changes and Strain with Stretching 
VirtualDub 1.9.6 was used to open the pre-recorded ultrasound video file. Footage of 
the dorsiflexion portion of the 2nd and 6th ankle perturbation was selected. These 
perturbations were selected to assess if there were any thixotropic effects of repeated 
perturbations. Every second frame of the selected footage was processed as pilot work 
showed this method increased the accuracy of the tracking. The edited image 
sequence was then exported as a Windows Bit Map (BMP) file. 
The exported image sequence was processed using a frame-by-frame cross-
correlation image analysis program written in MATLAB (Mathworks version 6.0), as 
described by (Dilley et al. 2001). This software calculates the relative excursion 
between consecutive frames sequentially in the ultrasound image clips. Specific 
analysis criteria, such as start and end frame numbers, start and end horizontal pixel 
shift numbers and pixel/mm values, were adjusted as appropriate.  
Three equal-sized regions of interest (ROI) were manually selected on the area of 
muscle closest to the MTJ and gastrocnemius aponeurosis (Figure 8.4). In the 
subsequent frame, where the new position of the ROI was sought, the coordinates of 
the selected ROI were offset along the horizontal plane of the image a pixel at a time 
within a predefined range. At each position the software programme compared the 
grey-scale values from the ROIs to that seen in the previous original frame and 
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calculated the correlation coefficient. The ROI in the second frame that produced the 
largest correlation with the previous frame was chosen as the new position of the ROI. 
This process was repeated for subsequent frames. Thus the programme was able to 
accurately track the displacement of the ROI (Figure 8.4 & 8.5) producing the 
cumulative longitudinal displacement of the ROI and the mean hypotenuse of the three 
ROIs (Figure 8.5) 
 
 
 
 
 
 
 
 
 
 
     
Figure 8.4: Image of selected ROI displayed using ultrasound imaging. 
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Figure 8.5: Image of calculation of velocity of displacement of ROI (row 1) in mm, 
hypotenuse (row 2) mm, horizontal displacement of ROI (row3) and vertical 
displacement of ROI (row 4) measured in mm. Note the minimal vertical movement. 
 
The displacement of the ROI during the second and sixth slow ankle perturbations at 
baseline and post intervention, for the high, medium and low applied torques for the 
MS participants, and low torque for the controls, were recorded and the percentage 
strain was defined as: 
Percentage strain= (ROI displacement/gastrocnemius muscle length) x100. 
Where the gastrocnemius length was measured with the ankle in 10o plantarflexion 
8.4 Analyses 
The total, muscle and tendon lengths of the gastrocnemius complex for the pwMS and 
controls were compared using a between groups repeated measures ANOVA with 
factors being STRETCH (baseline Vs post). 
Percentage strain and the displacement of the medial gastrocnemius muscle and  
 201 
 
aponeurosis following the low torque 10 min stretch was compared between the MS 
participants and the control group using a between groups repeated measures ANOVA 
(SPSS 17.0, IBM) with factors being TIME (2nd vs 6th perturbation) and STRETCH 
(baseline vs post).  
In pwMS a repeated measures ANOVA compared the effects of different applied 
torques on the percentage strain and ROI displacement with factors being FORCE 
(low, medium and high), TIME (2nd vs 6th perturbation) and STRETCH (baseline vs 
post).  
A Pearson’s rank correlation determined the relationship between the passive stiffness 
measured using the motor (see Chapters five and six), and percentage strain at 
baseline and following the application of the high torque. Additionally, the relationship 
between the change in total passive stiffness and the change in the percentage strain 
with the application of the high torque were determined. For all statistical tests, the 
level of significance was set at P<0.05.    
8.5 Results 
Ten pwMS were assessed with an average age of 58 yrs (± 10 yrs); height 166 cm (± 6 
cm); weight 71 kg (± 14 kg); length of time since diagnosis 7yrs (± 8 yrs). Two of the 
participants were on anti-spasticity medication (Baclofen); five participants were 
diagnosed with relapsing remitting MS, two with primary progressive MS and three with 
secondary progressive MS.  Participants with MS were compared to 12 healthy 
controls with an average age of 54 yrs (± 5 yrs); height 164 cm (± 8 cm) and weight 72 
kg (± 20 kg). Further demographic information can be obtained from chapter seven 
(Tables 7.1 and 7.2; Subjects 1-3, 5-8 and 10, 12, 13 were included in this study).   
8.5.1 Muscle and Tendon Length: MS and Control Comparison 
 
Length when measured in plantarflexion: 
The baseline total length of the gastrocnemius muscle-tendon complex normalised to 
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height was not significantly different between the pwMS and the control group when 
measured at 10o of plantarflexion where the muscle was off stretch (F(1,20)=1.3 
p>0.05) and there were no effects of stretch (F(1,20)=1.75 p>0.05 ) or group x stretch 
interactions (F(1,20))=0.22 p>0.05) . Similarly the Achilles tendon length was not 
significantly different between the MS and control group (F(1,20)=0.004 p>0.05) and 
there were no interaction effects (F(1,20)=0.07 p>0.05) or effects of stretch  
(F(1,20)=1.81 p>0.05). For the gastrocnemius muscle length there were no effects of 
group (F(1,20)=0.92 p>0.05) or stretch (F(1,20)=0.028 p>0.05). However, there was a 
trend towards significance for the group x stretch interaction (F(1,20)=3.69 p=0.069). 
Here, following the stretch the muscle length was increased in the control group whilst 
it slightly decreased on average in the pwMS (Figure 8.6). 
 
 
 
 
Figure 8.6: Total gastrocnemius muscle (Proximal) and Achilles tendon (distal) length 
(mm) measured with the foot in 10o plantarflexion. All lengths are normalised to the 
person’s height. Total gastrocnemius and tendon length at baseline (Base_Total),total 
gastrocnemius and tendon length post stretch (Post_Total), gastrocnemius muscle 
length at baseline (Base_Proximal), gastrocnemius muscle length post stretch 
(Post_Proximal), Achilles tendon length at baseline (Base_Distal), Achilles tendon 
length post stretch (Post_Distal). 
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Length when measured in dorsiflexion: 
The baseline total length of the gastrocnemius muscle-tendon complex normalised to 
height tended to be shorter in the pwMS when measured at 5o of dorsiflexion where the 
muscle was on stretch (F(1,20)=-3.3 p=0.08, Figure 8.7). There were no effects of 
stretch (F(1,20)=1.2 p>0.05) or interaction effects (F(1,20)=0.013 p>0.05). The Achilles 
tendon length was not significantly different between the MS and control group 
(F(1,20)=1.75 p>0.05) and there were no time x group interaction effects (F(1,20)=0.60 
p>0.05) or effects of stretch  (F(1,20)=1.2 p>0.05). As with the measures in 
plantarflexion there was a trend towards a significance for the group x stretch 
interaction for the gastrocnemius muscle length (F(1,20)=3.89 p=0.063) with the control 
group tending to show greater increases in muscle length following the stretch (Figure 
8.7) 
 
 
Figure 8.7: Total gastrocnemius muscle (Proximal) and Achilles tendon (distal) length 
(mm) measured with the foot in 5o dorsiflexion and normalised to height. Total 
gastrocnemius and tendon length at baseline (Base_Total),total gastrocnemius and 
tendon length post stretch (Post_Total), gastrocnemius muscle length at baseline 
(Base_Proximal), gastrocnemius muscle length post stretch (Post_Proximal), Achilles 
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tendon length at baseline (Base_Distal), Achilles tendon length post stretch 
(Post_Distal). 
 
8.5.2 Relationship Between Passive Stiffness and Muscle / Tendon Length 
Passive stiffness, as measured using the motor, showed a moderately strong 
correlation with Achilles tendon length at baseline and post stretch (Table 8.1, Figure 
8.8). Higher passive stiffness was associated with a longer Achilles tendon length. 
 
 Baseline - Pre stretch Post stretch 
Tendon Length Vs 
passive stiffness 
R=0.62* R=0.65* 
Muscle length Vs passive 
stiffness 
R=0.27 R=0.29 
 
Table 8.1: Relationships between passive stiffness and Achilles tendon and 
gastrocnemius muscle length measured with the ankle in dorsiflexion * Indicates 
significance, P< 0.05. 
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Figure 8.8: Relationship between passive stiffness and absolute Achilles tendon length 
in pwMS 
8.5.3 Displacement of the ROI: MS and Control Comparison 
There was no significant difference in displacement between the pwMS and control 
group (GROUP F(1,20)=0.48 p=0.50) and there was no significant difference in 
displacement between measures taken at baseline and following the application of a 
low torque stretch for 10 minutes (STRETCH F(1,20)=1.08 p=0.31, Figure 8.9).  
There was no significant difference between the second and sixth perturbation (TIME 
F(1,20)=0.001 p=0.98). There were no other significant interaction effects (TIME X 
GROUP interaction F(1,20)=1.11 p=0.30; STRETCH X GROUP interaction 
(F(1,20)=0.69 p=0.42; TIME X STRETCH X GROUP interaction (F(1,20)=0.90 p=0.35) 
(Figure 8.9).  
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Figure 8.9: Absolute length displacement of ROI before and after stretch intervention 
with the low applied torque for the second and sixth perturbation: baseline second 
perturbation (Base2), post stretch second perturbation (Post2), baseline sixth 
perturbation (Base6), post stretch sixth perturbation (Post6) between the MS and 
control group. Mean ±SEM are indicated.  
8.5.4 Absolute Displacement of ROI Following a Stretching Intervention in pw 
MS 
A significant difference in displacement between measures taken at baseline and post 
stretch intervention was observed (STRETCH F(1,9)=4.982 P=0.005; Figure 8.10), with 
significantly greater displacement observed post stretch intervention. There was no 
significant difference in absolute length displacement with torque (TORQUE 
F(2,18)=3.023 p=0.074). There was no significant effect observed between the second 
and the sixth perturbation at baseline or post stretch intervention (TIME F(1,9)=1.553 
P=0.224) (Figure 8.10). There was no other significant interaction effects; (TORQUE X 
TIME interaction (F(2,18)=1.501 p=0.250); TORQUE X STRETCH interaction 
(F(2,18)=0.448 p=0.646); TIME X STRETCH interaction (F(1,9)=0.021 p=0.888); 
TORQUE X TIME X STETCH interaction (F(2,18)=0.931 p=0.412).  
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Figure 8.10: Absolute length displacement of ROI before and after stretch intervention 
with low applied torque for the second and sixth perturbation: baseline second 
perturbation (Base2), Post stretch second perturbation (Post2), baseline sixth 
perturbation (Base6), post stretch sixth perturbation (Post6) for the MS group. SEM are 
indicated. H = high , M = medium and L =  low applied torque.   
8.5.5 Strain: MS and Control Comparison 
There was no significant difference in strain between the pwMS and control group 
(GROUP F(1,20)=0.49 P>0.05) and no significant difference in strain measures taken 
at baseline and post stretch intervention (STRETCH F(1,20)=1.06 P>0.05). There was 
no significant difference between the second and sixth perturbation (TIME 
F(1,20)=0.001 P=0.98); TIME X GROUP interaction (F(1,20)=1.11 p>0.05); STRETCH 
X GROUP interaction  (F(1,20)=0.53 p>0.05) and TIME X STRETCH X GROUP 
interaction (F(1,20)=0.89 p=0.36) (Figure 8.11). 
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Figure 8.11: Percentage strain of ROI before and after stretching intervention with low 
applied torque for the second and sixth perturbation: baseline second perturbation 
(Base2), Post stretch second perturbation (Post2), baseline sixth perturbation (Base6), 
post stretch sixth perturbation (Post6) between the MS and control group. SEM are 
indicated.  
8.5.6 Strain Following a Stretching Intervention in pwMS 
There was a significant difference in strain between measures taken at baseline and 
following the 10 minute stretch intervention (STRETCH F(1,9)=5.07 p=0.05) with a 
significant increase in strain being seen post intervention (Figure 8.12). There was no 
significant difference in strain measures with torque (TORQUE F(2,18)=1.76 p=0.20). 
There was no significant difference between the second and sixth perturbation at 
baseline or post intervention (TIME F(1,9)=1.53 p=0.25). Similarly, there was no 
significant TORQUE X TIME interaction (F(2,18)=1.43 p=0.27); no significant TORQUE 
X STRETCH interaction (F(2,18)=0.55 p=0.59); no significant TIME X STRETCH 
interaction (F(1,9)=0.12 p=0.74) and no significant TORQUE X TIME X STETCH 
interaction (F(2,18)=1.01 p=0.38).  
 
 209 
 
Figure 8.12: Percentage strain of ROI before and after intervention for the second and 
sixth perturbation: baseline second perturbation (Base_2), Post stretch second 
perturbation (Post_2), baseline sixth perturbation (Base_6), post stretch sixth 
perturbation (Post_6) for the MS group. SEM are indicated. H = high, M = medium and 
L = low applied torque.   
 
8.5.7  Relationship between Passive Stiffness and Gastrocnemius Muscle-
Tendon Strain  
In pwMS the relationship between strain and passive stiffness was determined after the 
application of a 10 minute low torque stretch. A moderately strong significant 
correlation (r>0.5, Cohen 1988) was observed between the post-stretch strain and 
post-stretch passive stiffness (Table 8.2, Figure 8.13). A higher passive stiffness was 
associated with an increase in strain. There were insubstantial to weak correlations 
(r<0.3 Cohen 1988) between the mean changes in strain and the change in passive 
stiffness as measured using the motor and the strain and stiffness measured at 
baseline (Table 8.2). 
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Table 8.2. Relationships between the strain and passive stiffness at baseline (pre 
stretch) and post 10 minute low torque stretch intervention. R = Pearson’s rank 
correlation. 
 
 
 
 
 
 
 
 
 
 
Figure 8.13: Passive stiffness measured post 10 minute low torque stretch compared 
with strain measures post stretch. All measures were taken with the foot in 10o 
plantarflexion. 
 
 
 
CONDITION R Value P Value 
Baseline strain vs baseline passive stiffness 0.53 0.12 
Post stretch strain vs post stretch passive stiffness 0.62 0.05 
Change in strain vs change in passive stiffness 0.03 0.94 
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8.6 Discussion 
The aim of this study was to investigate the long term adaptations that may occur in the 
gastrocnemius muscle-tendon complex in pwMS and the short term changes following 
a 10 minutes constant torque passive stretch based intervention.  
8.6.1 Differences in Total Gastrocnemius Muscle-Tendon Complex Length 
between pwMS and Controls 
The total baseline length of the gastrocnemius muscle-tendon complex in a position of 
10o plantarflexion was not significantly different between pwMS and the control group. 
However, when the gastrocnemius muscle was on stretch at 5o dorsiflexion there was a 
trend towards a difference between the groups with the controls demonstrating a longer 
total length compared to pwMS. It was anticipated that the total length would be 
identical between the two groups at these two positions, since every effort was made to 
fix the ankle and knee in identical positions in both groups and lengths were normalised 
to height. This trend suggests that in pwMS the heel may have come away from the 
footplate marginally as it was moved into dorsiflexion possibly due to increased 
stiffness in the muscle. Difficulties with maintaining ankle position during perturbations 
and isometric contractions when measuring muscle / tendon length and strain have 
been reported previously due to the small levers involved and the large force 
applied/generated at the ankle (Arampatiz et al. 2005). Although this result did not 
reach significance it must be acknowledged that this potential heel movement may 
have affected the results and more marked MS-control differences may have been 
seen with improved fixation systems. Future work could look at the reliability of this 
measurement system.   
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8.6.2 Gastrocnemius Muscle Stiffness and Achilles Tendon Compliance in MS 
There are several findings that suggest that the gastrocnemius muscle was stiffer and 
Achilles tendon longer and more compliant in some participants with MS. Firstly, 
muscle length increased following a 10 minute low torque stretch in controls whilst this 
was not seen in pwMS suggesting that the muscles were stiffer. Secondly, higher 
passive stiffness was associated with longer tendons in pwMS. Previous studies in 
stroke and CP have reported increased muscle stiffness and longer, more compliant 
tendons (Zhao et al. 2011). These findings lend support to this relationship.   
8.6.3  Potential Site of Increased Passive Stiffness in pwMS 
One interesting finding was that higher passive stiffness was associated with greater 
strain. This suggests that our selected ROI, the MTJ, was actually less stiff / more 
compliant in people with a greater overall passive stiffness. This further implies that the 
area of increased stiffness must be located outside of the measured ROI. As the free 
tendon is longer (and possibly more compliant) in people with more overall passive 
stiffness this suggests that the increased stiffness lies within the muscle belly. The 
cause of this increased stiffness could be shortening of the muscle fascicles. Recent 
human studies have shown that muscle fascicle length can be decreased in people 
with CNS lesions although this has not been reported in pwMS to date (Gao et al. 
2011; Kwah et al. 2012). Future works should therefore assess a broader ROI and / or 
measure muscle fascicle length directly.  
8.6.4  Effects of Stretching on Passive Stiffness 
The results of chapter seven show that a 10 minute constant torque stretch results in a 
reduction in muscle-tendon passive stiffness as measured using the motor. The 
question remains as to the structures responsible for this reduction.  
In pwMS stretching for 10 minutes at a constant torque resulted in a significant 
increase in strain in the ROI. As the ROI was located close to the tendon at the MTJ it 
is unclear whether the stretch targeted the main region that was stiff, which as  
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discussed above may be the bulk of the muscle more proximal to the region recorded 
with ultrasound.  One conclusion that could be drawn from the finding that the muscle 
length in pwMS did not change as much as the controls post stretch is that this stretch 
may not have targeted the stiffest region. 
Previous work highlights that the effects of stretching may not be uniform across the 
whole muscle-tendon complex. Nakamura et al. (2011) investigated in healthy 
participants the immediate effects of five minutes of constant torque stretching on the 
mechanical properties of the gastrocnemius muscle tendon unit using a dynamometer 
and ultrasonography. Total muscle-tendon and muscle stiffness were significantly 
reduced immediately following the intervention and 10 minutes post intervention as was 
observed in the studies undertaken for this thesis (see Chapters six and seven). 
Additionally, free tendon stiffness post intervention was found to be higher than the 
baseline measure (Nakamura et al. 2011). However, no significant difference in fascicle 
length was observed. It was therefore postulated that the change in muscle tendon 
stiffness observed post intervention could be due to changes in the properties of the 
internal tendon (aponeurosis); the ROI assessed in the current thesis study. In 
contrast, Gao et al. (2011) in a stroke population demonstrated that a 60 minute 
intelligent stretching regime does result in an increase in muscle fascicle length as well 
as a shortening of the tendon.  Differences between these studies in the underlying 
population (healthy vs stroke) and the duration of stretch (five minutes vs 60 minutes) 
highlights the need for more work in this area assessing different populations and 
durations of stretch while measuring multiple areas of the muscle-tendon complex.  
The current and past findings discussed above have important clinical implications for 
the management of hypertonia. The fact that longer, more compliant tendons 
associated with stiffer muscle groups have been reported in several populations with 
CNS damage suggests that the short term stretches that occur in everyday activities 
and are often implemented as part of a rehabilitation programme are resisted by the 
stiffer muscle and results in lengthening of the tendon. It would appear that, short term 
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stretches may exacerbate this issue. With a longer stretch, as applied in this thesis, 
stress relaxation may occur in the muscle and over the short and long duration result in 
muscle lengthening and a reduction in stiffness. 
The finding of a longer muscle length in the control group is consistent with study one 
(Chapter 5) and suggests that this may be a real difference. It is possible that statistical 
significance was limited by the small sample size due to participant drop out, rather 
than reflecting other factors such as measurement error.  
8.6.5 Changes in Gastrocnemius Muscle-Tendon Length with Stretching 
Following the application of a stretch the ankle was returned to the starting position and 
perturbed from 10o plantarflexion to 5o dorsiflexion. The length of the gastrocnemius 
muscle and Achilles tendon were assessed at the start and end of the perturbation and 
the displacement of an ROI at the muscle tendon complex assessed during the 
perturbation. As the position of the knee was fixed one would expect the total length of 
the muscle-tendon not to change following stretching when the ankle is placed in a 
standardised position. However, it is possible that the relative length of the muscle and 
tendon changes. 
This study found no significant difference in the length of the gastrocnemius muscle or 
Achilles tendon following the application of either a high, medium or low torque 
constant stretch as measured by the combined 3D motion analysis – ultrasound 
technique. This suggests that a 10 minute stretch does not lead to any significant 
changes in overall length of either the tendon or muscle component. The implications 
of this in light of the observed changes in ROI displacement and strain will be 
discussed further in chapter eight.  
8.6.6   Measurement of Gastrocnemius Muscle-Tendon Displacement and Strain  
There are several reported ways for evaluating the mechanical properties of the 
gastrocnemius muscle tendon unit. This experiment used tracking techniques of  
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manually selected ROI and a MATLAB software programme to calculate displacement. 
It has been demonstrated, in work looking at measuring strain in the Achilles tendon of 
rats, that the following techniques were all equally effective in accurately measuring 
strain: optical video for manual tracking of optical markers; optical video for DIC 
tracking of optical surface markers; and ultrasound video for DIC tracking of image 
texture within the tissue (Okotie et al., 2012). 
The use of ultrasound accounted for only a two dimensional view of the selected ROI 
which is a 3 dimensional structure and this may have some potential influence on the 
findings related to the muscle-tendon aponeurosis.  To minimise error, and to ensure 
smooth tracking of the selected ROI, continual visual checks were made and selected 
ROI were repositioned when the boxes did not appear to be tracking correctly (Herbert 
et al. 2011).  
8.6.7  Gastrocnemius Muscle-Tendon Displacement and Strain: Comparison 
Between MS and Controls 
There was no significant difference in the displacement of the ROI (the gastrocnemius 
muscle-tendon complex) and the percentage strain between the MS participants and 
control group. This finding is supported by the biomechanical measures of passive 
stiffness which demonstrated no significant difference between the MS and control 
group, indicating that the MS sample consisted of participants with only mild symptoms 
of hypertonia. Work by Hoang and colleagues in a comparable sample of pwMS 
observed similar findings and reported no significant difference in the mechanical 
properties of the gastrocnemius muscle-tendon complex between ambulatory MS 
patients and a healthy control group (Hoang et al. 2009).  
Other studies have however found that neurological lesions can result in significant 
differences in muscle and tendon properties. The muscle fibres of people post stroke, 
for example, have been reported to be stiffer and shorter than healthy controls with an 
associated longer more compliant Achilles tendon (Gao & Zhang, 2008; Zhao et al. 
2009). Further, in the Cerebral Palsy population, medial gastrocnemius strain was 
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significantly smaller than that of the healthy matched controls (Barber et al. 2011). The 
differences in findings between these studies and the work undertaken for this thesis 
may reflect differences in a range of factors including pathology, the severity of 
hypertonia, or in the methods used to calculate muscle stiffness. The studies in stroke 
assessed muscle fibre length changes when the muscle was either electrically 
stimulated or contracted isometrically. In contrast this thesis study assessed length 
changes following the application of a constant angle perturbation. This could result in 
differences in the underlying site of applied linear force (i.e. internally generated vs 
externally generated) and its transmission through the muscle-tendon complex (eg 
stressing mainly tendon – perimysium when applying an external force Vs additionally 
stressing endo- and epi- mysium when forces are generated internally). 
8.6.8 Gastrocnemius Muscle-Tendon Displacement and Strain: Effects of 
Stretching  
There were significantly greater levels of displacement of the ROI gastrocnemius 
muscle-tendon complex and greater strain in pwMS observed with a standardised 
perturbation following the 10 minute constant torque stretching intervention. As this 
ROI was placed within the muscle adjacent to the muscle-tendon junction this implies 
that the muscle fibres have moved more and so one may expect a longer end muscle 
length at the end of the perturbation. The fact that overall muscle length did not change 
suggests that either  
(a) the measure of muscle and tendon length using combined ultrasound / 3D motion 
analysis was not sensitive enough to detect small length changes as found by the 
ultrasound cross correlation method  
(b) the increase in displacement was not uniform across the whole muscle / tendon 
resulting in no overall change in the length of the muscle and tendon  
(c) the increase in the displacement/strain is due to changes in the overall imposed 
stretch of the gastrocnemius resulting from changes in how the ankle attaches to the 
manipulandum moving the foot, that is movement of the foot during the stretch. If this 
 217 
 
was true one would, however, expect an increase in overall length, which was not 
seen. 
Nakamura and colleagues (2011) have provided support for point (b) that changes 
occurring with a stretch may not be evenly distributed for further details see (8.6.4). 
The current study assessed displacement around the muscle–tendon junction. 
Therefore, the observed increase in displacement and strain post stretch may reflect 
isolated alterations in the aponeurosis and muscle-tendon junction. Future work should 
simultaneously assess changes in displacement / strain at multiple sites within the 
muscle and tendon following a period of stretching to ascertain the exact site(s) of 
change. 
8.6.9 Measurement of Passive Stiffness 
Passive stiffness measured biomechanically using a motor showed moderate to 
moderately strong correlations (r>0.5) with the displacement and strain of the 
gastrocnemius muscle–tendon complex. This suggests that the biomechanical 
measure and ultrasound technique are measuring two related but different constructs. 
The biomechanical measure assesses the overall muscle-tendon stiffness and would 
include errors associated with estimating anthropometric data used to negate the 
contribution of the weight of the foot (see Chapter 4). In contrast the ultrasound method 
provided a measure of localised strain. Following a period of stretching increases in 
strain can be seen in the muscle with simultaneous reductions in strain seen in the 
tendon (Abellaneda et al. 2009). This highlights that a lack of a strong correlation 
between localised muscle and gross biomechanical measures may be expected. 
As well as using biomechanical, EMG- and ultrasonography-based measures we also 
assessed the impact of stiffness in every study using the MSSS-88. As highlighted in 
appendix one, when the results of the three studies were combined a significant 
correlation (r=0.44) was seen between the total stiffness measured biomechanically 
(i.e. a combination of passive and stretch-mediated stiffness) and section three of the 
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MSSS-88 that assesses the effect of muscle spasm on walking. Additionally, sections 1 
(r=0.34), 2 (0.38), 4 (r=0.31) and 6 (r=0.27) of the MSSS88 showed weak correlation to 
biomechanical measures of total stiffness, for further detail (see appendix 1).  The lack 
of correlation with the other sections of the MSSS88 probably reflect the difficulty in 
distinguishing between the impact of spasticity and passive stiffness on function from 
other co-existing impairments such as fatigue and weakness. Further work is needed to 
explore the relationship between self-reported impact of stiffness, using measures such 
as the MSS88, and lab based and clinician rated objective measures.     
 Knowledge about changes in stiffness that occur with pathology, and the effects of 
different interventions on stiffness, may require detailed assessment of strain using 
ultrasound as described in this chapter. It is important to acknowledge that the ultimate 
aim of many clinical interventions is to improve functional ability; measures relating to 
function, as in the MSSS-88, are also therefore relevant. Clinical trials may benefit from 
using a range of outcome measures to investigate changes at an impairment, activity 
and participation level.  
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9. Chapter Nine: Summary and Future Directions 
9.1 Introduction: 
MS is a chronic demyelinating disorder of the central nervous system (CNS) and is one 
of the leading causes of neurological disability in young adults. Pathologically MS can 
be extremely variable and multiple variants have been identified; this is predominantly 
due to differences in the site and severity of damage in the CNS. This variability leads 
to the unpredictability of the presenting signs and symptoms at disease onset; including 
altered balance and co-ordination, visual disturbances, bladder and bowel dysfunction, 
pain, fatigue, cognitive dysfunction, weakness, stiffness and spasms (Boyce, 1998). 
Increased limb stiffness, or hypertonia, is present in up to 85% of people with MS and 
is clinically observed as an increased resistance to passive movements of a limb. It is 
associated with considerable functional limitations and pain leading to reduced quality 
of life (Barber et al. 2011;  Gao et al. 2011). 
The main contributing factors to hypertonia are an increase in passive and stretch 
reflex related stiffness (spasticity) (Dietz & Sinkjaer, 2007). Currently spasticity is 
managed primarily through the use of pharmacological agents, and  non-neural passive 
stiffness is predominantly managed through the use of stretching and physical adjuncts, 
with the fundamental focus being to: maintain or improve function; prevent the 
development of secondary complications; alter patterns of spasticity and spasm 
development; minimise pain; and improve comfort (Lockley & Buchanan, 2006).  
The current literature surrounding the use of stretching for the management of 
hypertonia is inconclusive.  Although previous research and reviews demonstrate some 
areas of agreement, disparity and inconsistencies of findings are also present. It is 
possible that the disparity in the literature stems from a lack of clarity surrounding the 
nature of hypertonia unrelated to stretch reflex activation. There are varying schools of 
thought regarding the contributing mechanisms of hypertonia including: changes in the 
extracellular matrix (ECM) of muscle and tendon; changes in intramuscular proteins, 
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changes in cross bridge attachment and changes in fascicle length and sarcomere 
length/number. Consequently, it is often not possible to identify the site or construct 
most affected in people with hypertonia; this results in further confusion regarding the 
efficacy of stretching passive interventions. Moreover poor knowledge of the optimal 
parameters for stretching interventions, the varied outcome measures used, and the 
variable nature of MS, all contribute to the lack of clarity in the literature. It is evident 
that there is a lot that is unknown regarding the management of hypertonia and further 
research is required. Knowledge of the optimal parameters for treatment such as: the 
type of stretch, applied force, stretch duration and method of application are key for the 
successful rehabilitation of people with hypertonia and it is clear that the paucity of 
information in this area has important clinical and function implications.  
9.2 Aim 
This thesis therefore aimed to assess the effects of different torques applied over 
different time durations on passive stiffness, spasticity and ROM; additionally, the site 
affected by stiffness and the area targeted by stretching was investigated. The thesis 
therefore aimed to: 
a) Define the torques that are applied during commonly prescribed manual 
stretches in pwMS (Chapter 5) 
b) Investigate the effects of different levels of applied torque and durations of 
stretch  on passive stiffness, spasticity and ROM in pwMS (Chapters 6 and 7) 
c) Investigate the effects of constant torque stretching on direct measures of 
muscle  strain using ultrasonography (Chapter 8) 
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9.3 Stretching science and practice 
 
Summary of novel findings 
Torques achieved and duration of manual stretches in pwMS: 
The mean ankle torque achieved when stretching the PF muscles was higher in 
standing conditions compared to seated stretches applied using the upper limbs. It is 
feasible to postulate that the significant increase in applied torque achieved during 
standing is due to the effects of gravity and body weight providing a form of constant 
applied torque. This finding is supported by work conducted by Baker, et al (2007) who 
investigated the effects of 30 minutes of standing on a tilt table compared to an 
exercise programme, results showed that significantly greater ankle and hip ROM was 
achieved with the standing condition compared to an exercise programme. 
Furthermore, work by Odeen and Knutsson, (1981) found greater reductions in 
hypertonus with tilt table standing compared to torque applied in supine, this further 
supports the findings of this thesis that higher levels of applied torque are associated 
with a greater increase in joint ROM. Similarly, based on the meta-analysis findings 
conducted in this thesis, constant torque stretches are potentially more beneficial at 
increasing ROM and decreasing spasticity than stretching at a constant angle and 
cyclically.  
The literature surrounding stretching for the treatment of hypertonia in people with CNS 
pathology is variable and specific investigation surrounding the most efficient stretching 
parameters that can produce long term carry over is limited. This is in part due to a lack 
of understanding regarding (a) the main structures contributing to the non-reflex 
component of hypertonia (b) what parameters are the most important to target/activate 
signaling pathways that lead to remodeling and muscle growth and achieve long term 
carryover of treatment benefits and (c) paucity of research investigating long term 
changes with stretching. However, it is clear from this work and other literature in the 
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area that parameters such as applied torque, stretch duration and type of stretch are 
important factors that can significantly alter joint ROM.  
PwMS, were able to achieve similar torques compared to matched controls but were 
unable to achieve the same degree of muscle lengthening. This in part may be due to 
the fact that pwMS had a higher level of baseline passive stiffness and significantly 
greater levels of spasticity. In addition, pwMS had significantly higher EMG activation in 
both the DF and PF muscles for all stretching conditions in study 1 (Chapter 5). This 
could be either a reflection of stretch reflex activation or increased muscle activity 
required to maintain the stretch position in standing due poor underlying balance. 
Therefore, it can be speculated that the increased resistance to movement either due 
to enhanced neural (spasticity) or intrinsic stiffness in this group has negatively 
influenced the lengthening potential of the PF muscle in pwMS.  
PWMS were able to sustain a PF stretch in standing, on average, for two and a half 
minutes with greater durations of up to four minutes with more supported stretches in 
sitting or in a standing frame. The current literature demonstrates that stretch durations 
from 30 minutes up to 6 hours are required to achieve a significant change in stiffness 
in people with CNS lesions. This therefore questions both the efficacy and feasibility of 
home exercise stretching programs and passive therapeutic stretching techniques 
implemented clinically.   
Effects of torque and duration on: passive stiffness, spasticity and ROM: 
This thesis has established that higher levels of torque are associated with a greater 
increase in ROM and longer durations of stretch, results in greater reductions in 
passive stiffness and greater increase in joint ROM. Neither applied torque nor stretch 
duration was found to influence spasticity in pwMS, and no high quality literature has 
demonstrated a significant reduction in spasticity with stretching at a constant torque, 
angle or cyclically. This further questions the feasibility of current stretching techniques 
for the management of spasticity and demonstrates the need for further work in this 
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area looking at different stretching techniques such as Proprioceptive Neuromuscular 
Facilitation. 
Preliminary work on site of stretch: 
People with hemiparesis due to chronic stroke for >1 year have been shown to 
demonstrate an increase in tendon length on the paretic side in addition to decreased 
stiffness. A more compliant tendon would elongate significantly more when loaded, 
potentially altering the force generating capacity and speed of force transmission of 
muscle; this would potentially impede movement, function and lead to muscle atrophy 
and decreased energy efficiency. In the stroke population it is thought that the ECM 
surrounding muscle is abnormally stiff and lies in series with a compliant tendon 
(Winters et al. 2009).  
Similarly, people with CP have been demonstrated to have significantly shorter muscle 
fascicles in work by Mohagheghi et al. 2007. This thesis has established a significant 
relationship between passive stiffness, strain and tendon length; indicating that higher 
levels of passive stiffness are associated with increased strain in the region of the MTJ, 
in addition to increased free tendon length. This finding is supported by study 1 that 
demonstrated that pwMS were not able to achieve a similar level of muscle lengthening 
to a similar applied force and chapter 8 where a trend towards a significant group x 
time interaction was found following a stretch where the muscle length was increased 
in the control group while it decreased on average in the pwMS.  
These findings have potentially revealed a potentially important problem; if stretches 
target compliant tendons this could have a detrimental effect on the efficacy of 
therapeutic interventions, compounding the problem of shortened muscle fascicles and 
elongated tendons which are thought to affect force output. This thesis presented 
preliminary, indirect evidence that increases in strain (compliance) were seen near the 
level of the MTJ but that the more proximal part of the muscle may not elongate with 
stretching.  This further emphasizes the need for more high quality research in this 
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area and could potentially among other things explain some of the disparities currently 
present in the stretching literature.  
Understanding the cause of passive stiffness:  
It is thought that within the physiological sarcomere slack length both titin and cross 
bridge formation were the main contributing factors to passive tension formation. 
Outside this range it is thought that the ECM is the highest contributing factor to 
passive stiffness development along with a contribution due to shortened sarcomeres 
and muscle fascicles.  
Shortened sarcomeres: 
Early work by Katz and Rymer (1989) suggested that mechanical changes in the 
contractile properties of a patient with hypertonia was due to a combination of 
degenerative or atrophic morphological changes in  the muscle structure including 
muscle atrophy with collagenous and elastic tissue infiltration. Investigations looking at 
muscle cells with the ECM removed using micromechanical testing apparatus had 
shown that the muscle fibres from patients with spasticity were over twice as stiff with a 
shorter resting length compared to healthy controls, suggesting intracellular changes 
associated with hypertonia and spasticity (Friden & Lieber, 2003; Wang et al. 1993). In 
contrast Lieber and Friden (2002) who used intraoperative laser diffraction techniques 
in order to compare Flexor Carpi Ulnaris (FCU) sarcomere length in children with 
chronic wrist flexion contracture with healthy controls reported that children with wrist 
flexion contractures had muscles with normal fibre length although the sarcomeres 
within the fibers were elongated.  Elongated sarcomeres would result in a greater 
resistance to elongation at a given overall muscle length as there is a non-linear 
increase in stiffness with lengthening (Lieber & Friden, 2002). 
Titin: 
As muscle is stretched beyond its slack length the subsequent passive tension 
developed within fibres has been attributed in part to titin. It is reported to contribute an 
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estimated 90% towards passive force in skeletal muscle within the physiological 
sarcomere length. Titins’ force is thought to reposition the thick filament in the centre of 
the sarcomeres length and contribute towards the structural integrity of the sarcomere 
during myofibrillogenesis (Fukuda et al, 1998). Thus loss of titin can result in abnormal 
sarcomeric organisation which has been established in cell culture Van derv en et al. 
(2000) and within the disuse atrophy model (udaka et al., 2008). In skeletal muscle two 
types of titins are expressed in slow and fast muscle with different sizes of IG and 
PEVK segments: both segments are longer in slow than in fast muscle fibers.   
Titin develops force in a non-linear manner when stretched with an external force and it 
is reported that stretches applied externally increases the end to end length in addition 
to reduced bending movement, which results in a decrease in passive force in muscle 
(Fukuda, 2008). However, due to the intimate relationship titin has, tightly binding to 
myosin and myosin-binding protein C, sarcomere extension by external forces may 
cause mechanical strain to thick filaments via titins’ longitudinal force, allowing myosin 
attachment to actin and the formation of cross bridges in a passive state (Labeit et al., 
1992).  
Recent work by Udaka et al, (2008) reported that ultra-structural changes can occur in 
the sarcomere following long-term disuse in both a longitudinal and lateral direction; 
this is often associated with a reduction in passive and active contractile force. 
However, to date there is no definitive data demonstrating that titin is altered secondary 
to spasticity but there is circumstantial evidence suggesting that it is possible  at least 
in  cardiac muscle (Wu et al., 2002; Warren et al., 2003).   
ECM: 
The ECM has a variety of functions and plays an important role in force transmission 
and tissue structure maintenance in tendons, ligaments, bone and muscle. The study 
of muscle ECM is considerably complex, however it has been demonstrated that the 
mechanical properties of isolated single muscle fiber segments measured in muscle 
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cells from patients with CP were shown to develop passive tension at a significantly 
shorter sarcomere length and the modulus of the stress strain relationship was double 
that of healthy controls. These findings suggest that there has been noteworthy 
remodeling of either intracellular or extracellular muscle structural components such as 
collagen and titin. Additionally, work conducted in decellularizing skeletal muscle has 
shown that the modulus for single fibres is almost identical to grouped fibres that have 
had the ECM biochemically removed. In contrast, the modulus of fibre bundles with 
intact ECM was approximately five fold higher than that of single fibres, leading to 
speculation that the ECM is an extremely stiff structure encompassing relatively 
compliant muscle fibres (Winters et al., 2009). 
Crossbridges: 
The support for the role of cross bridge formation to tension development relies mainly 
on work conducted in animals.  It is thought that when a muscle fibre is stretched there 
is an initial marked increase in stiffness, termed short range stiffness, which then 
decreases (Proske & Morgan, 1999). This initial increase in stiffness is felt to be due to 
the resistance applied by attached cross bridges’ “flexural rigidity” that then breaks, 
leading to the reduction in stiffness. Importantly this short range tension depends on 
the history of the muscle, whether it is lengthen or contracted prior to application of the 
stretch.  
In addition, it is thought that the muscles of patients with chronic CNS lesions may 
experience a severe slowing of the detachment rate, producing abnormal stiffness. It is 
thought that this may be an adaptation for the loss of cerebral control of tension. 
However, without more direct evidence for cross bridge stiffness in persons with CNS 
lesions and without a clear physiological mechanism, treatment based on this 
mechanism is premature. Furthermore Hagbarth et al, (1985) suggested that cross 
bridge connections between actin and myosin filaments at rest can potentially heighten 
muscle phasic stretch reflex activity.  
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In summary, an overview of literature on passive stiffness from quite disparate sources 
highlights that many potential sources of stiffness may interact; titin may lead to 
increase cross bridge attachment and increased cross bridge attachment has been 
hypothesized to enhance the phasic stretch reflex. Therefore, future work using human 
and animal models of stiffness and tone should look at these interactions and whether 
they are affected in models of hypertonia.  
Understanding molecular pathways that lead to fibrosis: 
Skeletal muscle fibrosis is an ongoing pathological problem in people with chronic 
myopathies, involving the continual laying down of collagen and other extracellular 
matrix proteins produced by fibroblasts in place of healthy myofibers (Zhoa et al., 2008). 
Fibroblasts have an important role in tissue healing and remodeling by secreting ECM 
proteins including collagen and growth factors. However, in some instances such as in 
the case of chronic myopathies, continued fibrosis often contributes to the pathological 
process. This process is also associated with decreased strength and increased 
passive stiffness of muscle fibers (Bischoff, 1994). Therefore, identification of the 
factors that regulate fibrosis is important in order to develop effective therapeutic 
interventions.  
Atrophy in muscles is reported to be linked to muscle fibrosis and an increase in fatty 
deposits within cells; both atrophy and hypertrophy are thought to be controlled by 
interacting pathways (Naderi et al., 2009).  Myostatin, which is from the family of 
transforming growth factor beta and is expressed in skeletal muscle; is thought to 
facilitate muscle atrophy, stimulate the proliferation of muscle fibroblasts and the 
production of ECM proteins, this process involves the activation of several pathways 
including Smad,p38 MAPK, PI3K/Akt, thus directly influencing fibrosis (Glass, 2005).    
Other mediators include transforming growth factor beta1 (TGFβ-1) which is thought to 
induce a modification in satellite cells from myogenic to fibroblasts. Furthermore, 
 228 
 
muscle fibroblasts are reported to express myostatin and its receptor activin IIB 
(Rebbapragada et al., 2003).   
Current research evidence shows that in the absence of myostatin, muscle 
regeneration increases and fibrosis decreases. In addition, it has been demonstrated in 
mice that distraction of the myostatin gene leads to muscle hypertrophy and 
hyperplasia (McPherron et al., 1997). In support of this work by Schuelke et al, (2004) 
has demonstrated the function of myostatin as an inhibitor of muscle growth in humans. 
This is reported to be through the mechanism of proliferation and differentiation of 
muscle precursor cells (Wagner et al., 2005). In the absence of myostatin muscle 
regeneration following acute or chronic injury has been observed to be faster.   
Thus it is clear that the muscle atrophy pathways and fibrosis pathways are intimately 
inter-linked. Understand the pathways underlying the regulation of connective tissue, 
titin and sacromere number would allow a) us to monitor the effects of stretching 
remotely i.e. using biomarkers (b) affect fibrosis pharmacologically (c) allow us to 
directly affect atrophy-fibrosis interactions through combined physical interventions e.g. 
stretching and strengthening combined.  
The future of stretching trials and clinical implications: 
This work highlights the fact that there are several parameters that can affect stiffness. 
Both stretch duration and applied force can significantly influence the ROM achieved 
when stretching, longer stretch durations achieve a greater reduction in passive 
stiffness and increase in ROM. However, it is possible that a combination of stretching 
and strengthening is required in order to be able to use the new available range gained 
through stretching and to break the interaction between the atrophy and fibrosis 
pathways. 
 Similarly, it has been established that stretching at a constant torque can significantly 
improve the passive joint ROM achieved over a short term period. However, this form 
of stretching had no influence on spasticity and it is possible that these short term 
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stretches may be targeting the compliant tendons in people with CNS lesions as 
opposed to the potentially stiffer muscle fibers, thus potentially accentuating this 
problem. Therefore, it is feasible to postulate that therapeutic stretching that 
incorporates direct deep tissue massage to muscle fascicles could be used to target 
the stiffer muscle fibers that may not be targeted with short term stretch.  Hagbarth and 
Eklund, (1965) highlighted that brief vibration of the bellies of tendons of healthy 
muscle, which did not induce a tonic vibration reflex, caused a decrease in stiffness by 
disengaging attached cross bridges. Perhaps such mechanical agitation applied to 
muscle of patients with hypertonia after a contraction could facilitate the dislodging of 
cross bridge connections between filaments.  
Understanding how these multiple factors and interactions affect stiffness in the long 
term in humans is difficult due to the length of time required to conduct individual 
clinical trials investigating the above mentioned parameters. Therefore animal models 
of hypertonia may be more appropriate.  
The efficacy of stretch and the question as to whether stretching is “good or bad” with 
regards to its overall clinical effect is still unclear. Gunn et al, (2013), for example, has 
shown a decreased frequency of falls in people with MS and moderate stiffness (as 
measured by the MAS) compared to those with lower or higher stiffness. This 
relationship may reflect the fact that some degree of hypertonia may be useful for 
stability. In keeping with this, work by Marsden and Stevenson, (2013) investigating 
balance dysfunction in people with HSP demonstrated that postural sway was related 
to muscle paresis and decreased sensory input and importantly people with higher total 
ankle stiffness had less anterior / posterior sway which was postulated to help with 
stabilization of the body.  Thus hypertonia may not always be detrimental to functional 
activities and a greater understanding of the relationship between stiffness enhancing 
stability but decreasing movement is required and how this changes across a person’s 
lifespan and disease course. 
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9.4 Summary of Literature Review Findings 
The findings from a review of the literature indicate that stretching interventions, 
applied as part of a controlled or uncontrolled trial can significantly improve ankle ROM. 
In controlled trials the 95% CI ranged from 3.3 to 8.62o, favoring treatment. It remains 
unclear if these findings, although statistically significant, translate to a clinical 
worthwhile effect, as it is not known what constitutes a minimally significant clinical 
difference.  
It is assumed that transient stretch mediated effects may be useful for the immediate 
clinical situation however future work needs to be directed at improving understanding 
regarding the clinical utility of these improvements. The effects of stretching on passive 
stiffness and spasticity as measured using biomechanical and electrophysiological 
measures all show effect sizes whose 95% confidence limits cross zero. Therefore, it is 
unclear where the actual treatment effect lies. It is possible that the variable nature and 
presentation of stiffness/spasticity, the potential inconsistency in measures obtained 
over different treatment sessions (Cadenhead et al., 2002; Odeen, 1981; Selles et al., 
2005) and test repetitions (Nuyens et al. 2001)  have contributed to findings reported in 
the literature. Furthermore, stretching may have differential effects on the muscle and 
tendon depending on the degree of underlying stiffness (Abellaneda et al. 2009). 
Therefore, techniques to measure muscle fibre stiffness and tendon stiffness directly 
may be more sensitive at revealing changes with stretching compared to gross 
measures of the muscle-tendon stiffness. 
9.5 Summary of Experimental Findings 
Study one (Chapter five), investigated the types of forces that pwMS could achieve 
while doing common clinically prescribed stretches for the plantarflexors. Both control 
and MS groups produced higher torques in standing conditions that used body weight 
and the effect of gravity; achieving greater reductions in stiffness. Participants with MS 
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produced less torque and achieved less lengthening of the plantarflexors when using 
their arms to apply a stretch; this may potentially reflect weakness and fatigue of the 
upper limb muscles resulting in an inability to generate a significant force to stretch the 
plantarflexor muscles. A net plantarflexor ankle torque can be caused by forces 
associated with passively stretching the plantarflexors and/or actively contracting the 
plantarflexors; the inverse dynamics approach used in the current study to calculate the 
ankle torque was unable to distinguish between these possibilities. 
It was noted that people with lower functional ability as measured by the Barthel Index 
tended to favor the more supported FRAME and PULL stretching conditions whilst 
participants with higher functional ability favored the WALL and STEP stretches. 
However, no correlation was found between applied torque, level of stiffness and 
functional ability. On the basis of these results it is apparent that stretches in standing 
are more effective at improving ankle ROM and decreasing stiffness; however this may 
not be feasible for some individuals with more severe disability.  
Experiments to date using motors to apply a stretching intervention have used arbitrary 
forces/torques, thus the first study within this thesis has established novel information 
regarding the level of applied torques that can be independently produced by pwMS. 
These findings can be used to investigate the effects of stretching using motors, with 
the results being also applicable to manually applied stretches. Although gravity and 
body weight can help to stretch the ankle plantarflexors it may not be possible to apply 
similar forces to other stiff muscle groups such as the knee extensors. In such cases a 
motor may be needed to apply higher force; therefore the studies reported here could 
also help to guide the development of interventions that aim to deliver stretches using a 
motor.  
Studies two and three, reported in chapters six and seven, used a range of torques 
established in study one. They investigated the effects of a high, medium, and low 
constant torque applied over a 10 and 30 minute stretching duration. The use of a 
motor allows the stiffness of the whole muscle-tendon complex to be measured. This 
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was conducted by imposing stereotyped stretches and measuring both the mechanical 
and EMG response.  This method has the advantage that it can measure stretch-
evoked stiffness in the same units as passive stiffness. These studies indicated that 
stretching for both 10 and 30 minutes significantly improved ROM in pwMS. This is in 
line with what has been reported in the literature.  
It is clear that both applied torque and stretch duration are important factors to be 
considered when implementing interventions to improve range at the ankle in pwMS 
with hypertonia. Higher applied torques resulted in greater improvements in ROM. 
Further, a greater percentage change in ROM was seen after a 30 minute stretch 
compared to a 10 minute stretch. This implies that for participants with contracture or 
significantly reduced ROM, such as those in study  two, that both stretch duration and 
applied torque have to be considered in order to attain optimal improvement in ROM 
immediately post intervention.  
A significantly greater decrease in passive stiffness was achieved with 30 minutes of 
stretch compared to 10 minutes, suggesting that patients with enhanced passive 
stiffness would potentially benefit from longer duration stretches irrespective of the 
force applied. The level of applied torque however, had no significant effect on 
measures of passive stiffness or spasticity. It is speculated that the high variability in 
baseline passive stiffness and spasticity among participants may have resulted in the 
above finding. Additionally, overlaps in the absolute levels of applied torque between 
different conditions may also have contributed to the observed findings when torque 
levels were normalised to body weight; suggesting the importance of  absolute torque 
level applied in interventions. The small effect of the implemented stretching 
intervention on hypertonia potentially suggests the need to look at other stretching 
treatments/techniques with/without administration of anti-spasticity medication. 
Chapter eight investigated the effects of constant torque stretching on direct measures 
of muscle strain using ultrasonography. The findings suggested that pwMS have stiffer 
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muscle and more compliant tendons, which is in line with the findings in the literature. 
Muscle length was found to increase following a low torque stretch in healthy controls 
whilst this was not seen in pwMS, suggesting that their muscles are stiffer. In addition, 
higher passive stiffness was associated with longer tendons in pwMS which is 
supported by work in stroke and CP populations. One cause of this increased stiffness 
could be shortening of the muscle fascicles. Recent human studies have shown that 
muscle fascicle length can be decreased in people with CNS lesions although this has 
not been reported in pwMS to date (Gao et al. 2011; Kwah et al., 2012). Alternatively, 
changes in muscle stiffness could be due to changes in the properties of the internal 
tendon (Nakamura et al. 2011). Further work is required measuring multiple areas of 
the muscle-tendon complex to establish the exact site and cause of increased passive 
stiffness in people whose severity of stiffness varies. 
There were significantly greater levels of gastrocnemius muscle-tendon complex 
displacement and greater strain in pwMS following the 10 minute low torque stretching 
intervention. The observed increase in displacement and strain post stretch may reflect 
isolated alterations in the aponeurosis and muscle-tendon junction. Due to the ROI 
selected it was not possible to establish the effects of stretching on the muscle 
fascicles, it is therefore difficult to make any definitive statements regarding the area 
that the applied intervention was targeting. However, it is possible that the current 
stretching intervention may not be targeting the stiffest regions, therefore future work 
needs to look at a bigger ROI encompassing muscle fascicle/muscle bell as well as 
tendon complex.  
9.6 Study Limitations 
 
There are several potential factors that affect the overall study interpretation including: 
the patient group targeted, the numbers recruited, the clinical feasibility of the stretches 
applied, the outcome measures used and the relationship between the short and long 
term effects of stretching. 
 234 
 
 
 
Study participants: 
The motor system used to assess stiffness required participants to have a minimum of 
90 degrees ankle range with no inversion or eversion deformities in order to be able to 
safely use the motor. These inclusion criteria restricted the participants that could take 
part in the study and may be a contributing factor to the mild stiffness presentations of 
participants recruited. PwMS were also recruited based on their subjective reports of 
muscle stiffness. However, objective measurements indicated that the participants 
recruited, particularly in study three (Chapter seven) were not significantly stiffer from 
controls. This questions the accuracy of the subjective rating of stiffness by individuals 
with MS. It may be that subjective reports of stiffness reflect factors different from those 
objectively measured in the current study.  
Self-report measures of stiffness:  
Throughout this thesis the MSSS-88 was used at baseline to measure the subjective 
impact of muscle stiffness on aspects of daily life, including pain and function. This 
spasticity measure is unique in its attempt to try to measure the patient experience of 
spasticity (Hobart et al. 2006); it was therefore felt important to use it in this study. 
However, although the measure was published in 2006, apart from the original data 
published by the developers, a literature search highlighted that no MS studies have 
yet used this measure. While using the MSSS-88 has the advantage therefore of 
enabling unique information to be provided in this thesis (which will enable the validity 
of this measure to be further explored), it has the disadvantage of providing data that it 
not yet able to be compared to previous work.  Of note, as highlighted in appendix one, 
only the total stiffness measured at the ankle using motor driven perturbations 
correlated significantly (p=0.001, r=0.44) with section three of the MSSS-88.  The  
weak correlations between the other sections of the MSSS-88 with the objective 
measures possibly reflects the difficulty in distinguishing between the impact of 
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spasticity and passive stiffness on aspects of daily life, pain, mood, social functioning  
from other co-existing impairments such as fatigue and weakness. Further, both the 
subjective reports of stiffness (for eligibility screening) and the MSSS-88 ask about the 
effects of global symptoms rather than focusing on one body part such as the ankle. It 
is interesting that the only moderately significant correlation (r=0.44, p=0.001) was with 
a subjective rating of the impact of spasms on activities of daily living such as walking 
and lower limb movements which the ankle plantarflexors play a critical role in. 
The findings suggest the need for a more robust method of defining stiffness for the 
inclusion of participants into similar studies. Suggestions include using a clinical scale 
such as the Ashworth scale or more objective measures such as motor driven 
perturbations. Unlike the self-report measures, both of these assessments can 
specifically target the ankle plantarflexors i.e. the muscle group of interest.  This does 
not imply that subjective reports of spasticity / spasms are not potentially useful as an 
outcome measure; evaluating the impact of stretching on broader aspects such as daily 
functioning is clearly important since this is the ultimate aim of many clinical 
interventions. 
Study participant numbers: 
The sample sizes in studies two and three were based on work by Yeh et al. (2007). 
Yeh et al (20007) found an effect size of one when comparing a constant angle and 
constant torque stretch. The participant numbers required were based on the 
assumption that a similar effect size would be seen between the different levels of 
applied torque in the current thesis (see Chapter four). However, there was a large 
variability in stiffness levels pre/post stretching among the participants in studies two 
and three which affected the size of effect that could be detected. For example, for the 
measure of total stiffness, with a sample size of 14 and a standard deviation of 0.19 (as 
observed in the thesis) there would need to be a 70% difference in stiffness reduction 
with stretching between torque conditions to reach statistical significance (power=0.85; 
α=0.05). In this study there was only 50% difference in stiffness change following the 
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high and low torque stretch; this would require a sample size of 28 to detect a 
significant difference. In future, larger sample sizes and /or improved screening 
procedures as discussed above to achieve a more homogeneous population would 
therefore be required. 
Clinical feasibility of the applied stretches: 
In experiment two  a 30 minute stretch was chosen as previous work (eg Yeh et al 
2007, Bressel et al, 2002) had indicated that significant improvements of stiffness could 
be achieved over this time. As the initial study aimed to explore the impact of applied 
torque on stiffness / ROM it was decided to use a stretch duration that had previously 
been shown to be effective i.e. 30 minutes. The subsequent use of a 10 minute stretch 
was based on the finding that during the 30 minute stretch the effects seemed to 
plateau around the 10 minute mark. However, in experiment one pwMS could only 
sustain a stretch for 118-134 seconds i.e. 2 minutes. Therefore the clinical usefulness 
of these more prolonged stretches could be questioned particularly if they are expected 
to be applied manually. Future work could therefore look at even shorter stretch 
periods and / or the effects of 10 minutes of cumulative stretching. 
 
The applied torque level administered in studies two and three had to be recalculated 
from original values due to early participants not being able to tolerate the high force. 
Therefore a new high force was calculated by establishing the midpoint between the 
original high and medium values. It is possible that this adjustment to the torque level 
may have contributed to the findings regarding torque reported in chapters six, seven 
and eight; this may have been prevented if the stretching sessions had been broken up 
as mentioned above.  The fact that a similar level of motor driven stretch was not as 
well tolerated as the self-administered stretch suggests that people may perceive the 
stretch related sensation differently in the two situations. This could be due to other 
sensations being activated in either stretch (e.g. load related receptors in the self-
administered stretch) that affect peoples’ perception. Another possibility is that there 
are differences in the person’s locus of control; with the motor imposed stretch people 
 237 
 
may be more fearful and less tolerant of higher stretch related sensations, even though 
they were able to stop the stretch at any time, as they are not directly applying the 
stretch. These potential differences between motor driven and self-administered 
stretches have implications for the future use of motor driven stretches as a way of 
investigating stretching interventions, i.e. they may not be entirely applicable to clinical 
situations. 
Outcome measures used: 
The studies measured passive stiffness and stretch-evoked stiffness using motor 
driven perturbations. This measure assesses the overall stiffness of the muscle tendon 
complex as well as additional structures (e.g. joint capsule) that cross the ankle joint.  
As discussed in chapter eight, due to difficulties maintaining ankle position during 
perturbations, there is the potential for some movement of the foot during the stretch. 
Thus, the stiffness measured during the ankle perturbations may also include a 
contribution of structures in the foot such as the plantar fascia.  
Stretch-reflex related stiffness was measured as the difference between the total 
stiffness measured during a fast stretch and the passive stiffness measured during the 
slow stretch. This measure correlated with the size of the EMG evoked response 
(R2=0.3-0.4) as previously described (Marsden et al 2012) suggesting that it is a valid 
measure. However, the correlation was not perfect and errors in the estimation of limb 
weight / contribution of the manipulandum may have affected the results. The muscle 
activation will not only contribute to limb stiffness but also to the viscous, velocity 
dependent resistance. As measures were taken after the limb had stopped moving this 
viscous component was not measured. In future, assessing the effects of stretching 
and pathology on the viscous component would be interesting. This thesis defined 
spasticity as being due to an enhanced stretch reflex; this is in keeping with the 
definition of Lance (Lance 1980). However, other groups have suggested that spasticity 
is more complicated than this and potentially encompasses abnormalities, for example, 
in cutaneomuscular reflexes and co-contraction (Stevenson & Marsden, 2006). These 
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factors were not measured in the thesis and so it may be that the effects of stretching 
on all components/aspects of spasticity were not fully explored. This viewpoint depends 
on the definition of spasticity adopted. 
Chapter eight addressed some of the potential difficulties with the measurement of 
muscle / tendon stiffness with motor driven perturbation by using ultrasonography.  
However, ultrasound only provided a two dimensional view of the selected ROI and this 
may have some influence on the findings related to the muscle-tendon aponeurosis 
which is a three dimensional structure. Therefore it can be concluded that all measures 
have some drawback and that a combined approach may be useful in future clinical 
trials /studies.  
Short and Long term effects of stretching: 
This thesis looked at the short term effects of stretching on stiffness and ROM. It is 
therefore not known if the increases in ROM and decreases in stiffness are sustained 
for longer than 30 minutes, if the therapeutic effects of stretching accumulate over time 
or if they are dose related. However, monitoring stretch-induced effects over 30 
minutes post stretch provided information about the post-stretch time course. It is 
assumed that transient stretch mediated effects may be useful for the immediate 
clinical setting e.g. rehabilitation of balance and gait in the immediate post stretch 
period; although this has yet to be investigated in clinical studies.  
It is assumed that repetitive stretches that are effective at reducing stiffness in the short 
term will result in long term changes in stiffness and ROM due to tissue remodeling. 
This would require changes in the ECM and/or length of muscle fascicles and as such 
a change in protein turnover. Changes in protein turnover would in turn require a 
change in the activity of certain genes. The signal triggering this change is assumed to 
be a stretch although animal work and cellular studies have not yet elucidated the 
pathways linking stretch to a change in gene activation. 
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It may be that the stretches and associated stretch evoked signal studied in the current 
thesis are different from those leading to long term adaptive changes. Muscles behave 
in a thixotropic manner in that their stiffness is dependent on movement. When stretch 
is applied to a relaxed muscle that has been maintained in a lengthened position the 
initial resistance is lower (Lakie & Robson, 1988). It is possible that the stretches led to 
a reduction in stiffness by affecting muscle thixotropy. As discussed in chapter two, 
muscle thixotropy is felt to be generated by the breaking of stable cross bridges in the 
muscle. If the reductions in stiffness are mainly due to this mechanism rather than an 
effect, for example on the ECM or muscle fascicle, it may be that it is not possible to 
predict the long term consequences of stretching (that may target these latter 
structures) by their short term effects. The optimal parameters for a short term 
reduction in stiffness may not necessarily be the optimal parameters that lead to a long 
term reduction in stiffness. 
9.7 Future Work 
Research regarding the long term effects of stretching for the treatment of hypertonia is 
limited. Therefore future research should look at the effects of stretching in different 
patient groups over a longer term (+30 minutes/over days/weeks). However, studying 
the effects of different parameters of stretching, as performed here, may not be feasible 
in terms of time, and cost. One additional difficulty when working with pwMS is that the 
condition is progressive making it more difficult to study the longer term effects of 
stretching as it is difficult to determine whether changes are pathology related or 
intervention related.  For longer term studies, if the aim is to assess the effects of 
stretching on stiffness it may be that a chronic stroke population may provide  a more 
stable and homogeneous group.  
Further work should use combined electrophysiological and biomechanical measures 
in order to assess the effects of different stretching regimes on the time course of 
hypertonia. It is also important to establish what stimulus is required for long term 
adaptations and whether stretching in isolation is sufficient enough or whether we need 
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to address co-existing weakness in this population by combining stretching with 
strengthening exercises. In animal models of immobilization increases in muscle 
atrophy go hand in hand with increases in muscle fibrosis suggesting that these two 
processes are linked (Williams & Goldspink 1984). Therefore it may be that both 
atrophy and fibrosis need to be addressed simultaneously. 
This thesis has shown that both stretch duration and torque level are important 
considerations for increasing ankle ROM and decreasing passive stiffness. It has 
highlighted that it is important to determine not just the presence but also the site of 
any increase in passive stiffness and how this is affected by stretching. The thesis 
highlights that there are several methods of measuring limb stiffness and that a 
combined approach may be useful in future clinical trials. Therefore this thesis will help 
to inform the design of future clinical trials not just into the long term effects of 
stretching but also other physical and pharmacological interventions that target ROM 
and stiffness.   
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11. Appendix 1 
 
Comparison of MSSS88 with biomechanical measures of stiffness 
The relationship between sections 1-8 of the MSSS88 were compared with 
biomechanical measures of total stiffness, passive stiffness and stretch reflex related 
stiffness for all participants  who took part in study 1-3. All the participants had a 
progressive condition and each experiment was conducted months apart; therefore, 
each subject who participated in all three experiments was considered as a separate 
entry. 
 Comparisons were determined using a Pearson’s rank correlation; a Bonferroni 
correction was made to account for the multiple comparisons (n=24 significance taken 
P<0.05/24=0.0021). Therefore, a p value ≤ 0.0019 was considered as a significant 
relationship (see Table A1). 
Results 
Section three of the MSSS88, looks at the effect of muscle spasm on daily activities 
and limb movements; when compared with total stiffness which encompasses passive 
and stretch reflex stiffness elements, a statistical significance was observed and 
demonstrated a moderate correlation (r=0.44).  This indicated that participants who 
scored lower on section three of the MSSS88 tended to have lower total stiffness 
values (see Figure A1). 
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MS888 
Sections 
Total Stiffness Passive Stiffness Stretch Reflex 
Mediated Stiffness 
r p r p r p 
Section 1 0.34 0.01 0.22 0.10 0.28 0.04 
Section 2 0.38 0.01 0.32 0.02 0.20 0.17 
Section 3 0.44 0.001* 0.28 0.04 0.39 0.004 
Section 4 0.31 0.02 0.26 0.06 0.17 0.24 
Section 5 0.22 0.12 0.14 0.32 0.20 0.17 
Section 6 0.27 0.05 0.22 0.11 0.14 0.31 
Section 7 0.19 0.17 0.05 0.71 0.30 0.03 
Section 8 0.21 0.13 0.08 0.58 0.28 0.03 
Sum 0.33 0.01 0.22 0.10 0.26 0.04 
 
Table: A.1 Relationship between sections 1-8 of the MSSS88 and biomechanical 
measures of total stiffness, passive stiffness and stretch reflex mediated stiffness at 
baseline for all MS participants. Sum = total of sections 1-8 compared with stiffness 
measures.  * Significant following bonferonni correction for multiple comparisons 
R = Pearson’s rank correlation 
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Figure A.1: Total stiffness compared with section 3 of the MSSS88 measure of the 
effect of muscle spasm on walking in MS.  
 
 
 
 
 
 
